<SEC-DOCUMENT>0001047469-18-002075.txt : 20180323
<SEC-HEADER>0001047469-18-002075.hdr.sgml : 20180323
<ACCEPTANCE-DATETIME>20180323162244
ACCESSION NUMBER:		0001047469-18-002075
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20180424
FILED AS OF DATE:		20180323
DATE AS OF CHANGE:		20180323
EFFECTIVENESS DATE:		20180323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Innoviva, Inc.
		CENTRAL INDEX KEY:			0001080014
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943265960
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30319
		FILM NUMBER:		18710381

	BUSINESS ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		6502389600

	MAIL ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	THERAVANCE INC
		DATE OF NAME CHANGE:	20020207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED MEDICINE INC
		DATE OF NAME CHANGE:	20000302
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>a2234992zdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#18ZAE11201_1">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT> <FONT SIZE=2><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=4><B> SCHEDULE 14A</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Proxy
Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934 (Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2> Filed by the Registrant <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Filed by a Party other than the Registrant <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=3 style="font-family:times;"><FONT SIZE=2><BR>
Check the appropriate box:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Preliminary Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B> Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Proxy Statement</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Definitive Additional Materials</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Soliciting Material under &sect;240.14a-12<BR></FONT>
</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;<BR></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="17pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=5><B> INNOVIVA, INC.</B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Registrant as Specified In Its Charter)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><BR><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>


<HR NOSHADE SIZE="1.0pt" WIDTH="100%" COLOR="#000000">

</FONT> <FONT SIZE=2> (Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=5 style="font-family:times;"><FONT SIZE=2><BR>
Payment of Filing Fee (Check the appropriate box):</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#253;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>No fee required.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and&nbsp;0-11.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Title of each class of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Aggregate number of securities to which transaction applies:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Proposed maximum aggregate value of transaction:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(5)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Total fee paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Fee paid previously with preliminary materials.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><BR><FONT SIZE=2> <FONT FACE="WINGDINGS">&#111;</FONT></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD COLSPAN=3 style="font-family:times;"><BR><FONT SIZE=2>Check box if any part of the fee is offset as provided by Exchange Act Rule&nbsp;0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>(1)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><BR><FONT SIZE=2>Amount Previously Paid:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(2)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Form, Schedule or Registration Statement No.:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(3)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Filing Party:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>(4)</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>Date Filed:<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&nbsp;</TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=298239,FOLIO='blank',FILE='DISK121:[18ZAE1.18ZAE11201]BA11201A.;4',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P style="font-family:times;"><FONT SIZE=2><B>
<IMG SRC="g114007.jpg" ALT="LOGO" WIDTH="220" HEIGHT="36">
  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>March&nbsp;23,
2018 </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Dear
Fellow Innoviva Stockholder: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
am pleased to invite you to attend Innoviva,&nbsp;Inc.'s 2018 Annual Meeting of Stockholders (the "Annual Meeting"), to be held on Tuesday, April&nbsp;24, 2018 at the offices of
Gunderson Dettmer Stough Villeneuve Franklin&nbsp;&amp; Hachigian,&nbsp;LLP, 220 West 42nd&nbsp;Street, 21st&nbsp;Floor, New York, NY 10036. The Annual Meeting will begin promptly at
9:00&nbsp;a.m., local time. For directions to the Annual Meeting, please write to our Corporate Secretary at Innoviva,&nbsp;Inc., 2000 Sierra Point Parkway, Suite&nbsp;500, Brisbane, California
94005. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
Board of Directors (the "Board of Directors") is recommending a highly qualified, experienced and diverse slate of director nominees for election to the Board of Directors at the
Annual Meeting. At the Annual Meeting, we will ask you to: (1)&nbsp;elect five directors; (2)&nbsp;cast a non-binding advisory vote to approve named executive officer compensation;
(3)&nbsp;ratify the selection of Ernst&nbsp;&amp; Young&nbsp;LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending
December&nbsp;31, 2018; and (4)&nbsp;take action upon any other business as may properly come before the Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
accompanying materials include the Notice of Annual Meeting of Stockholders and proxy statement (the "Proxy Statement"). The Proxy Statement describes the business that we will
conduct at the Annual Meeting. It also provides information about us that you should consider when you vote your shares. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Also
enclosed with these proxy materials is a proxy card and postage-paid return envelope. Proxy cards are being solicited on behalf of our Board of Directors. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whether
or not you will be able to attend the Annual Meeting, it is very important that your shares be represented. We urge you to read the accompanying Proxy Statement carefully and to
use the enclosed proxy card to vote for the Board of Directors' nominees, and in accordance with the Board of Directors' recommendations on the other proposals, as soon as possible. You may vote your
shares by signing and dating the enclosed proxy card and returning it in the postage-paid envelope provided, whether or not you plan to attend the Annual Meeting. For your convenience, you may also
vote your shares via the Internet or by a toll-free telephone number by following the instructions on the enclosed proxy card. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
your brokerage firm, bank, dealer or other similar organization is the holder of record of your shares (</FONT><FONT SIZE=2><I>i.e.</I></FONT><FONT SIZE=2>, your shares are held in
"street name"), you will receive voting instructions from the holder of record. You must follow these instructions in order for your shares to be voted. Your broker is required to vote those shares in
accordance with your instructions. </FONT><FONT SIZE=2><B>We urge you to instruct your broker or other nominee, by following those instructions, to vote your shares on the proxy
card.</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Holders
of shares as of the close of business on March&nbsp;19, 2018, the record date for voting at the Annual Meeting, are urged to submit a proxy card, even if your shares were sold
after such date. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you have any questions regarding this information or the proxy materials, please visit our website at www.inva.com or contact our investor relations department at
investor.relations@inva.com. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
behalf of your Board of Directors, thank you for your continued support and interest. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Very truly yours,</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2><B>
<IMG SRC="g303095.jpg" ALT="GRAPHIC" WIDTH="132" HEIGHT="36">
 </B></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD style="font-family:times;"><BR><FONT SIZE=2>Eric d'Esparbes<BR></FONT> <FONT SIZE=2><I>Interim Principal Executive Officer, Senior Vice President and Chief Financial Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=1004031,FOLIO='blank',FILE='DISK121:[18ZAE1.18ZAE11201]BC11201A.;8',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="be11201_innoviva,_inc._2000_sierra_poi__inn04637"> </A>
<A NAME="toc_be11201_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Innoviva,&nbsp;Inc.<BR>  2000 Sierra Point Parkway, Suite&nbsp;500<BR>  Brisbane, California 94005<BR>  NOTICE OF ANNUAL MEETING OF STOCKHOLDERS<BR>  <BR>    To Be Held On April&nbsp;24, 2018    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>Dear
Stockholder: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You
are cordially invited to attend the Annual Meeting of Stockholders of Innoviva,&nbsp;Inc., a Delaware corporation (the "Company"). The meeting will be held on Tuesday,
April&nbsp;24, 2018 at 9:00&nbsp;a.m., local time, at the offices of Gunderson Dettmer Stough Villeneuve Franklin&nbsp;&amp; Hachigian,&nbsp;LLP, 220 West 42nd&nbsp;Street, 21st&nbsp;Floor,
New York, NY 10036 for the following purposes: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:75%;margin-left:12%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="65pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Proposal 1:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>To elect five directors to serve for the ensuing year.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Proposal 2:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>To approve a non-binding advisory resolution regarding executive compensation.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Proposal 3:</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>To ratify the selection by the Audit Committee of the Board of Directors of Ernst&nbsp;&amp; Young&nbsp;LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&nbsp;31,
2018.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
conduct any other business properly brought before the Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These
items of business are more fully described in the Proxy Statement accompanying this Notice. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
record date for the Annual Meeting is March&nbsp;19, 2018. Only stockholders of record at the close of business on that date may vote at the Annual Meeting or any adjournment
thereof. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>YOUR VOTE IS VERY IMPORTANT. EVEN IF YOU PLAN TO ATTEND THE ANNUAL MEETING, WE REQUEST THAT YOU READ THE PROXY STATEMENT AND VOTE YOUR SHARES BY SIGNING AND
DATING THE ENCLOSED PROXY CARD AND RETURNING IT IN THE POSTAGE-PAID ENVELOPE PROVIDED OR BY VOTING VIA THE INTERNET OR BY TELEPHONE BY FOLLOWING THE INSTRUCTIONS PROVIDED ON THE ENCLOSED PROXY
CARD.</B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you have any questions regarding this information or the proxy materials, please visit our website at www.inva.com or contact our investor relations department at
investor.relations@inva.com. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>
<IMG SRC="g303095.jpg" ALT="GRAPHIC" WIDTH="132" HEIGHT="36">
 </B></FONT><FONT SIZE=2><BR>
<BR>
Eric d'Esparbes<BR></FONT> <FONT SIZE=2><I>Interim Principal Executive Officer,<BR>
Senior Vice President and Chief Financial Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>Brisbane,
California<BR>
March&nbsp;23, 2018 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>Important Notice Regarding the Availability of Proxy Materials for the Annual<BR>
Meeting of Stockholders to be held on Tuesday, April&nbsp;24, 2018:  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> The Proxy Statement is available at http://investor.inva.com/proxy.cfm.  </B></FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=402163,FOLIO='blank',FILE='DISK121:[18ZAE1.18ZAE11201]BE11201A.;7',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_de11201_1_1"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="de11201_innoviva,_inc._2000_sierra_poi__inn04517"> </A>
<A NAME="toc_de11201_1"> </A>
<BR></FONT><FONT SIZE=2><B>  Innoviva,&nbsp;Inc.<BR>  2000 Sierra Point Parkway, Suite&nbsp;500<BR>  Brisbane, California 94005    <BR>    <BR>    PROXY STATEMENT<BR>  FOR THE 2018 ANNUAL MEETING OF STOCKHOLDERS    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This proxy statement (the "Proxy Statement") is furnished in connection with solicitation of proxies by our Board of Directors (the "Board of
Directors") for use at the 2018 Annual Meeting of Stockholders (the "Annual Meeting") to be held on Tuesday, April&nbsp;24, 2018 at 9:00&nbsp;a.m., local time, and any postponements or
adjournments thereof. The Annual Meeting will be held at the offices of Gunderson Dettmer Stough Villeneuve Franklin&nbsp;&amp; Hachigian,&nbsp;LLP, 220 West 42nd&nbsp;Street, 21st&nbsp;Floor, New
York, NY 10036. For directions to the Annual Meeting, please write to our Corporate Secretary at Innoviva,&nbsp;Inc., 2000 Sierra Point Parkway, Suite&nbsp;500, Brisbane, California 94005. As used
in this Proxy Statement, the terms "Innoviva," the "Company," "we," "us," and "our" mean Innoviva,&nbsp;Inc. and its subsidiaries unless the context indicates otherwise. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


QUESTIONS AND ANSWERS ABOUT THIS PROXY MATERIAL AND VOTING  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Why am I receiving these materials?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We sent you this Proxy Statement and the enclosed proxy card because the Board of Directors of Innoviva,&nbsp;Inc. is soliciting your proxy to
vote at the Annual Meeting to be held Tuesday, April&nbsp;24, 2018 at 9:00&nbsp;a.m., local time, and any postponements or adjournments thereof. You are invited to attend the Annual Meeting to
vote on the proposals described in this Proxy Statement. However, you do not need to attend the Annual Meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy
card, or follow the instructions on the enclosed proxy card to submit your proxy via telephone or on the Internet. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
intend to mail this Proxy Statement and accompanying proxy card on or about March&nbsp;23, 2018 to all stockholders of record entitled to vote at the Annual Meeting. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What is included in the proxy materials?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The proxy materials include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> This Proxy Statement for the Annual Meeting; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our 2017 Annual Report to Stockholders, which consists of our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2017;
and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The proxy card. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Can I attend the Annual Meeting?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You are invited to attend the Annual Meeting if you were a stockholder of record or a beneficial owner as of March&nbsp;19, 2018 (the "Record
Date"). Admission will begin at 8:30&nbsp;a.m., local time, on the date of the Annual Meeting, and you must present valid picture identification, such as a driver's license or passport, and, if
asked, provide proof of stock ownership as of the Record Date. The use of mobile phones, pagers, recording or photographic equipment, tablets and/or computers is not permitted at the Annual Meeting.
The Annual Meeting will begin promptly at 9:00&nbsp;a.m., local time. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Who can vote at the Annual Meeting?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Only stockholders of record at the close of business on the Record Date will be entitled to vote at the Annual Meeting. On the Record Date,
there were 101,143,959 shares of the Company's Common </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>1</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=629102,FOLIO='1',FILE='DISK121:[18ZAE1.18ZAE11201]DE11201A.;4',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<A NAME="page_de11201_1_2"> </A>

<P style="font-family:times;"><FONT SIZE=2>Stock,
par value $0.01 per share (the "Common Stock"), outstanding. The holders of Common Stock have the right to one vote for each share they held as of the Record Date. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with Delaware law, a list of stockholders entitled to vote at the Annual Meeting will be available at the place of the Annual Meeting on Tuesday, April&nbsp;24, 2018 and
will be accessible for ten days prior to the Annual Meeting at our principal place of business, 2000 Sierra Point Parkway, Suite&nbsp;500, Brisbane, California 94005, between the hours of
9:00&nbsp;a.m. and 5:00&nbsp;p.m., local time. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stockholder of Record: Shares Registered in Your Name  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If on the Record Date your shares were registered directly in your name with our transfer agent, Computershare, then you are a stockholder of
record. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to fill out and return the enclosed
proxy card or vote by proxy via telephone or the Internet as instructed on your proxy card to ensure your vote is counted. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Beneficial Owner: Shares Registered in the Name of a Broker or Bank  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If on the Record Date your shares were held in an account at a brokerage firm, bank, dealer or other similar organization, then you are the
beneficial owner of shares held in "street name" and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered the stockholder of
record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. If you do not provide
instructions for voting the shares that you beneficially own, that organization cannot vote your shares on the election of directors (Proposal 1)&nbsp;or on the non-binding advisory resolution
regarding executive compensation (Proposal 2). We encourage you to provide voting instructions to the brokerage firm, bank, dealer or other similar organization that is the record holder of your
shares. A number of brokers and banks enable beneficial holders to give voting instructions&nbsp;via telephone or the Internet. Please refer to the voting instructions provided by your bank or
broker. You are also invited to attend the Annual Meeting. However, since you are not the stockholder of record, you may not vote your shares in person at the Annual Meeting unless you provide a valid
proxy from your broker, bank or other custodian. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What does it mean if I receive more than one proxy card?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Many of our stockholders hold their shares in more than one account and may receive separate proxy cards or voting instructions forms for each
of those accounts. If you receive more than one proxy card, your shares are registered in more than one name or are registered in different accounts. Please sign, date and return or otherwise submit
your proxy with respect to </FONT><FONT SIZE=2><B>each</B></FONT><FONT SIZE=2> proxy card to ensure that all of your shares are voted. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you have any questions regarding this information or the proxy materials, please visit our website at </FONT><FONT SIZE=2><I>www.inva.com</I></FONT><FONT SIZE=2> or contact our
investor relations department at investor.relations@inva.com. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=5,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=750940,FOLIO='2',FILE='DISK121:[18ZAE1.18ZAE11201]DE11201A.;4',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<A NAME="page_de11201_1_3"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What am I voting on?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following chart sets forth the proposals scheduled for a vote at the Annual Meeting, our Board of Directors recommendation with respect to
such proposals, the vote required for such proposals to be approved and whether broker discretionary voting is allowed on such proposals. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="8pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="8pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="81pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="8pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="87pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="8pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="8pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-left:solid #000000 1.0pt; "><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-left:solid #000000 1.0pt; " -->


&nbsp;</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Proposal</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Board<BR>
Recommendation</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Vote<BR>
Required</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Broker<BR>
Discretionary<BR>
Voting<BR>
Allowed</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 </B></FONT><FONT SIZE=2>&nbsp;</FONT><BR></TH>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><B>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </B></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><b>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</B></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><b>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</B></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><B>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </B></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><b>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</B></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><B>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </B></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><b>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</B></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><b>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</B></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-left:solid #000000 1.0pt; "><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-left:solid #000000 1.0pt; " -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B> Proposal 1:</B></FONT><FONT SIZE=2> Elect five directors to serve until the 2019 Annual Meeting of Stockholders.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> FOR</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Majority Votes<BR>
Cast</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>No</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


</FONT> <FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-left:solid #000000 1.0pt; "><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-left:solid #000000 1.0pt; " -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B> Proposal 2:</B></FONT><FONT SIZE=2> Approval a non-binding advisory resolution regarding executive compensation.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> FOR</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Majority Votes<BR>
Cast</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>No</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


</FONT> <FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-left:solid #000000 1.0pt; "><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-left:solid #000000 1.0pt; " -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><B> Proposal 3:</B></FONT><FONT SIZE=2> Ratify the appointment of Ernst&nbsp;&amp; Young&nbsp;LLP as our independent registered public accounting firm for the year ending December&nbsp;31, 2018.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> FOR</B></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Majority Votes<BR>
Cast</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Yes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


</FONT> <FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Majority Votes Cast</I></FONT><FONT SIZE=2> means, with respect to Proposal 1, that the number of votes cast "FOR" a director's election exceeds 50% of the votes
cast with respect to that director's election and, with respect to Proposals 2 and 3, that the proposal would be approved if it receives an affirmative majority of the votes cast. For this purpose,
votes cast shall exclude abstentions and broker non-votes. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Broker Discretionary Voting</I></FONT><FONT SIZE=2> occurs when a broker does not receive voting instructions from the beneficial owner and votes those shares in
its discretion on any proposal on which it is permitted to vote. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
an uncontested election of directors, such as Proposal 1, our Bylaws mandate that directors be elected by a majority vote of votes cast, as described below under "ELECTION OF
DIRECTORS&#151;MAJORITY VOTING BYLAW." In contested elections, our Bylaws mandate that directors be elected by a plurality vote. For purposes of our Bylaws, a contested election is any election
of directors for which our Secretary determined that the number of nominees for director exceeds the number of directors to be elected as of the date seven days prior to the scheduled mailing date of
the proxy statement for such meeting. Our Secretary has determined that the election at the Annual Meeting is an uncontested election. Accordingly, the provisions of our Bylaws relating to majority
voting for directors in uncontested elections will be applicable to the Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to our Bylaws, written notice by stockholders of qualifying nominations for election to our Board of Directors must have been received by our Secretary by February&nbsp;19,
2018. We did not receive any such nominations and no other nominations for election to our Board of Directors may be made by stockholders at the Annual Meeting. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
for some reason any of the Board of Directors' nominees are unable to serve, or for good cause will not serve, if elected, the persons named as proxies may vote for a substitute
nominee recommended by the Board of Directors and, unless you indicate otherwise on the proxy card, your shares will be voted in favor of the Board of Directors' remaining nominees. As of the date of
the Notice of Annual Meeting of Stockholders, we know of no reason why any of the Board of Directors' nominees would be unable or for good cause unwilling to serve as a director if elected. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How do I vote?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;With regard to the election of directors (Proposal 1), you may (i)&nbsp;vote "</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" the five
nominees to the Board of Directors, (ii)&nbsp;vote "</FONT><FONT SIZE=2><B>Against</B></FONT><FONT SIZE=2>" the election of one or more of the nominees and vote
"</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" the remaining nominees, (iii)&nbsp;vote "</FONT><FONT SIZE=2><B>Against</B></FONT><FONT SIZE=2>" all of the nominees or (iv)&nbsp;you may
withhold your </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=6,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=896560,FOLIO='3',FILE='DISK121:[18ZAE1.18ZAE11201]DE11201A.;4',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<A NAME="page_de11201_1_4"> </A>

<P style="font-family:times;"><FONT SIZE=2>authority
to vote for any nominee you specify. You may not vote your proxy "</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" the election of any persons in addition to the five named nominees. For
Proposals 2 and 3, you may vote "</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" or "</FONT><FONT SIZE=2><B>Against</B></FONT><FONT SIZE=2>" or abstain from voting. We do not have cumulative
voting rights for the election of directors. The procedures for voting are explained below. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stockholder of Record: Shares Registered in Your Name  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you are a stockholder of record as of the Record Date, you may vote by using the enclosed proxy card, vote by proxy on the Internet or by
telephone, or vote in person at the Annual Meeting. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual
Meeting and vote in person if you have already voted by proxy. </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the postage-paid envelope
provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To vote on the Internet, please follow the instructions provided on your proxy card. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To vote by telephone, please follow the instructions provided on your proxy card. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>
<!-- BOXING PARAGRAPH(S) -->
 </FONT></P>
<DIV style="width:100%;border:solid #000000 1pt;margin-right:1pt;padding-top:6pt;padding-right:8pt;padding-bottom:7pt;padding-left:9pt;">

<P style="font-family:times;"><FONT SIZE=2><B>We provide Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions.
However, please be aware that you must bear any costs associated with your Internet access, such as usage charges from Internet access providers.</B></FONT></P>
 <p style="font-family:times;margin-bottom:-11pt;"></p>
</DIV>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Beneficial Owner: Shares Registered in the Name of a Broker or Bank  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you are a beneficial owner of shares registered in the name of your broker, bank or other agent as of the Record Date, you should have
received instructions for granting proxies with these proxy materials from that organization rather than from us. A number of brokers and banks enable beneficial holders to give voting
instructions&nbsp;via telephone or the Internet. Please refer to the voting instructions provided by your bank or broker. To vote in person at the Annual Meeting, you must provide a valid proxy from
your broker, bank or other agent. Follow the instructions from your broker, bank or other agent included with these proxy materials, or contact your broker, bank or other agent to request a proxy
form. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How many votes do I have?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On each matter to be voted upon, you have one vote for each share of Common Stock you owned as of the Record Date. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What if I return a proxy card but do not make specific choices?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you return a signed proxy card without marking any voting selections, your shares will be voted
(1)&nbsp;"</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" the election of each of the five nominees for director, (2)&nbsp;"</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" approval of
the non-binding advisory resolution regarding executive compensation and (3)&nbsp;"</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" ratification of Ernst&nbsp;&amp; Young&nbsp;LLP as our
independent registered public accounting firm for the fiscal year ending on December&nbsp;31, 2018. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
you are not a record holder (</FONT><FONT SIZE=2><I>i.e.</I></FONT><FONT SIZE=2>, your shares are held through a broker, bank, brokerage firm, dealer or other similar organization),
your broker is required to vote such shares in accordance with the instructions you provide. If you do not give instructions to your broker, your broker will not be able </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=7,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=974661,FOLIO='4',FILE='DISK121:[18ZAE1.18ZAE11201]DE11201A.;4',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<A NAME="page_de11201_1_5"> </A>

<P style="font-family:times;"><FONT SIZE=2>to
vote your shares with respect to the election of directors (Proposal 1)&nbsp;or on the non-binding advisory resolution regarding executive compensation (Proposal 2). </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What happens if additional matters are presented at the Annual Meeting?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If any other matters are properly presented for consideration at the Annual Meeting, including, among other things, consideration of a motion to
adjourn the Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting additional proxies),
the persons named in the proxy card and acting thereunder will have discretion to vote on those matters in accordance with their best judgment. We do not currently anticipate that any other matters
will be raised at the Annual Meeting. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How are votes counted?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Votes will be counted by the inspector of elections appointed for the Annual Meeting, who will separately count
"</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" and "</FONT><FONT SIZE=2><B>Against</B></FONT><FONT SIZE=2>" votes, abstentions and broker non-votes, if any. Abstentions, which will be counted
as shares present for purposes of determining a quorum, will not be considered in determining the results of the voting for any of the proposals on the agenda. Broker non-votes, if any, as described
in the next paragraph, have no effect and will not be counted toward the vote total for any of the proposals on the agenda. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
your shares are held by your broker as your nominee (that is, in "street name"), you will need to obtain a proxy form from the institution that holds your shares and follow the
instructions included on that form regarding how to instruct your broker to vote your shares. If you do not give instructions to your broker, your broker can vote your shares with respect to
"discretionary" items, but not with respect to "non-discretionary" items. Discretionary items are proposals considered routine under the rules on which your broker may vote shares held in street name
without your voting instructions. On non-discretionary items for which you do not give your broker instructions, the shares will be treated as broker non-votes. Under current broker voting rules, any
election of a member of the Board of Directors, whether contested or uncontested, is considered "non-discretionary" and therefore brokers are not permitted to vote your shares held in street name for
the election of directors in the absence of instructions from you. Each of the proposals other than Proposal 3 are "non-discretionary" and therefore if you hold your shares through a broker, bank or
other agent, your shares will not be voted on Proposals 1 or 2 unless you provide voting instructions to the record holder. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Can I change my vote after submitting my proxy?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. You may revoke your proxy in any one of four
ways:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> You may change your vote using the Internet or telephone methods described above prior to the Annual Meeting, in which case only your latest
Internet or telephone proxy submitted prior to the Annual Meeting will be counted. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> You may submit another properly completed proxy card with a later date. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> You may send a written notice that you are revoking your proxy to the Corporate Secretary of the Company at 2000 Sierra Point Parkway,
Suite&nbsp;500, Brisbane, California 94005. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> You may attend the Annual Meeting and vote in person. If you are not a record holder of shares, you must provide a "legal" proxy from the
record holder in order to vote your shares in person at the Annual Meeting. Simply attending the Annual Meeting will not, by itself, revoke your proxy. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=8,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=619035,FOLIO='5',FILE='DISK121:[18ZAE1.18ZAE11201]DE11201A.;4',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<A NAME="page_de11201_1_6"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How may my brokerage firm or other intermediary vote my shares if I fail to provide timely directions?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brokerage firms and other intermediaries holding shares of Common Stock in street name for customers are generally required to vote such shares
in the manner directed by their customers. In the absence of timely directions, your broker will have discretion to vote your shares on our sole routine matter&#151;Proposal 3 (to ratify the
appointment of Ernst&nbsp;&amp; Young&nbsp;LLP). Your broker will not have discretion to vote on the following "non-routine" matters absent direction from you: Proposal 1 (the election of directors)
or Proposal 2 (the advisory resolution regarding executive compensation). </FONT><FONT SIZE=2><B>Please note that brokers may not vote your shares on the election of directors in the absence of your
specific instructions as to how to vote, so we encourage you to provide instructions to your broker regarding the voting of your shares.</B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What is the quorum requirement?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A quorum of stockholders is necessary to hold a valid Annual Meeting. A quorum will be present if a majority of all shares outstanding on the
Record Date, are represented at the Annual Meeting by stockholders present either in person or by proxy. On the Record Date, there were 101,143,959 shares of Common Stock outstanding and entitled to
vote. Thus, 50,571,980 shares must be represented by stockholders present either in person at the Annual Meeting or by proxy to have a quorum. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Your
shares will be counted toward the quorum only if you submit a valid proxy vote or vote in person at the Annual Meeting. Abstentions and any broker non-votes will be counted toward
the quorum requirement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Is my vote confidential?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proxy instructions, ballots and voting tabulations that identify individual stockholders are handled in a manner that protects your voting
privacy. Your vote will not be disclosed either within Innoviva or to third parties, except as necessary to meet applicable legal requirements, to allow for the tabulation of votes and certification
of the vote, or to facilitate a successful proxy solicitation. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


How can I find out the results of the voting at the Annual Meeting?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published, if available, on a
Current Report on Form&nbsp;8-K that we expect to file with the SEC within four business days after the end of the Annual Meeting. If final voting results are not available to us in time to
file&nbsp;a Form&nbsp;8-K within four business days after the Annual Meeting, we intend to file&nbsp;a Form&nbsp;8-K to report preliminary results, and to file an amendment to such
Form&nbsp;8-K to report the final results within four business days after the final results are known to us. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Who is paying for this proxy solicitation?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will pay for the entire cost of soliciting proxies. In addition to these mailed proxy materials, our directors and employees may also solicit
proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may reimburse brokerage firms,
banks and other agents for the cost of forwarding proxy materials to beneficial owners. We may engage the services of a professional proxy solicitation firm to aid in the solicitation of proxies from
certain brokers, bank nominees and other institutional owners. Our costs for such services, if retained, will not be significant. If you choose to access the proxy materials and/or vote through the
Internet, you are responsible for any Internet access charges you may incur. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=9,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=370494,FOLIO='6',FILE='DISK121:[18ZAE1.18ZAE11201]DE11201A.;4',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<A NAME="page_de11201_1_7"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


What does it mean if multiple members of my household are stockholders but we only received one set of
proxy materials in the mail?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted a procedure called "householding," which the SEC has approved. Under this procedure, we deliver a single copy of the proxy
materials to multiple stockholders who share the same address unless we received contrary instructions from one or more of the stockholders. This procedure reduces our printing costs, mailing costs,
and fees. Stockholders who participate in householding will continue to be able to access and receive separate proxy cards. Upon written request, we will deliver promptly a separate copy of the Notice
of Annual Meeting of Stockholders and, if applicable, the proxy materials to any stockholder at a shared address to which we delivered a single copy of any of these documents. To receive a separate
copy of the proxy materials, stockholders should send their requests to our principal executive offices at Innoviva,&nbsp;Inc., 2000 Sierra Point Parkway, Suite&nbsp;500, Brisbane, California
94005, Attention: Corporate Secretary. Stockholders who hold shares in street name (as described below) may contact their brokerage firm, bank, broker-dealer or other similar organization to request
information about householding. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


When are stockholder proposals due for next year's Annual Meeting?  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If you wish to submit a proposal to be considered for inclusion in next year's proxy materials or nominate a director, your proposal must be in
proper form according to SEC Regulation&nbsp;14A, Rule&nbsp;14a-8 and be received by the Corporate Secretary of the Company on or before November&nbsp;23, 2018. If you wish to submit a proposal
to be presented at the 2019 annual meeting of stockholders but which will not be included in the Company's proxy materials, your Solicitation Notice, as defined in our Bylaws, must be received by the
Corporate Secretary of the Company at Innoviva,&nbsp;Inc., 2000 Sierra Point Parkway, Suite&nbsp;500, Brisbane, California 94005, Attention: Corporate Secretary, no earlier than January&nbsp;7,
2019 and no later than February&nbsp;6, 2019. You are advised to review our Bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations.
Innoviva's current Bylaws may be found on the corporate governance subsection of the investor relations section of our corporate website at </FONT> <FONT SIZE=2><I>www.inva.com</I></FONT><FONT SIZE=2>. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=10,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=750098,FOLIO='7',FILE='DISK121:[18ZAE1.18ZAE11201]DE11201A.;4',USER='JFUSS',CD='21-MAR-2018;10:45' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dg11201_1_8"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dg11201_proposal_1_election_of_directors"> </A>
<A NAME="toc_dg11201_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 1<BR>  <BR>    ELECTION OF DIRECTORS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our Board of Directors currently consists of ten directors. However, as of the Annual Meeting, the size of our Board of Directors will decrease
to five directors. The five nominees for election to the Board of Directors at the Annual Meeting, and their ages as of the Record Date, their positions and offices held with the Company and certain
biographical information are set forth below. Your proxy cannot be voted for a greater number of persons than the number of nominees named in this Proxy Statement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


The Board of Directors unanimously recommends that you vote "FOR" all of the Board of Directors'
nominees.  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
director to be elected will hold office until the next annual meeting of stockholders, or until the director's death, resignation or removal. All of the nominees listed below are
currently directors of the
Company and their nomination has been recommended by the Nominating/Corporate Governance Committee and approved by the Board of Directors. It is our policy to encourage nominees for director to attend
the Annual Meeting. Generally, we schedule our annual meeting of stockholders on the same day as a meeting of our Board of Directors to facilitate attendance by the director nominees. Five of our
seven directors serving as of our 2017 annual meeting attended the meeting in person. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
of the nominees named in this Proxy Statement have been nominated by our Board of Directors to be elected by holders of our Common Stock and each person nominated for election has
agreed to serve if elected. We are not aware of any reason why any nominee would be unable to serve as a director. If a nominee for election is unable to serve, the shares represented by all valid
proxies will be voted for the election of any other person that our Board of Directors may nominate as a substitute. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


NOMINEES  </B></FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="20pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="263pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Name </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Age </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Positions and Offices<BR>
Held With the Company </B></FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George W. Bickerstaff, III</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>62</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mark DiPaolo, Esq.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>47</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jules Haimovitz</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>67</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Odysseas D. Kostas, M.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>43</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sarah Schlesinger, M.D.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>58</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>Director</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
have determined that each of these director nominees possesses the requisite communication skills, personal integrity, business judgment, ability to make independent analytical
inquiries, and willingness to devote adequate time and effort necessary to serve as an effective member of the Board of Directors. Other specific experiences, qualifications, attributes or skills of
nominees that contributed to our conclusion that the nominees should serve as directors are noted below. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>George W. Bickerstaff III</I></FONT><FONT SIZE=2> has served as a member of our Board of Directors since December 2017 and is currently a member of the Audit
Committee of the Board of Directors (the "Audit Committee"). He currently serves as a Managing Director of M.M. Dillon&nbsp;&amp;&nbsp;Co.,&nbsp;LLC, an investment banking firm. Prior to joining
M.M. Dillon&nbsp;&amp;&nbsp;Co.,&nbsp;LLC, Mr.&nbsp;Bickerstaff held various positions with Novartis International AG, a global leader in pharmaceuticals and consumer health, including Chief
Financial Officer of Novartis Pharma AG. Mr.&nbsp;Bickerstaff currently serves on the board of directors of Inovio Pharmaceuticals,&nbsp;Inc., CareDx,&nbsp;Inc., Cardax,&nbsp;Inc. and Axovant
Sciences&nbsp;Ltd. Mr.&nbsp;Bickerstaff previously served on the board of directors of ARIAD Pharmaceuticals,&nbsp;Inc. until it was acquired by Takeda Pharmaceutical Company Limited in February
2017. Mr.&nbsp;Bickerstaff has demonstrated leadership in his </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=11,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=707984,FOLIO='8',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_9"> </A>

<P style="font-family:times;"><FONT SIZE=2>field,
his understanding of our industry and his senior management experience contributed to our conclusion that he should serve as a director. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Mark DiPaolo, Esq.</I></FONT><FONT SIZE=2> has served as a member of our Board of Directors since February 2018. Mr.&nbsp;DiPaolo has been a Partner and the
General Counsel of Sarissa Capital Management&nbsp;LP, a registered investment advisor, since May 2013. Sarissa Capital Management&nbsp;LP focuses on improving the strategies of companies to
enhance shareholder value. From 2005&nbsp;-&nbsp;2013, Mr.&nbsp;DiPaolo served as a senior member of Icahn Capital's investment team, working on all aspects of Carl Icahn's activist investment
strategy. Prior to working with Icahn Capital, Mr.&nbsp;DiPaolo was an attorney with Willkie Farr&nbsp;&amp; Gallagher&nbsp;LLP. Since August 2017, Mr.&nbsp;DiPaolo has been a member of the board
of directors of Novelion Therapeutics,&nbsp;Inc., a publicly traded biopharmaceutical company. Mr.&nbsp;DiPaolo received his B.A. degree from Fordham University and his J.D. degree from Georgetown
University. Mr.&nbsp;DiPaolo's substantial experience in operations, transactions, law and corporate governance and knowledge of our field contributed to our conclusion that he should serve as a
director. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Jules Haimovitz</I></FONT><FONT SIZE=2> has served as a member of our Board of Directors since February 2018. Mr.&nbsp;Haimovitz is currently President of
Haimovitz Consulting,&nbsp;Inc. He previously served as a member of the board of directors of Ariad Pharmaceuticals, where he was also a member of the audit committee; Dial Global,&nbsp;Inc.,
where he was also member of the audit committee; and Imclone Pharmaceuticals, where he served as chairperson of the audit committee. Mr.&nbsp;Haimovitz has also served as Chief Executive Officer or
Chief Operating Officer of the following companies: Spelling Entertainment,&nbsp;Inc., King World Productions and VJN,&nbsp;Inc. Mr.&nbsp;Haimovitz holds a B.S. and M.A. degree in Mathematics
from Brooklyn College. Mr.&nbsp;Haimovitz has demonstrated leadership in his field, his knowledge of financial and financing matters and his prior board service contributed to our conclusion that he
should serve as a director. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Odysseas D. Kostas, M.D.</I></FONT><FONT SIZE=2> has served as a member of our Board of Directors since December 2017 and is currently a member of the
Compensation Committee of the Board of Directors (the "Compensation Committee") and the Nominating/Corporate Governance Committee of the Board of Directors (the "Nominating/Corporate Governance
Committee"). He is a Partner and Senior Analyst at Sarissa Capital Management&nbsp;LP. Sarissa Capital focuses on improving the strategies of companies to enhance shareholder value. Prior to joining
Sarissa Capital, Dr.&nbsp;Kostas served as a Director at Evercore ISI (formerly ISI), covering the biotechnology and pharmaceutical industries. Previously, he practiced internal medicine as part of
the Yale New Haven Health System and was engaged as a consultant to various biotechnology companies. Dr.&nbsp;Kostas currently serves on the board of directors of Enzon Pharmaceuticals.
Dr.&nbsp;Kostas has a B.S from Massachusetts Institute of Technology (MIT) and a M.D. from University of Texas Southwestern Medical School. Dr.&nbsp;Kostas has demonstrated leadership in his
field, his knowledge of our industry and experience in our industry contributed to our conclusion that he should serve as a director. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><I>Sarah J. Schlesinger, M.D.</I></FONT><FONT SIZE=2> has served as a member of our Board of Directors since February 2018. Dr.&nbsp;Schlesinger is an Associate
Professor of Clinical Investigation at Rockefeller University and Senior Attending Physician at Rockefeller University Hospital. Dr.&nbsp;Schlesinger led the Dendritic Cell section of the Division
of Retrovirology at the Walter Reed Army Institute of Research and was also a member of the Division of Infectious and Parasitic Disease Pathology at the Armed Forces Institute of Pathology from 1994
to 2002. In 2002, Dr.&nbsp;Schlesinger rejoined Rockefeller University and began working with the International AIDS Vaccine Initiative as a Scientist in Vaccine Research and Design.
Dr.&nbsp;Schlesinger has been a member of Rockefeller University Hospital's Institutional Review Board ("IRB") (Ethics Committee) since 2003 and previously served as IRB's vice-chairperson. In 2017
she assumed the position of chairperson of the IRB. She is currently the director of the education and training programs at Rockefeller University Center for Clinical and Translational Science and
serves on the Medical Staff Executive Committee of Rockefeller University Hospital. Dr.&nbsp;Schlesinger currently serves on the board of three non-profit organizations: the AIDS Vaccines Advocacy
Coalition, Global </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=12,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=326530,FOLIO='9',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_10"> </A>

<P style="font-family:times;"><FONT SIZE=2>Viral
and The Hastings Center, the pre-eminent center for the study of bioethics. Dr.&nbsp;Schlesinger served as an independent corporate director of Ariad Pharmaceuticals from 2013 until its sale
to Takeda Pharmaceutical Company Limited in 2017. Dr.&nbsp;Schlesinger has a B.A. from Wellesley College and a M.D. from Rush Medical College in Chicago, Illinois. Dr.&nbsp;Schlesinger has
demonstrated leadership in her field and her substantial knowledge of our industry contributed to our conclusion that she should serve as a director. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Incumbent Directors Not Standing For Election  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In February 2018, each of William H. Waltrip, Patrick G. LePore, Barbara Duncan, Catherine J. Friedman and Paul A. Pepe (collectively, the
"Incumbent Directors") notified the Board of Directors that they did not intend to stand for re-election at the Annual Meeting, so that they may devote their respective efforts to other commitments.
None of the Incumbent Directors decision to not stand for reelection was the result of any disagreement with the Company relating to the Company's operations, policies or practices. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Agreement with Sarissa  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On February&nbsp;12, 2018, we entered into an agreement (the "Sarissa Agreement") with Sarissa Capital Management&nbsp;LP, and certain of
its affiliates (collectively, the "Sarissa Group"). Concurrently with the execution of the Sarissa Agreement, pursuant to resolutions approved by the Board of Directors, the total number of directors
constituting the Board of Directors was increased from eight (8)&nbsp;to ten (10)&nbsp;directors in accordance with our Amended and Restated Bylaws, and each of Jules Haimovitz, Sarah Schlesinger,
M.D. and Mark DiPaolo, Esq. were appointed as directors to fill an existing and the resulting vacancies on the Board of Directors with a term expiring at the Annual Meeting or until their respective
successors have been duly elected and qualified. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Sarissa Agreement, we also agreed, among other things, to (a)&nbsp;convene the Annual Meeting no later than May&nbsp;1, 2018, and to not postpone or adjourn (once
convened) the Annual Meeting without the prior written consent of the Sarissa Group, and (b)&nbsp;nominate a five-person slate for election as directors at the Annual Meeting consisting solely of
Odysseas Kostas, M.D., George Bickerstaff, III, Jules Haimovitz, Sarah Schlesinger, M.D. and Mark DiPaolo, Esq. If prior to the Annual Meeting, any of the foregoing nominees is unable to serve or
informs us that he or she does not wish to serve or ceases to serve (or indicates to us his or her desire to cease to serve) as a director for any reason, the Sarissa Group will have the ability to
identify a replacement, subject to the provisions of the Sarissa Agreement. We also agreed to reimburse the Sarissa Group for its reasonable out-of-pocket fees and expenses (including legal expenses)
in an aggregate amount of up to $2.7&nbsp;million. In addition, we agreed that prior to the completion of the Annual Meeting, we will not, without the prior written consent of the Sarissa Group,
(i)&nbsp;increase the size of (or support any person who is seeking to increase the size of) the Board of Directors or fill any vacancy on the Board of Directors, or (ii)&nbsp;amend our
certificate of incorporation or bylaws. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Sarissa Agreement further provides that, so long as we have not materially breached the Sarissa Agreement, the Sarissa Group will, and will cause its affiliates to, vote all of the
shares of Common Stock that are beneficially owned by them as of the record date for the 2018 Annual Meeting for the election of each of Odysseas Kostas, M.D., George Bickerstaff, III, Jules
Haimovitz, Sarah Schlesinger, M.D. and Mark DiPaolo, Esq. at the Annual Meeting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Required Vote for Proposal 1  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The affirmative vote of a majority of the votes cast at the Annual Meeting is required for the election of each of the director nominees. You
may vote "</FONT><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2>" or "</FONT><FONT SIZE=2><B>AGAINST</B></FONT><FONT SIZE=2>" on each of the nominees for election as director. Shares represented by
signed proxy cards will be voted on Proposal 1 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=13,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=139746,FOLIO='10',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_11"> </A>

<P style="font-family:times;"><FONT SIZE=2>"</FONT><FONT
SIZE=2><B>FOR</B></FONT><FONT SIZE=2>" the election of Messrs.&nbsp;Bickerstaff, Haimovitz and DiPaolo and Drs. Kostas and Schlesinger to the Board of Directors at the Annual Meeting,
unless otherwise marked on the card. Pursuant to our Amended and Restated Bylaws, a majority of votes cast means that the number of votes cast "</FONT><FONT SIZE=2><B>FOR</B></FONT><FONT SIZE=2>" a
director's election must exceed fifty percent (50%) of the number of votes cast with respect to that director's election. For this purpose, votes cast shall exclude abstentions and broker non-votes. A
broker non-vote with respect to the election of a director will not be voted with respect to such director, although it will be counted for purposes of determining whether there is a quorum. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to our Corporate Governance Guidelines, as amended, each of Messrs.&nbsp;Bickerstaff, Haimovitz and DiPaolo and Drs. Kostas and Schlesinger will be required to tender an
irrevocable, conditional resignation that will be effective only upon both (i)&nbsp;the failure of such director to receive the required vote at the Annual Meeting for reelection and (ii)&nbsp;our
board of directors' acceptance of such resignation. If any of the director nominees fail to receive the required vote for reelection, the Nominating/Corporate Governance Committee of our Board of
Directors will act on an expedited basis to determine whether to accept such director's resignation, and it will submit its recommendation for prompt consideration by our Board of Directors. The
Nominating/Corporate Governance Committee and the Board of Directors may consider any factors they deem relevant in deciding whether to accept a director's resignation. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS</B></FONT><BR><FONT SIZE=2><B>A VOTE "FOR" EACH OF THE COMPANY'S NOMINEES.</B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=14,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=623982,FOLIO='11',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_12"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


INDEPENDENCE OF THE BOARD OF DIRECTORS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As required under the listing standards of The Nasdaq Global Market ("Nasdaq"), a majority of the members of a Nasdaq-listed company's board of
directors must qualify as "independent," as affirmatively determined by its board of directors. Our Board of Directors consults with counsel to ensure that the Board of Directors' determinations are
consistent with all relevant laws and regulations regarding the definition of "independent," including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management
and counsel have reviewed the directors' responses to a questionnaire asking about their transactions, relationships and arrangements with the Company (and those of their
immediate family members) and other potential conflicts of interest. Other than as set forth in this Proxy Statement, these questionnaires did not disclose any transactions, relationships or
arrangements that question the independence of our directors. After reviewing this information, our Board of Directors affirmatively determined that all of our directors are independent directors
within the meaning of the applicable Nasdaq listing standards. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


ELECTION OF DIRECTORS&#151;MAJORITY VOTING BYLAW  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On February&nbsp;8, 2017, we amended and restated our Bylaws to implement a majority voting standard in uncontested elections of directors.
The majority voting standard provides that a director shall be elected to the Board of Directors by the vote of the majority of the votes cast at any meeting for the election of directors at which a
quorum is present. Under such a "majority voting standard," the number of votes cast "</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" the election of a nominee must exceed fifty percent (50%) of
the number of votes cast with respect to that nominee's election. Under a majority voting standard, abstentions and broker non-votes would not be counted as votes cast either
"</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" or "</FONT><FONT SIZE=2><B>Against</B></FONT><FONT SIZE=2>" a director's election and will thus have no effect in determining whether the
requisite vote had been obtained. However, in the event of a contested election of directors, directors shall be elected by the vote of a plurality of the votes cast at any meeting held for the
election of directors at which a quorum is present. A contested election means any election of directors for which the Secretary of the Company determined that the number of nominees for director
exceeds the number of directors to be elected as of the date seven days prior to the scheduled mailing date of the proxy statement for such meeting. In a contested election, stockholders shall not be
permitted to vote against any nominee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to our Corporate Governance Guidelines, as amended, the Board of Directors shall nominate for election or reelection as director only candidates who have tendered, in advance of
such nomination, an irrevocable, conditional resignation that will be effective only upon both (i)&nbsp;the failure to receive the required vote at the next stockholders' meeting at which such
person faces reelection and
(ii)&nbsp;the Board of Directors' acceptance of such resignation. In addition, the Board of Directors shall fill director vacancies and new directorships only with candidates who agree to tender,
promptly following their appointment to the Board of Directors, the same form of resignation tendered by other directors in accordance with our Corporate Governance Guidelines, as amended. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
the Corporate Governance Guidelines, as amended, if an incumbent director fails to receive the required vote for reelection, the Nominating/Corporate Governance Committee will act
on an expedited basis to determine whether to recommend that the Board of Directors accept such director's irrevocable, conditional resignation, and the Nominating/Corporate Governance Committee shall
submit such recommendation for prompt consideration by the Board of Directors. The Board of Directors shall decide whether or not to accept such resignation and shall promptly disclose and explain its
decision in a Current Report on Form&nbsp;8-K (or successor form) filed with the SEC within ninety&nbsp;(90) days after the date the results of the relevant election are certified by the inspector
of elections. An incumbent director whose resignation is under consideration shall abstain from participating in the Nominating/Corporate Governance Committee's deliberations and recommendation
regarding such </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=15,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=625675,FOLIO='12',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_13"> </A>

<P style="font-family:times;"><FONT SIZE=2>resignation
as well as the Board of Directors' deliberations and its decision regarding such resignation. The Nominating/Corporate Governance Committee may consider any factors it deems relevant in
deciding whether to recommend that the Board of Directors accept a director's resignation. In deciding whether to accept a director's resignation, the Board of Directors shall consider the
recommendation of the Nominating/Corporate Governance Committee, the factors considered by the Nominating/Corporate Governance Committee and any additional information and factors that the Board of
Directors believes to be relevant. If the incumbent director's resignation is not accepted by the Board of Directors, he or she shall continue to serve until his or her successor is elected and
qualified, or until sooner displaced. If the Board of Directors accepts such an incumbent director's resignation or if a nominee who failed to receive the required vote is not an incumbent director,
the Board of Directors may fill the resulting vacancy or decrease the size of the Board of Directors in accordance with the Company's Bylaws. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


INFORMATION REGARDING THE BOARD OF DIRECTORS AND ITS COMMITTEES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As required under Nasdaq listing standards, our independent directors meet in regularly scheduled executive sessions at which only independent
directors are present. The Chairman of the Board of Directors typically presides over these executive sessions. The Board of Directors has an Audit Committee, a Compensation Committee, a
Nominating/Corporate Governance Committee
and a Stock Option Committee. The following table provides membership and meeting information for each of the Board of Directors' committees during 2017: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="27pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Director

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Audit </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Compensation </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nominating/<BR>
Corporate<BR>
Governance </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Option </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael W. Aguiar</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Barbara Duncan</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Catherine J. Friedman</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Patrick G. LePore</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Paul A. Pepe</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(4)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James L. Tyree<SUP>(6)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>William H. Waltrip</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total meetings in fiscal year 2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>10</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>8</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>7</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(7)</SUP></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Appointed
Chairperson of the Compensation Committee on July&nbsp;20, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Appointed
on July&nbsp;20, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Appointed
as a member and Chairperson of the Nominating/Corporate Governance Committee on March&nbsp;3, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Appointed
on July&nbsp;20, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Resigned
as a member and Chairperson of the Nominating/Corporate Governance Committee on March&nbsp;3, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(6)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Resigned
from the Board of Directors and as a member and Chairperson of the Compensation Committee and as a member of the Nominating/Corporate
Governance Committees on June&nbsp;2, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(7)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
Stock Option Committee did not meet in 2017.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=16,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=263096,FOLIO='13',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_14"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table provides membership and meeting information for each of the Board of Directors' committees as of the Record Date: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="27pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="67pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="103pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Director


<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Audit </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Compensation </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Nominating/Corporate<BR>
Governance </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George W. Bickerstaff,&nbsp;III<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Barbara Duncan</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Catherine J. Friedman</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Odysseas D. Kostas, M.D.<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Patrick G. LePore</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Paul A. Pepe</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>William H. Waltrip</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Current
Committee Chairperson.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Bickerstaff
joined the Audit Committee on January&nbsp;4, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Ms.&nbsp;Friedman
resigned from the Audit Committee on January&nbsp;4, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Dr.&nbsp;Kostas
joined the Compensation Committee and Nominating/Corporate Governance Committee on January&nbsp;4, 2018.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
of the Record Date, there were no members of the Stock Option Committee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Below
is a description of each committee of the Board of Directors. The Board of Directors has determined that each member of the Audit Committee, the Compensation Committee and the
Nominating/Corporate Governance Committee meets the applicable rules and regulations regarding "independence" and that each such member is free of any relationship that would interfere with his
individual exercise of independent judgment with regard to the Company. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Audit Committee  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee oversees our accounting practices, systems of internal controls, enterprise risk management and financial reporting
processes. For this purpose, the Audit Committee performs several functions. The Audit Committee determines and approves the engagement of the independent auditors; determines whether to retain or
terminate the existing independent
auditors or to appoint and engage new independent auditors; reviews and approves all audit and permissible non-audit services provided by our independent auditors; confers with management and the
independent auditors regarding the effectiveness of internal controls, financial reporting processes and disclosure controls; reviews our overall enterprise risk management framework, consults with
management and the independent auditors regarding our policies governing financial risk management; reviews and discusses reports from the independent auditors on critical accounting policies used by
us; establishes procedures, as required under applicable law, for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing
matters and the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; reviews and approves related-person transactions in accordance
with our policies and procedures with respect to related-person transactions and applicable Nasdaq rules; reviews the financial statements to be included in our Annual Report on Form&nbsp;10-K; and
discusses with management and the independent auditors the results of the annual audit and the results of quarterly reviews and any significant changes in our accounting principles. Our Audit
Committee charter can be found on the corporate governance section of our corporate website at </FONT><FONT SIZE=2><I>www.inva.com</I></FONT><FONT SIZE=2>. The current members of the Audit Committee
are George Bickerstaff, Barbara Duncan and Paul A. Pepe (Chairperson). The Audit Committee met ten (10)&nbsp;times during 2017. Prior to or promptly following </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>14</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=17,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=604824,FOLIO='14',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_15"> </A>

<P style="font-family:times;"><FONT SIZE=2>the
Annual Meeting, we expect the Board to appoint directors to the Audit Committee following the expiration of the current Audit Committee members' terms. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board of Directors annually reviews the Nasdaq listing standards definition of independence for Audit Committee members and has determined that all current and prospective members of
our Audit Committee are independent (as independence is currently defined in the Nasdaq listing standards). The Board of Directors has determined that Paul A. Pepe is an audit committee financial
expert as defined by Item&nbsp;407(d) of Regulation&nbsp;S-K. The Board of Directors made a qualitative assessment of Mr.&nbsp;Pepe's and level of knowledge and experience based on a number of
factors, including his post-graduate education in finance and many years of relevant experience. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Committee  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee reviews and approves our overall compensation strategy and policies. Specifically, the Compensation Committee reviews
and approves corporate performance goals and objectives relevant to the compensation of our executive officers and other senior management; reviews and approves the compensation and other terms of
employment of our principal executive officer and other executive officers; approves the individual bonus programs in effect for the principal executive officer, other executive officers and key
employees for each fiscal year;
recommends to the Board of Directors the compensation of the directors; recommends to the Board of Directors the adoption or amendment of equity and cash incentive plans and approves the adoption of
and amendments to these plans; grants stock options and other equity awards; administers our equity incentive plans and similar programs; monitors application of stock ownership guidelines; and
administers, concurrently with the Board of Directors, the executive officer recoupment policy. A more detailed description of the Compensation Committee's functions can be found in the Compensation
Committee's charter, which is published in the corporate governance section of our website at </FONT><FONT SIZE=2><I>www.inva.com</I></FONT><FONT SIZE=2>. The current members of the Compensation
Committee are Barbara Duncan, Catherine&nbsp;J.&nbsp;Friedman (Chairperson), Odysseas Kostas, M.D. and Paul Pepe. All current members of the Compensation Committee are independent (as independence
is defined for board members in the Nasdaq listing standards and as independence is defined for compensation committee members in the Nasdaq listing standards). Prior to or promptly following the
Annual Meeting, we expect the Board to appoint directors to the Compensation Committee following the expiration of the current Compensation Committee members' terms. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee met eight (8)&nbsp;times during 2017. Neither our former chief executive officer nor current Interim Principal Officer participates in the determination of
his own compensation or the compensation of directors. However, they may make recommendations to the Compensation Committee regarding the amount and form of the compensation of the other executive
officers and key employees, and may participate in the Compensation Committee deliberations about their compensation. No other executive officers participate in the determination of the amount or form
of the compensation of executive officers or directors. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee has retained Frederic W. Cook&nbsp;&amp;&nbsp;Co. ("FW Cook") as its independent compensation consultant. FW Cook serves at the pleasure of the Compensation
Committee rather than our management and its fees are approved by the Compensation Committee. FW Cook provides the Compensation Committee with data about the compensation paid by our peer group and
other employers who compete with us for executives, updates the Compensation Committee on new developments in areas that fall within the Compensation Committee's jurisdiction and is available to
advise the Compensation Committee regarding all of its responsibilities. FW Cook also provides data and recommendations concerning the compensation of directors. The Compensation Committee has
assessed the independence of FW Cook pursuant to SEC rules and concluded that no conflict of interest exists that would prevent FW Cook from independently representing the Compensation Committee. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>15</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=18,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=92806,FOLIO='15',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_16"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Compensation Committee, in consultation with FW Cook, reviews and approves the overall strategy for compensating members of the Board of Directors. Specifically, the Compensation
Committee reviews the compensation of the directors and recommends to the Board of Directors any changes to the compensation of the directors. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Nominating/Corporate Governance Committee  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Nominating/Corporate Governance Committee is responsible for identifying, reviewing and evaluating candidates to serve as directors of the
Company (consistent with criteria approved by the Board of Directors), evaluating and making recommendations to the Board of Directors concerning stockholder nominees for election as directors,
reviewing and evaluating incumbent directors, recommending to the Board of Directors for selection candidates for election to the Board of Directors, making recommendations to the Board of Directors
regarding the membership of the committees of the Board of Directors, assessing the performance of the Board of Directors and advising the Board of Directors on corporate governance principles for the
Company. Our Nominating/Corporate Governance Committee charter can be found on the corporate governance section of our corporate website at </FONT> <FONT SIZE=2><I>www.inva.com</I></FONT><FONT SIZE=2>. The current members of the Nominating/Corporate
Governance Committee are Catherine Friedman, Odysseas Kostas, M.D. and Patrick G. LePore
(Chairman). Prior to or promptly following the Annual Meeting, we expect the Board to appoint directors to the Nominating/Corporate Governance Committee following the expiration of the current
Nominating/Corporate Governance Committee members' terms. All current members of the Nominating/Corporate Governance Committee are independent (as independence is currently defined in the Nasdaq
listing standards). The Nominating/Corporate Governance Committee met seven (7)&nbsp;times during 2017. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Nominating/Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including being able to read and understand basic
financial statements and having the highest personal integrity and ethics. The Nominating/Corporate Governance Committee also considers such factors as having relevant expertise upon which to be able
to offer advice and guidance to management, sufficient time to devote to our affairs, demonstrated excellence in his or her field, the ability to exercise sound business judgment and the commitment to
rigorously represent the long-term interests of our stockholders. However, the Nominating/Corporate Governance Committee retains the right to modify these qualifications from time to time. Candidates
for director nominees are reviewed in the context of the current composition of our Board of Directors, our operating requirements and the long-term interests of our stockholders. While we do not have
a formal policy on diversity, our Nominating/Corporate Governance Committee considers diversity of experience as one of the factors it considers in conducting its assessment of director nominees,
along with such other factors as it deems appropriate given the then current needs of the Board of Directors and the Company, to maintain a balance of knowledge, experience and capability. In the case
of incumbent directors, our Nominating/Corporate Governance Committee reviews such directors' overall service to the Company during their term, including the number of meetings attended, level of
participation, quality of performance, and any other relationships and transactions that might impair such directors' independence. In the case of new director candidates, the Nominating/Corporate
Governance Committee also determines whether the nominee must be independent for Nasdaq purposes, which determination is based upon applicable Nasdaq listing standards, applicable SEC rules and
regulations and the advice of counsel, if necessary. The Nominating/Corporate Governance Committee uses its network of contacts to compile a list of potential candidates, but may also engage, if it
deems appropriate, a professional search firm. The Nominating/Corporate Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible
candidates after considering the function and needs of the Board of Directors. The Nominating/Corporate
Governance Committee meets to discuss and consider such candidates' qualifications and then selects a nominee for recommendation to the Board of Directors by majority vote. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>16</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=19,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=233202,FOLIO='16',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<A NAME="page_dg11201_1_17"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Nominating/Corporate Governance Committee will consider director candidates recommended by stockholders and evaluate them using the same criteria as candidates identified by the
Board of Directors or the Nominating/Corporate Governance Committee for consideration. If a stockholder of the Company wishes to recommend a director candidate for consideration by the
Nominating/Corporate Governance Committee, the stockholder recommendation should be delivered to the Corporate Secretary of the Company at the principal executive offices of the Company, and must
include information regarding the candidate and the stockholder making the recommendation as required by the Stockholder&#151;Director Communications Policy. Our
Stockholder&#151;Director Communications Policy can be found on the corporate governance section of our website at </FONT><FONT SIZE=2><I>www.inva.com</I></FONT><FONT SIZE=2>. </FONT></P>

<UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Stock Option Committee  </I></FONT></P>

</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Stock Option Committee, of which our former chief executive officer and director was the sole member in 2017, may grant equity awards under
the 2012 Equity Incentive Plan (the "2012 Incentive Plan") to employees who are not executive officers. During 2017, the Stock Option Committee did not meet. The Stock Option Committee does not
currently have any members. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of Catherine J. Friedman, Patrick LePore and Paul Pepe served on the Compensation Committee during 2017 and James L. Tyree served on the
Compensation Committee until his resignation from the Board of Directors on June&nbsp;2, 2017. None of the members of the Compensation Committee was at any time during the 2017 fiscal year (or at
any other time) an officer or employee of the Company. None of our executive officers serves as a member of the board of directors or compensation committee of any entity that has one or more
executive officers serving as a member of our Board of Directors or our Compensation Committee. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


BOARD LEADERSHIP STRUCTURE  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Waltrip has served as lead independent director since April 2005 and as Chairman of the Board of Directors since October 2014. As the
lead independent director and as Chairman, Mr.&nbsp;Waltrip coordinates the activities of the other independent directors, including coordinating an appropriate schedule of Board of Directors and
committee meetings, suggesting agenda topics for meetings of the Board of Directors, coordinating on the quality, quantity and timeliness of information submitted by management to independent
directors, developing agendas for and serving as chairman of the executive sessions of the Board of Directors' independent directors, discussing the results of the Chief Executive Officer's
performance evaluation with the Chairman of the Compensation Committee and, together with the Compensation Committee Chairman, delivering the results of the evaluation to the Chief Executive Officer,
and coordinating with the Corporate Secretary responses to questions and/or concerns from stockholders, employees or other interested parties. Prior to or promptly following the Annual Meeting, we
expect the Board to appoint a director to succeed Mr.&nbsp;Waltrip as Chairman upon expiration of his term as a director at the Annual Meeting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Board of Directors has determined to separate the roles of Chairman and Chief Executive Officer. Separating these positions allows our Chief Executive Officer to focus on our
day-to-day business, while further enabling the Chairman of the Board of Directors to lead the Board of Directors in its fundamental role of providing advice to and independent oversight of
management. Our Board of Directors recognizes the time, effort and energy that our Chief Executive Officer is required to devote to his position in the current business environment, as well as the
commitment required to serve as our Chairman of the Board of Directors, particularly as the Board of Directors' oversight responsibilities continue to grow. We believe that having separate positions
and having an independent outside director serve as Chairman of the Board of Directors is the appropriate leadership structure for our Company at this time and demonstrates our commitment to good
corporate governance. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>17</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=10,SEQ=20,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=949922,FOLIO='17',FILE='DISK121:[18ZAE1.18ZAE11201]DG11201A.;14',USER='CHE107203',CD='21-MAR-2018;15:01' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_di11201_1_18"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


RISK OVERSIGHT MANAGEMENT  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee reviews our overall enterprise risk management framework, including our overall risk exposures and our processes around the
management and monitoring of such risks, and the allocation of responsibilities for specific risk areas across our management, the Board of Directors and committees of the Board of Directors. The
Audit Committee will discuss with our management our major financial, legal, reporting and compliance risk exposures and the steps management has taken to monitor and control such exposures, including
our risk assessment and risk management policies and guidelines. The Compensation Committee oversees risks related to our compensation programs and discusses with management its annual assessment of
our employee compensation policies and programs. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


MEETINGS OF THE BOARD OF DIRECTORS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors met forty-one (41)&nbsp;times during 2017. Each director attended 75% or more of the aggregate of the meetings of the
Board of Directors and of the committees on which he or she served, held during the period for which such member was a director or committee member. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholders interested in communicating with the Board of Directors or a particular director should send correspondence to
Innoviva,&nbsp;Inc. at 2000 Sierra Point Parkway, Suite&nbsp;500, Brisbane, California 94005, Attention: Corporate Secretary. Each communication should set forth (i)&nbsp;the name and address of
the stockholder as it appears on the Company's books and, if the Common Stock is held by a brokerage firm or other intermediary, the name and address of the beneficial owner of the Common Stock and
(ii)&nbsp;the number of shares of the Company's Common Stock that are owned of record by the record holder and beneficially by the beneficial owner. Pursuant to our stockholder-director
communications policy, the Corporate Secretary has been instructed, in his discretion, to screen out communications from stockholders that are not related to the duties and responsibilities of the
Board of Directors. If deemed an appropriate communication, the Corporate Secretary will forward such communication, depending on the subject matter, to the chairperson of a committee of the Board of
Directors or a particular director, as appropriate. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


CODE OF BUSINESS CONDUCT  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has adopted the Innoviva,&nbsp;Inc. Code of Business Conduct that applies to all directors, officers and employees. The Code of
Business Conduct, as amended and restated on May&nbsp;1, 2017, is available on the corporate governance section of our website at </FONT><FONT SIZE=2><I>www.inva.com</I></FONT><FONT SIZE=2>. If the
Company makes any substantive amendments to the Code of Business Conduct or grants any waiver from a provision of the Code of Business Conduct to any executive officer or director, the Company will
promptly disclose the nature of the amendment or waiver as required by applicable law. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
non-employee directors receive both cash and equity compensation for services provided as a director. Equity compensation is structured as periodic automatic grants under a program
implemented under our 2012 Equity Incentive Plan, which are non-discretionary. In October 2017, both the cash and equity components of our compensation program for our non-employee directors were
amended, effective immediately, as described below. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash Compensation.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Prior to the October 2017 amendment of our non-employee director compensation program, each member of our Board of
Directors who
was not an employee was paid the following retainers for Board of Directors and committee service:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> $50,000 annual retainer for service as a member of our Board of Directors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an additional $25,000 annual retainer for service as the lead independent director of our Board of Directors (provided such individual was not
then serving as chairman of our Board); </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>18</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=21,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=626782,FOLIO='18',FILE='DISK121:[18ZAE1.18ZAE11201]DI11201A.;10',USER='CHE107203',CD='21-MAR-2018;15:03' -->
<A NAME="page_di11201_1_19"> </A>
<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an additional $50,000 annual retainer for service as the chairman of our Board of Directors; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> $10,000 annual retainer for service as a member of our Audit Committee; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an additional $15,000 annual retainer for service as the chairperson of our Audit Committee; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> $10,000 annual retainer for service as a member of our Compensation Committee; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> an additional $12,500 annual retainer for service as the chairperson of our Compensation Committee; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> $5,000 annual retainer for service as a member of our Nominating/Corporate Governance Committee; and </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> An additional $7,500 annual retainer for service as the chairperson of our Nominating/Corporate Governance Committee. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2017, the lead independent director retainer was eliminated and the retainer paid to the chairman of our board was reduced to $25,000 per year. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
members of our Board of Directors are also eligible for reimbursement for their expenses incurred in attending Board of Directors' meetings in accordance with Company policy. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity Compensation.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Prior to the October 2017 amendment of our non-employee director compensation program, our non-employee directors
received the
following initial equity awards upon joining our Board of Directors and annual equity awards in connection with each annual meeting of stockholders:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Annual Equity Awards&#151;Upon the conclusion of each regular annual meeting of stockholders, each non-employee director who continued
to serve as a member of the Board of Directors was automatically granted an RSU award covering a number of shares of our Common Stock equal to $250,000 divided by the closing price of a share of our
Common Stock on the date of grant, rounded down to the nearest whole share. Each annual RSU award vested on the sooner of the next annual stockholder meeting or the one year anniversary of the date of
grant, subject to the director's continuous service through such date. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Initial Equity Awards&#151;On the date of joining our Board of Directors, each new non-employee director was automatically granted a
one-time initial RSU award covering a number of shares of our Common Stock equal to $250,000 divided by the closing price of a share of our Common Stock on the date of grant, rounded down to the
nearest whole share. This initial RSU award vested in two equal annual installments over the director's first two years of service. In addition, the new non-employee director also received the annual
equity award described above (if joining on the date of our annual meeting of stockholders) or a pro-rated annual equity award (if joining on any other date) that vested on the sooner of the next
annual stockholder meeting or the one-year anniversary of the date of grant. The size of each pro-rated annual equity award was based on the number of whole months remaining until the anniversary of
the prior year's stockholders' meeting. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
October 2017, the value of the annual equity awards was reduced to $225,000 and the value of the initial equity awards was reduced to $125,000. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
RSU awards granted to our non-employee directors pursuant to the automatic grant program will vest in full if the Company is subject to a change in control or the director dies while
in service and will be settled in shares of our Common Stock on the vesting date. RSU awards granted to our non-employee directors pursuant to the automatic grant program after October 2017 will also
vest in full if the director becomes disabled while in service. Additionally, all RSU awards granted to our non-employee directors pursuant to the automatic grant program carry dividend equivalent
rights to be </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>19</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=22,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=132582,FOLIO='19',FILE='DISK121:[18ZAE1.18ZAE11201]DI11201A.;10',USER='CHE107203',CD='21-MAR-2018;15:03' -->
<A NAME="page_di11201_1_20"> </A>

<P style="font-family:times;"><FONT SIZE=2>credited
with an amount equal to all cash dividends paid on the underlying shares of our Common Stock while unvested, which are paid in cash upon vesting. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the automatic RSUs described above, directors are also eligible to receive other equity awards under our 2012 Equity Incentive Plan. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reductions in Non-Employee Director Compensation.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In October 2017, the following reductions were made to the cash and equity
compensation payable to
our non-employee directors:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The lead independent director retainer was eliminated; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The annual retainer paid to the chairman of our Board of Directors was reduced to $25,000; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The value of the annual equity awards described above was reduced to $225,000; and </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
value of the initial equity awards described above was reduced to $125,000. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Director Compensation Table  </I></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth all of the compensation awarded to, earned by, or paid to each person who served as a director during 2017, other
than a director who also served as a named executive officer. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="72pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Name </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fees Earned or<BR>
Paid in Cash<BR>
($)<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards<BR>
($)<SUP>(2)(3)(4)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(h)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George Bickerstaff, III<SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,766</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>199,989</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>201,755</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Barbara Duncan</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>60,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>250,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>310,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Catherine J. Friedman</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>77,846</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>250,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>327,846</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Odysseas Kostas, M.D.<SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,766</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2><SUP>(6)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>199,989</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>201,755</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Patrick G. LePore</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>70,382</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>250,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>320,382</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Paul A. Pepe</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>81,602</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>250,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>331,601</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>James L. Tyree<SUP>(7)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>32,788</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>250,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>282,788</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>William H. Waltrip</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>105,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>250,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>355,000</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
the annual retainers earned or paid to each director.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
amounts in these columns represent the aggregate grant date fair value of stock awards granted to the director during 2017 computed in accordance
with FASB ASC Topic 718. See Note&nbsp;6 of the notes to our consolidated financial statements in our Annual Report on Form&nbsp;10-K filed with the SEC on February&nbsp;23, 2018 for a
discussion of all assumptions made by the Company in determining the grant date fair value of our equity awards.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>As
of December&nbsp;31, 2017, the directors held outstanding RSUs under which the following number of shares of our Common Stock are issuable:
Mr.&nbsp;Bickerstaff, III (14,513); Ms.&nbsp;Duncan (31,314); Ms.&nbsp;Friedman (35,027); Dr.&nbsp;Kostas (14,513); Mr.&nbsp;LePore (32,664); Mr.&nbsp;Pepe (35,027); and Mr.&nbsp;Waltrip
(27,442).
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>As
of December&nbsp;31, 2017, the following directors held outstanding options to purchase the following number of shares of our Common Stock:
Ms.&nbsp;Friedman (15,170); Mr.&nbsp;Pepe (15,170); Mr.&nbsp;Tyree (15,170); and Mr.&nbsp;Waltrip (45,510).
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Appointed
as a director on December&nbsp;19, 2017.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(6)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>These
fees were paid to Sarissa Capital Management&nbsp;LP.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(7)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Tyree
resigned as a director on June&nbsp;2, 2017.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>20</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=23,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=335007,FOLIO='20',FILE='DISK121:[18ZAE1.18ZAE11201]DI11201A.;10',USER='CHE107203',CD='21-MAR-2018;15:03' -->
<A NAME="page_di11201_1_21"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


NON-EMPLOYEE DIRECTOR STOCK OWNERSHIP GUIDELINES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In July of 2010, the Board of Directors adopted stock ownership guidelines for non-employee directors. Pursuant to these guidelines, beginning
on the later of July&nbsp;20, 2015 or after five years of service, non-employee directors are expected to hold shares of our Common Stock (including RSUs, and whether or not vested) with a value
equal to at least three times their annual base cash retainer. The guidelines were amended in October of 2017 to increase the number of shares our non-employee directors are expected to hold to a
value equal to at least ten times their annual cash retainer. Our non-employee directors have five years from the date of the amendment to comply with the increased guideline. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
non-employee directors with at least one year of service on our Board of Directors own sufficient shares of our Common Stock or unvested RSUs to satisfy the stock ownership
guidelines, as amended. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>21</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=24,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=386659,FOLIO='21',FILE='DISK121:[18ZAE1.18ZAE11201]DI11201A.;10',USER='CHE107203',CD='21-MAR-2018;15:03' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dk11201_1_22"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk11201_proposal_2"> </A>
<A NAME="toc_dk11201_1"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 2    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk11201_advisory_vote_on_executive_compensation"> </A>
<A NAME="toc_dk11201_2"> </A></FONT> <FONT SIZE=2><B>  ADVISORY VOTE ON EXECUTIVE COMPENSATION    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In accordance with SEC rules, stockholders are being asked to approve, on a non-binding advisory basis, the compensation of our named executive
officers as disclosed in this Proxy Statement. This is commonly referred to as a "Say-On-Pay" proposal. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices
described in this Proxy Statement. As described further in the "Security Ownership of Certain Beneficial Owners and Management" section of this Proxy Statement, beginning on page 26, including the
"Compensation Discussion and Analysis" and the related tables and narrative, the primary goals of our compensation program are to fairly compensate employees, attract and retain highly qualified
employees, motivate the performance of our employees towards, and reward the achievement of, clearly defined corporate goals, and align our employees' long-term interests with those of our
stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017
was a successful year for Innoviva, as we met or exceeded the majority of the corporate goals that were set for the year. Additionally, our stock price appreciated in value from
$10.70 per share at the end of 2016 to $14.19 per share at the end of 2017. The year was highlighted by record revenues, operating profits and cash flow which were enabled by strong commercial
performance of RELVAR&reg;/BREO&reg; ELLIPTA&reg;, ANORO&reg; ELLIPTA&reg;, and the initiation of sales by our partner, Glaxo Group Limited (GSK), in the U.S.
market of TRELEGY&reg; ELLIPTA&reg;. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following
the 2017 Say-On-Pay vote, where approval by our stockholders was lower than in prior years, our Compensation Committee implemented a number of changes in connection with 2018
compensation decisions, and which are further highlighted in the "Compensation Discussion and Analysis." It is also anticipated that following the Annual Meeting our Compensation Committee will be
comprised of three members, none of whom served as directors or members of our Compensation Committee at the time that 2017 compensation decisions were made. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
accordance with Section&nbsp;14A of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), we are asking stockholders to vote on the following resolution: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>RESOLVED</B></FONT><FONT SIZE=2>, that the Company's stockholders approve the compensation of the Company's named executive officers as disclosed in the 2017
Summary Compensation Table and the accompanying tables and narrative, including "Compensation Discussion and Analysis." </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Say-On-Pay vote is advisory, and therefore not binding on our Compensation Committee or Board of Directors. Our Board of Directors and our Compensation Committee value the opinions
of our stockholders, however, and will carefully review and consider the voting results when evaluating our executive compensation programs. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS<BR>
A VOTE "FOR" PROPOSAL 2.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>22</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=25,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=105814,FOLIO='22',FILE='DISK121:[18ZAE1.18ZAE11201]DK11201A.;13',USER='CHE105540',CD='21-MAR-2018;19:03' -->
<A NAME="page_dk11201_1_23"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk11201_proposal_3"> </A>
<A NAME="toc_dk11201_3"> </A>
<BR></FONT><FONT SIZE=2><B>  PROPOSAL 3    <BR>    </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk11201_ratification_of_selection_of_i__rat02991"> </A>
<A NAME="toc_dk11201_4"> </A></FONT> <FONT SIZE=2><B>  RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee has selected Ernst&nbsp;&amp; Young&nbsp;LLP, independent registered public accounting firm, as our independent auditors for
the fiscal year ending December&nbsp;31, 2018 and has further directed that management submit the selection of independent auditors for ratification by the stockholders at the Annual Meeting.
Ernst&nbsp;&amp; Young&nbsp;LLP has audited our financial statements since 1996. Representatives of Ernst&nbsp;&amp; Young&nbsp;LLP are expected to be present at the Annual Meeting. They will have an
opportunity to make a statement if they so desire and will be available to respond to appropriate questions. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither
our Bylaws nor other governing documents or law require stockholder ratification of the selection of Ernst&nbsp;&amp; Young&nbsp;LLP as our independent registered public
accounting firm. However, the Board of Directors is submitting the selection of Ernst&nbsp;&amp; Young&nbsp;LLP to the stockholders for ratification as a matter of good corporate practice. If the
stockholders fail to ratify the selection, the Audit Committee of the Board of Directors will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee of
the Board of Directors in its discretion may direct the appointment of different independent auditors at any time during the year if it determines that such a change would be in the best interests of
the Company and its stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
affirmative vote of the holders of a majority of the shares present in person or represented by proxy and entitled to vote at the Annual Meeting will be required to ratify the
selection of Ernst&nbsp;&amp; Young&nbsp;LLP. Abstentions will be counted toward the tabulation of votes cast on proposals presented to the stockholders and will have the same effect as negative
votes. Broker non-votes are counted toward a quorum, but are not counted for any purpose in determining whether this matter has been approved. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table represents aggregate fees billed or to be billed to the Company for the fiscal years ended December&nbsp;31, 2017 and December&nbsp;31, 2016 by Ernst&nbsp;&amp;
Young&nbsp;LLP, our principal accountant. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="30pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Fiscal Year<BR>
Ended<BR>
December&nbsp;31, </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2017 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>2016 </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(in thousands)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Fees<SUP>(1)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>730</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>568</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Audit Related Fees<SUP>(2)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>87</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Tax Fees<SUP>(3)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>264</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>300</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All Other Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:20pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total Fees</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>994</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>955 </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="TOP">
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>For
professional services rendered for the integrated audits of annual financial statements, including the audit of annual financial statements for the
years ended December&nbsp;31, 2017 and 2016 and the audit of internal control over financial reporting as of December&nbsp;31, 2017 and 2016. For the years ended December&nbsp;31, 2017 and 2016,
the audit fees also include the review of quarterly financial statements included in our quarterly reports on Form&nbsp;10-Q, fees for services associated with our registration statements, and
accounting consultations.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Audit
related fees for the year ended December&nbsp;31, 2016 include the audits associated with the royalties earned from the collaboration
arrangement with GlaxoSmithKline for the year ended December&nbsp;31, 2015.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Tax
fees include tax compliance, advisory and planning services.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All
fees described above were pre-approved by the Audit Committee. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>23</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=26,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=44397,FOLIO='23',FILE='DISK121:[18ZAE1.18ZAE11201]DK11201A.;13',USER='CHE105540',CD='21-MAR-2018;19:03' -->
<A NAME="page_dk11201_1_24"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


PRE-APPROVAL POLICIES AND PROCEDURES  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee's policy is to pre-approve all audit and permissible non-audit services rendered by Ernst&nbsp;&amp; Young&nbsp;LLP, our
independent registered public accounting firm. The Audit Committee pre-approves specified services in defined categories of audit services, audit-related services and tax services up to specified
amounts, as part of the Audit Committee's approval of the scope of the engagement of Ernst&nbsp;&amp; Young&nbsp;LLP or on an individual case-by-case basis before Ernst&nbsp;&amp; Young&nbsp;LLP is
engaged to provide a service. The Audit Committee has determined that the rendering of the services other than audit services by Ernst&nbsp;&amp; Young&nbsp;LLP is compatible with maintaining the
principal accountant's independence. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><B> THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS<BR>
A VOTE "FOR" PROPOSAL 3.  </B></FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>24</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=27,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=388121,FOLIO='24',FILE='DISK121:[18ZAE1.18ZAE11201]DK11201A.;13',USER='CHE105540',CD='21-MAR-2018;19:03' -->
<A NAME="page_dk11201_1_25"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dk11201_report_of_the_audit_committee(1)"> </A>
<A NAME="toc_dk11201_5"> </A>
<BR></FONT><FONT SIZE=2><B>  REPORT OF THE AUDIT COMMITTEE(1)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee has reviewed and discussed with our management the audited financial statements of the Company included in our Annual Report
on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2017 (the "10-K"). </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Audit Committee has also reviewed and discussed with Ernst&nbsp;&amp; Young&nbsp;LLP the audited financial statements in the 10-K. In addition, the Audit Committee discussed with
Ernst&nbsp;&amp; Young&nbsp;LLP those matters required to be discussed by the auditors with the Audit Committee under Public Company Accounting Oversight Board (the "PCAOB") Audit Standard
No.&nbsp;1301, </FONT><FONT SIZE=2><I>Communications with Audit
Committees</I></FONT><FONT SIZE=2>. Additionally, Ernst&nbsp;&amp; Young&nbsp;LLP provided to the Audit Committee the written disclosures required by PCAOB Ethics and Independence Rule&nbsp;3526, </FONT> <FONT SIZE=2><I>Communication with Audit
Committees Concerning Independence</I></FONT><FONT SIZE=2> and discussed with Ernst&nbsp;&amp; Young&nbsp;LLP the independent auditors' independence. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
upon the review and discussions described above, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in the Company's 10-K
for filing with the SEC. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Submitted
by the following members of the Audit Committee: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Paul A. Pepe, Chairman<BR>
George W. Bickerstaff, III<BR>
Barbara Duncan</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
<HR NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT"> </FONT></P>

 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
material in this report is not "soliciting material," is not deemed "filed" with the SEC and is not to be incorporated by reference in any filing of Innoviva
under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>25</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=28,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=302662,FOLIO='25',FILE='DISK121:[18ZAE1.18ZAE11201]DK11201A.;13',USER='CHE105540',CD='21-MAR-2018;19:03' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dm11201_1_26"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dm11201_security_ownership_of_certain___sec02525"> </A>
<A NAME="toc_dm11201_1"> </A>
<BR></FONT><FONT SIZE=2><B>  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT    <BR>    </B></FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information known to us regarding beneficial ownership of our voting securities as of March&nbsp;19,
2018 by:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> each person known by us to be the beneficial owner of more than 5% of any class of our voting securities; </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> our named executive officers; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> each of our directors; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> all executive officers and directors as a group. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beneficial
ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Except as noted by footnote, and
subject to community property laws where applicable, the persons named in the table below have sole voting and investment power with respect to all shares of Common Stock shown as beneficially owned
by them. The table below is based upon information supplied by officers, directors and principal stockholders and Schedules&nbsp;13G filed with the SEC. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
table lists applicable percentage ownership based on 101,143,959 shares of Common Stock outstanding as of March&nbsp;19, 2018. Options to purchase shares of our Common Stock that
are exercisable within 60&nbsp;days of March&nbsp;19, 2018 and RSUs that may be settled on or within 60&nbsp;days of March&nbsp;19, 2018 are deemed to be beneficially owned by the persons
holding these options for the purpose of computing percentage ownership of that person, but are not treated as outstanding for the purpose of computing any other person's ownership percentage. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Beneficial Ownership </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and Address of Beneficial Owner<SUP>(1)</SUP>

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percent of Total<BR>
Outstanding Common<BR>
Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>5% Stockholders</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>GlaxoSmithKline&nbsp;plc<SUP>(2)</SUP><BR>
980 Great West Road<BR>
Brentford<BR>
Middlesex<BR>
TW8&nbsp;9GS<BR>
United Kingdom</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
32,005,260</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
31.64</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>FMR&nbsp;LLC<SUP>(3)</SUP><BR>
245 Summer Street<BR>
Boston, MA 02210</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
13,794,465</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
13.64</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>The Vanguard Group<SUP>(4)</SUP><BR>
100 Vanguard Blvd.<BR>
Malvern, PA 19355</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
7,161,282</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
7.08</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>BlackRock,&nbsp;Inc.<SUP>(5)</SUP><BR>
55 East 52<SUP>nd</SUP>&nbsp;Street<BR>
New York, NY 10022</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
11,291,145</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
11.16</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>26</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=29,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=453366,FOLIO='26',FILE='DISK121:[18ZAE1.18ZAE11201]DM11201A.;11',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_dm11201_1_27"> </A>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="86pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="102pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Beneficial Ownership </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name and Address of Beneficial Owner<SUP>(1)</SUP>

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percent of Total<BR>
Outstanding Common<BR>
Stock </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>Named Executive Officers and Directors</B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael W. Aguiar<SUP>(6)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
987,740</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George W. Bickerstaff, III<SUP>(7)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
5,442</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mark DiPaolo, Esq<SUP>(8)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
2,427</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Barbara Duncan<SUP>(9)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
40,861</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Catherine J. Friedman<SUP>(10)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
88,975</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Jules Haimovitz<SUP>(11)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
14,627</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Odysseas D. Kostas, M.D<SUP>(12)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
5,442</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Patrick G. LePore<SUP>(13)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
45,471</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Paul A. Pepe<SUP>(14)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
88,975</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Sarah J. Schlesinger, M.D<SUP>(15)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
2,427</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>William H. Waltrip<SUP>(16)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
207,299</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George Abercrombie, RPh, MBA<SUP>(17)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
405,750</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Eric d'Esparbes<SUP>(18)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
384,866</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael Faerm<SUP>(19)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
121,637</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Theodore Witek, Jr., Dr.P.H.<SUP>(20)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
172,805</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
*</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-top:10pt;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>All current executive officers and directors as a group (13 persons)<SUP>(21)</SUP></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
1,465,367</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>
1.44</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>*</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Less
than one percent.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Unless
otherwise indicated, the address for each beneficial owner is c/o Innoviva,&nbsp;Inc., 2000 Sierra Point Parkway, Suite&nbsp;500, Brisbane,
California 94005.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
on a Schedule&nbsp;13D/A filed with the SEC on April&nbsp;13, 2017. Shares are held of record by Glaxo Group
Limited&nbsp;("GGL"), a limited liability company organized under the laws of England and Wales and a wholly-owned subsidiary of GlaxoSmithKline&nbsp;plc ("GSK"), an English public
limited company.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
various individuals, funds and entities that are deemed to be the beneficial owners of these shares, and the individuals, funds and entities
having sole and shared voting power over these shares, are set forth in the Schedule&nbsp;13G/A filed on February&nbsp;13, 2018 and on which the information reported herein is based.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
on a Schedule&nbsp;13G/A filed with the SEC on February&nbsp;7, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
on a Schedule&nbsp;13G/A filed with the SEC on February&nbsp;8, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(6)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Aguiar
resigned as President, Chief Executive Officer and director effective February&nbsp;6, 2018. Information is based on Company
records as of the time of Mr.&nbsp;Aguiar's resignation and subsequent transactions of which the Company has been made aware of through March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(7)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
5,442 shares subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(8)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
2,427 shares subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(9)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
19,857 shares subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(10)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes:
(i)&nbsp;15,170 shares subject to stock options exercisable within 60&nbsp;days of March&nbsp;19, 2018 and (ii)&nbsp;19,857 shares
subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(11)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
2,427 shares subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(12)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
5,442 shares subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(13)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
19,857 shares subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>27</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=30,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=497826,FOLIO='27',FILE='DISK121:[18ZAE1.18ZAE11201]DM11201A.;11',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_dm11201_1_28"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(14)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes:
(i)&nbsp;15,170 shares subject to stock options exercisable within 60&nbsp;days of March&nbsp;19, 2018 and (ii)&nbsp;19,857 shares
subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(15)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
2,427 shares subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(16)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes:
(i)&nbsp;45,510 shares subject to stock options exercisable within 60&nbsp;days of March&nbsp;19, 2018 and (ii)&nbsp;19,857 shares
subject to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(17)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes:
(i)&nbsp;233,424 restricted shares subject to performance-based and time-based vesting and (ii)&nbsp;95,833 shares subject to stock
options exercisable within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(18)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
286,458 restricted shares subject to performance-based and time-based vesting.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(19)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Faerm
resigned as Senior Vice President and Chief Business Officer and director effective February&nbsp;7, 2018. Information is based on
Company records as of the time of Mr.&nbsp;Faerm's resignation.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(20)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
117,188 shares subject to stock options exercisable within 60&nbsp;days of March&nbsp;19, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(21)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
an aggregate of 288,871 shares subject to options exercisable within 60&nbsp;days of March&nbsp;19, 2018, 117,450&nbsp;shares subject
to RSUs that will settle within 60&nbsp;days of March&nbsp;19, 2018 and 519,882 restricted shares subject to performance-based and time-based vesting. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


SECTION&nbsp;16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;16(a) of the Exchange Act requires our directors, executive officers, and holders of more than 10% of our Common Stock to file
reports regarding their ownership and changes in ownership of our securities with the SEC, and to furnish us with copies of all Section&nbsp;16(a) reports that they file. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe that during the fiscal year ended December&nbsp;31, 2017, our directors, executive officers, and greater than 10% stockholders complied with all applicable
Section&nbsp;16(a) filing requirements. In making these statements, we have relied upon a review of the copies of Section&nbsp;16(a) reports furnished to us and written representations from
certain parties that no other reports were required. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>28</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=31,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=193810,FOLIO='28',FILE='DISK121:[18ZAE1.18ZAE11201]DM11201A.;11',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_do11201_1_29"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="do11201_compensation_discussion_and_analysis"> </A>
<A NAME="toc_do11201_1"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION DISCUSSION AND ANALYSIS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This section discusses our executive compensation polices and decisions and the most important factors relevant to an analysis of these policies
and decisions. It provides qualitative information regarding the manner and context in which compensation is awarded to and earned by our named executive officers and offers perspective on the data
presented in the tables and narrative that follow. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
2017, our "named executive officers" include:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Michael W. Aguiar, our former President and Chief Executive Officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Eric d'Esparbes, our Senior Vice President and Chief Financial Officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> George B. Abercrombie, our Senior Vice President and Chief Commercial Officer; </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Theodore J. Witek, Jr., our Senior Vice President and Chief Scientific Officer; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Michael E. Faerm, our former Senior Vice President and Chief Business Officer. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
February&nbsp;6, 2018, Mr.&nbsp;d'Esparbes was appointed interim Principal Executive Officer. Mr.&nbsp;d'Esparbes succeeded Mr.&nbsp;Aguiar following his resignation as
President and Chief Executive Officer. Mr.&nbsp;d'Esparbes has continued to serve as our Senior Vice President and Chief Financial Officer while acting as interim Principal Executive Officer. In
addition, on February&nbsp;7, 2018, Mr.&nbsp;Faerm resigned as our Senior Vice President and Chief Business Officer. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Executive Summary  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017 was a successful year for Innoviva, as we met or exceeded the majority of the corporate goals that were set for the year. The year was
highlighted by record revenues, operating profits and cash flow which were enabled by strong commercial performance of RELVAR&reg;/BREO&reg; ELLIPTA&reg;, ANORO&reg;
ELLIPTA&reg;, and the initiation of sales by our partner, Glaxo Group Limited (GSK), in the U.S. market of TRELEGY&reg; ELLIPTA&reg;. Specific highlights included the
following:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Our stock price appreciated in value from $10.70 per share at market close on December&nbsp;30, 2016 (the last trading day of 2016) to $14.19
per share at market close on December&nbsp;29, 2017 (the last trading day of 2017). </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Royalties earned in 2017 reached $227.9&nbsp;million, up 56% from 2016. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Net royalty revenues in 2017 were $214.1&nbsp;million, compared to $132.7&nbsp;million in 2016, an increase of 61% during the period. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Net income attributable to Innoviva stockholders in 2017 was up 125% compared to 2016, reaching $134.1&nbsp;million (or $1.25 per basic
share), compared to $59.5&nbsp;million in 2016 (or $0.54 per basic share). </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Corporate Governance Policies  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have the following corporate governance policies that complement our executive compensation program: </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Stock Ownership Guidelines that were adopted in February 2012 require each of our executive officers to own shares and share equivalents equal in value to a multiple of base salary,
specifically six times salary for the CEO and two times salary for the other executive officers. Officers are required to be in compliance with these guidelines by the five year anniversary of the
adoption of the guidelines, or, if later, by the five year anniversary of their commencement of service as an executive officer. Thereafter, compliance will be measured annually. If, at the compliance
measurement date, the executive officer does not meet the guideline, then until such officer is in compliance, he or </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>29</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=32,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=85470,FOLIO='29',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<A NAME="page_do11201_1_30"> </A>

<P style="font-family:times;"><FONT SIZE=2>she
will be expected to hold 50% of the after-tax Innoviva shares acquired thereafter, whether by option exercise, vesting or settlement of equity awards, or an open-market purchase. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Recoupment Policy, or clawback policy, permits the Company to recoup a portion of executive officers' cash bonuses in the event the Company is required to prepare an accounting
restatement due to material noncompliance with financial reporting requirements, to the extent that the bonus is earned based on financial metrics that are the subject of the restatement. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Philosophy and Objectives  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The primary goal of our executive compensation program is to maintain a compensation program that fairly compensates employees, allows us to
attract and retain highly qualified employees, motivates the performance of employees towards clearly defined corporate goals, rewards goal achievement and aligns employees' long-term interests with
those of our stockholders. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
June 2014, we successfully separated our drug discovery and development business into a separate publicly traded company, following which we transformed our business from a drug
discovery company to a company focused on royalty management. In connection with such transformation, our philosophy has been to transition from a pay model that emphasized the drug pipeline-driven
business of a research and development company to a compensation program that is better suited to a company that manages the royalties of its biopharmaceutical portfolio. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
believe the skills and experience required to be successful managing the drug portfolio include not only those of a biopharmaceutical executive, including both commercial and
development functions, but also experience in maximizing the value of long-lived financial assets. Our Compensation Committee continues to evaluate our executive compensation practices in light of our
new business model and the needs of our business. Our Compensation Committee has reviewed peer group data for context when making compensation decisions, but the Company does not target a particular
level of relative compensation. Instead our Compensation Committee applies its discretion and business judgment to make individual compensation decisions. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Committee  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Following the Annual Meeting, the Compensation Committee is expected to be comprised of three members, none of whom served as directors or
members of the Compensation Committee at the time that 2017 compensation decisions were made. During 2017, the Compensation Committee was comprised of three independent members of the Board of
Directors. The
Compensation Committee's primary responsibilities are to review the performance of our management in achieving corporate objectives and to assure that the named executive officers as well as other
members of senior management are compensated effectively in a manner consistent with our compensation philosophy and competitive practice. Historically and in connection with 2017 compensation
decisions, our CEO has assessed the contributions of senior management relative to the corporate goals and made a recommendation to the Compensation Committee with respect to any merit increase in
salary, cash bonus (based on the fiscal year's cash bonus pool for all employees determined by the Compensation Committee) and annual equity award for each member of the executive team, other than
himself. In addition, the Compensation Committee met with the CEO to evaluate, discuss and modify or approve these recommendations. The Compensation Committee also conducted a similar evaluation of
the CEO's contributions when the CEO was not present, and determined any increase in salary, cash bonus and annual equity award for the CEO. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Vote on Executive Compensation  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At our 2017 annual meeting of stockholders, approximately 53% of our stockholders voted "</FONT><FONT SIZE=2><B>For</B></FONT><FONT SIZE=2>" a
non-binding advisory resolution approving the compensation of our named executive officers, as </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>30</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=33,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=267480,FOLIO='30',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<A NAME="page_do11201_1_31"> </A>

<P style="font-family:times;"><FONT SIZE=2>disclosed
in the proxy statement for that meeting. However, this followed a 2016 vote in which 91% of our stockholders voted "For" our executive compensation program. The Compensation Committee makes
the majority of its executive officer pay decisions in the first quarter of each year, so most 2017 compensation decisions were made prior to the 2017 stockholder vote. After the 2017 vote and
following discussions with stockholders and the Compensation Committee's independent executive compensation consultant, the Compensation Committee implemented a number of changes in connection with
its 2018 compensation decisions. These changes are not reflected in our named executive officer's 2017 compensation as our 2017 compensation programs were already in place at the time of the advisory
vote. The changes that the Compensation Committee made for 2018 included:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Freezing base salaries and target bonuses for our named executive officers. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Setting fewer goals for our annual bonus plan with weightings determined in advance. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Increasing the proportion of performance-based to time-based equity awards that are granted annually from 33% to at least 50%. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> For the 2018 performance-based equity awards: (i)&nbsp;measuring performance after three years only, rather than after two and three years;
and (ii)&nbsp;capping the payout at 75% of target if absolute total shareholder return over the performance period is negative. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
connection with such compensation changes for 2018, our Compensation Committee also determined that funding for our 2017 annual bonuses would not exceed actual EBITDA achievement
versus the pre-established 2017 EBITDA goal. As further discussed below, actual 2017 annual bonuses were only paid at target despite overachievement of the 2017 EBITDA goal. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Compensation Consultant  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has the authority under its charter to engage the services of outside advisors, experts and others to assist the
Compensation Committee. In accordance with this authority and as described in the "Compensation Committee" section beginning on page 15, the Compensation Committee confers from time to time with its
independent executive compensation consultant, FW&nbsp;Cook. FW&nbsp;Cook is retained by and reports directly to the Compensation Committee and its role is to assist and advise the Compensation
Committee on matters related to compensation for executive officers, other key employees and non-employee directors. FW Cook does not work on projects for management except as an agent of the
Compensation Committee and with the advance knowledge and approval of the Chairman of the Compensation Committee. The Compensation Committee has the sole authority to retain and dismiss its outside
compensation consultants. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Peer Group  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In making compensation decisions, our Compensation Committee refers to comparative compensation data from a group of peer companies. The peer
group utilized for compensation decisions in 2017 was established in July 2015. The peer group was focused on other biopharmaceutical companies that were of similar size, were primarily focused on
commercial activities (as opposed to drug discovery activities), and relied on other organizations for direct product promotion and sales. The criteria utilized in selecting the peer group was focused
on companies with a commercial drug, market capitalizations between 0.5&nbsp;-&nbsp;2.5 times our market capitalization at the time the peers were chosen (range of about $600&nbsp;million to
$5&nbsp;billion in light of our $2.1&nbsp;billion market capitalization at the time), limited or no internal sales force and an emphasis on companies without compounds in phase&nbsp;3 of
research and development. In selecting peer companies, market capitalization was emphasized since it directly affects equity compensation values and is the relevant metric in terms of stockholder
value managed by the executive team on behalf of stockholders. Our market capitalization at the time the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>31</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=34,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=437722,FOLIO='31',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<A NAME="page_do11201_1_32"> </A>

<P style="font-family:times;"><FONT SIZE=2>peer
group was selected was $2.1&nbsp;billion compared to a peer group median of $2&nbsp;billion. Our peer group established in July 2015 consists of the following companies: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>AMAG Pharmaceuticals</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Anacor</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Arena Pharmaceuticals</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>ARIAD Pharmaceuticals</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Dyax</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Halozyme</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Immunogen</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Insys</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Ironwood&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Ligand Pharmaceuticals&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Mannkind</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Momenta Pharmaceuticals&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Nektar Therapeutics</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Orexigen</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Pacira</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>PDL BioPharma,&nbsp;Inc.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Compensation Committee typically revisits our peer group every two years. Accordingly, in October 2017, a revised peer group was established for use in evaluating 2018 compensation
decisions. The goal of the review was to reduce the size range utilized for market capitalization while focusing on drug development companies with at least one commercial drug, a small employee
population and no internal sales force. Our Compensation Committee believes that these criteria reflect our labor market as well as the key characteristics of our business. The peer group established
in October 2017 had a market capitalization (at median, utilizing 2016 data points) of approximately $850&nbsp;million compared to our market capitalization of roughly $1.3&nbsp;billion at the
time. This placed us at above the 75<SUP>th</SUP>&nbsp;percentile in relative size for both revenue and market capitalization. The peer group consists of the following companies, which are mostly
smaller companies but viewed by the Compensation Committee as a sample without size bias: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="39%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="39%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>AMAG Pharmaceuticals</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Coherus BioSciences,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Corcept Therapeutics&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Eagle Pharmaceuticals&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Enanta Pharmaceuticals&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>FibroGen&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Immunogen&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Lexicon Pharmaceuticals,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Ligand Pharmaceuticals&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Momenta Pharmaceuticals&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Nektar Therapeutics</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>PDL BioPharma,&nbsp;Inc.</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>Retrophin,&nbsp;Inc.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Sucampo Pharmaceuticals&nbsp;Inc.</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
making compensation decisions, the Compensation Committee does not target a particular percentile of the peer group data. The actual 2017 compensation of our named executive
officers varied, in some cases it was above the median of our peer group, and in other cases it was below the median. For Mr.&nbsp;Aguiar, our former CEO, his total compensation for 2017 as reported
in the 2017 Summary Compensation Table was below the median of other CEOs in the Company's peer group. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Principal Elements of Compensation  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Base Salaries  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Base salaries are set to reflect compensation commensurate with the individual's current position and work experience. Our goal in this regard
is to attract and retain high caliber talent for the position and to provide a base wage that is not subject to performance risk. Salary for our named executive officers is established based on the
underlying scope of their respective responsibilities, taking into account competitive market compensation. In making base salary decisions our Compensation Committee reviews market data, however that
data provides only a reference point for the Compensation Committee. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
Compensation Committee reviews base salaries for our named executive officers annually, generally in the first quarter of each year. Historically, the CEO had proposed salary
adjustments (in target percentages) to the Compensation Committee (other than for himself) based on any changes in </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>32</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=35,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=333403,FOLIO='32',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<A NAME="page_do11201_1_33"> </A>

<P style="font-family:times;"><FONT SIZE=2>market
salaries, individual performance and/or changes in job duties and responsibilities. The Compensation Committee would then determine any salary adjustment applicable to each of the named
executive officers. For 2017, our former CEO recommended a merit increase of 3.5% for Messrs.&nbsp;d'Esparbes, Faerm, Abercrombie and Witek, which following discussion by the Compensation Committee
were approved. Our Compensation Committee also approved a 3.5% merit increase in Mr.&nbsp;Aguiar's base salary from $749,858 to $776,103. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Annual Cash Incentive Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our named executive officers are eligible for annual cash incentives under a Company-wide bonus program. Annual cash incentives for our named
executive officers are designed to reward the achievement of key corporate goals for the year, which we believe in turn should increase stockholder value over time. The annual cash incentive awards
for our named executive officers are based on our achievement of specific performance goals over which we have direct control or significant influence and that are established at the beginning of the
fiscal year. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the end of the year, our Compensation Committee reviews the Company's performance against the goals and determines the overall level of achievement, which determines the size of the
Company's bonus pool for all employees. Shortly thereafter, the Compensation Committee determines individual bonus amounts for the named executive officers. In making both of these determinations, the
Compensation Committee typically considers a briefing from the Company's former CEO on Company-wide performance against goals and the individual contributions of the named executive officers (other
than himself) toward achievement of the goals. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each
of our named executive officers has a target bonus stated in terms of a percentage of the officer's base salary. No changes were made to the target bonus percentages of our named
executive officers in 2017 and they remained at 75% for our former CEO and at 50% for each of our other named executive officers. In 2017, similar to recent years, each of our named executive officers
was eligible to earn up to two times their target bonus percentage. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Bonus Goals  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the first quarter of 2017, our Compensation Committee established the goals applicable to our Company-wide bonus program for 2017. The table
below sets forth our 2017 goals that applied to our bonus program for all employees, including our named executive officers, the determination of our Compensation Committee on whether or not each goal
was achieved and, to the extent a goal was achieved, whether it was determined to be overachieved. These goals (other than with respect to one supplemental goal) did not include any sales targets for
BREO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> and ANORO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2>, our partnered respiratory programs, since we do not have
direct control over sales and marketing activities. Specific weightings are not assigned to the goals, in order to provide our Compensation Committee with flexibility to determine each goal's relative
weight and importance on the basis of actual results. The Compensation Committee focused on EBITDA from our partnered programs as the most important measure since it requires both revenue and
management of controllable costs to create EBITDA. Additionally, in connection with the compensation changes discussed above for 2018, our Compensation Committee also determined that funding for our
2017 annual bonuses would not exceed actual EBITDA achievement versus the pre-established 2017 EBITDA goal. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>33</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=36,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=851563,FOLIO='33',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<A NAME="page_do11201_1_34"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
addition to the Company-wide goals set forth below, our Compensation Committee also established an individual goal for our former CEO, focused on successful investor relations. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Goal

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Achieved </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Overachieved </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Directly Controllable Goals</I></B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Financial Performance&#151;$172&nbsp;million EBITDA (excluding stock-based compensation)</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Review of Potential New Asset Purchases</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2>Four assets reviewed,
three through diligence, plus assessment by Compensation Committee of quality</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Indirectly Controllable Goals</I></B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>GSK Relationship/2017 Annual Budget Goals</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:10pt;"><font size=2></FONT><FONT SIZE=2> RELVAR</FONT><FONT
SIZE=2><I>&reg;</I></FONT><FONT SIZE=2>/BREO</FONT><FONT SIZE=2><I>&reg;</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2>Inclusion of Study to
Understand Mortality and MorbidITy (SUMMIT) in chronic obstructive pulmonary disease (COPD)&#151;data in
label&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2>Stretch goal: File
Salford Lung Study results/data in label for COPD</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2> Completion of Salford
Lung Study in asthma</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2>Track and encourage
Salford Lung Study asthma data in label</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:10pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:20pt;"><font size=2></FONT><FONT SIZE=2> ANORO</FONT><FONT
SIZE=2><I>&reg;</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2> Completion of
ANORO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> ELLIPTA</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> vs. Stiolto head to head study</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:10pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:20pt;"><font size=2></FONT><FONT SIZE=2>Closed Triple</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2> Completion of InforMing
the PAthway of COPD Treatment (IMPACT)
study&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2>Potential approval of
TRELEGY</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> ELLIPTA</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> (Closed Triple) in the U.S.&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:10pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:20pt;"><font size=2></FONT><FONT SIZE=2>GSK</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2>Develop compelling
customer/market insights and commercial proposals to
GSK&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2>Maintain competitive
BREO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2>/ ANORO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> ELLIPTA</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> Share of Voice</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2> Effectively influence
GSK Medical Affairs Operations to maximize promotion of RELVAR</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2>/ BREO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> ELLIPTA</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> and
ANORO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> ELLIPTA</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT
SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2> Continue to foster
productive relationships</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:20pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:30pt;"><font size=2></FONT><FONT SIZE=2>Stretch Goal: GSK
implements specialty sales force in the U.S. ahead of generic Advair approval</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B><I>Supplemental Goals</I></B></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Achieve $190&nbsp;million in total royalties earned in 2017</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Effectively influence GSK commercial operations to maximize market share for RELVAR&reg;/BREO&reg; ELLIPTA&reg; and ANORO&reg;
ELLIPTA&reg;</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:10pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:20pt;"><font size=2></FONT><FONT SIZE=2>Annual detailing Share of
Voice for BREO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> ELLIPTA</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> and ANORO</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2> ELLIPTA</FONT><FONT SIZE=2><I>&reg;</I></FONT><FONT SIZE=2>
to remain within +/&#150; 5 points of Symbicort; and Stiolto or Bevespi (vs. the competitive product with the highest Share of Voice), respectively</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Develop compelling market insights and arguments (and present to GSK) supporting deployment of a U.S. Specialty Sales Force in support of
BREO&reg; ELLIPTA&reg; and ANORO&reg; ELLIPTA&reg;</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Develop compelling market insights and arguments (and present to GSK) supporting continued promotion of BREO&reg; ELLIPTA&reg; in COPD in
the U.S. following approval of the TRELEGY&reg; ELLIPTA&reg;</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:10pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:20pt;"><font size=2></FONT><FONT SIZE=2> Continue to press GSK
for data and evidence confirming GSK's belief of an Asthma-to-COPD promotional spillover effect</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Maintain our positive, productive and collaborative relationship with GSK</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>X</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;text-align:left;"><p align=left style="font-family:times;margin-top:0pt;margin-bottom:-12pt;margin-left:10pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"text-align:left;" -->


</FONT> <FONT SIZE=2> </font> <font size=2> &#149;</font></p> <p align=left style="font-family:times;margin-top:0pt;margin-left:20pt;"><font size=2></FONT><FONT SIZE=2>Achieve at least 12
different meetings of varying varieties with GSK personnel</FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD VALIGN="TOP" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><I>Positive Investor Relations Management</I></FONT></TD>
<TD VALIGN="TOP" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
on EBITDA of $208&nbsp;million.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
on the Company reviewing eight assets, four through diligence.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Based
on $228&nbsp;million in total royalties earned.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>34</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=37,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=331196,FOLIO='34',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<A NAME="page_do11201_1_35"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
majority of the goals listed above were achieved and in certain cases overachieved, which the Compensation Committee viewed as a significant accomplishment. Despite overachievement
of the EBITDA goal and achievement of a majority of our goals for 2017, our Compensation Committee determined that the 2017 bonus pool would be set at 100% of target for all employees, including the
Company's named executive officers other than Messrs.&nbsp;Aguiar and Faerm. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
bonuses for 2017 performance are shown in the table below and reflected in the Non-Equity Incentive Compensation column of the "Summary Compensation Table" on page 42: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="28%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="28%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="58pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Title </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Cash Bonus<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Percentage<BR>
of Target<BR>
(%) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael W. Aguiar</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>President and Chief Executive Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>250,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Eric d'Esparbes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Senior Vice President and Chief Financial Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
220,773</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
100</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George B. Abercrombie</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Senior Vice President and Chief Commercial Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
218,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
100</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Theodore J. Witek, Jr.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Senior Vice President and Chief Scientific Officer Clinical and Medical Affairs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
217,670</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
100</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>%</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael E. Faerm</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Senior Vice President and Chief Business Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
100,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><BR><SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2><BR>
N/A</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Aguiar
was paid $250,000 in lieu of his 2017 performance bonus pursuant to the terms of the separation agreement he entered into with us at
the time of his termination.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Mr.&nbsp;Faerm
was paid $100,000 in lieu of his 2017 performance bonus pursuant to the terms of the separation agreement he entered into with us at
the time of his termination.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Incentive Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The types of equity compensation that may comprise the mix of officer compensation consist of: (i)&nbsp;stock options with time-based vesting,
which require the market value of our Common Stock to increase before they are valuable; (ii)&nbsp;performance-contingent restricted stock units ("RSUs") and restricted stock awards ("RSAs"), the
right to which is dependent upon successful completion of corporate performance goals; and (iii)&nbsp;RSUs or RSAs with time-based vesting. In 2017, we granted RSUs and RSAs to our named executive
officers (with both time-based and performance-based vesting), which we believed were more appropriate than stock options for our 2017 business model as RSUs and RSAs can provide reduced dilution
compared to stock options, RSUs and RSAs are designed to capture dividends paid to stockholders, and reward growth as well as value maintenance. We do not use a targeted cash/equity split to set
officer compensation. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
order to align the officer's interests with those of our stockholders, a significant equity award is made to a named executive officer at the first regularly scheduled meeting of the
Compensation Committee after the officer commences employment. These initial new hire awards are generally within a guideline range recommended by FW Cook, normally around 1.5 to 2.5 times the annual
equity awards described below, and adjusted to reflect considerations individual to a specific candidate as well as arms-length negotiations as part of the hiring process. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual
equity awards are generally considered during the first quarter of each year, following annual performance reviews and based on recommendations to the Compensation Committee from
the </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>35</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=7,SEQ=38,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=68913,FOLIO='35',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<A NAME="page_do11201_1_36"> </A>

<P style="font-family:times;"><FONT SIZE=2>CEO
(other than with respect to himself). One-third of our named executive officers' 2017 target annual equity awards was subject to performance-based vesting and the remaining two-thirds was subject
to time-based vesting, as further described below. Additional equity awards may be made in connection with an officer earning a promotion or taking on additional duties or for retention purposes in
certain circumstances. Annual equity awards generally vest over a four-year period for time-based awards, while the performance period (and any accompanying time-based vesting component) varies for
performance-based awards. The Company believes that the resulting overlapping vesting schedule from awards made in prior years, together with the number of shares subject to each award, helps ensure a
meaningful incentive to remain in the Company's employ and to enhance stockholder value over time. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
annual equity grant guidelines are stated as a dollar amount, which we believe matches the approximate cost incurred by the Company and is most relevant for a company with our
business model, market capitalization, and type of equity award being granted. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Annual Equity Awards  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Annual equity awards were made in the first quarter of 2017 and were set at 110% of guideline, as a result of the Company's overachievement of
its 2016 performance goals. The 2017 equity awards were made in the first quarter of 2017, prior to the 2017 vote of our stockholders on the compensation of our named executive officers. As with the
2016 annual equity awards, the 2017 awards were designed with one-third of the target award subject to performance-based vesting and the remaining two-thirds of the award with standard time-based
vesting. All of our named executive officers received their 2017 annual equity award (both the time-based and performance-based portions) in the form of RSAs other than Mr.&nbsp;Witek, who received
RSUs due to Canadian tax considerations. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following table shows for each of our named executive officers the annual equity award guideline, the total annual equity award at 110% of the guideline based on the 15-day average
trading price ending three full trading days prior to the date the awards were granted (which was $10.9947), the portion of the 2017 annual equity award subject to time-based vesting and the portion
of the 2017 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>36</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=8,SEQ=39,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=91733,FOLIO='36',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<A NAME="page_do11201_1_37"> </A>


<P style="font-family:times;"><FONT SIZE=2>annual
equity award subject to performance-based vesting (at target). The guideline grant values were generally near the median of our peer group, with our CEO set below the median. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:73%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"110%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="110%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="21%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="21%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="68pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="89pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH NOWRAP  ALIGN="LEFT" style="font-family:times;"><DIV style="border-bottom:solid #000000 1.0pt;margin-bottom:0pt;width:auto;display:inline-block;*display:inline;zoom:1;;"><FONT SIZE=1><B>Name

<!-- COMMAND=ADD_SCROPPEDRULE,auto;display:inline-block;*display:inline;zoom:1; -->

 </B></FONT></DIV></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Title </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Guideline<BR>
Dollar<BR>
Value </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total 2017<BR>
Annual<BR>
Equity<BR>
Award at<BR>
110% of<BR>
Guideline<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Time-Based<BR>
Portion of<BR>
2017<BR>
Annual Equity<BR>
Award </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Performance-Based<BR>
Portion of 2017<BR>
Annual Equity<BR>
Award ("2017<BR>
Performance<BR>
Awards")<SUP>(2)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael W. Aguiar</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>President and Chief Executive Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,500,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>250,121</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>166,747</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>83,374</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Eric d'Esparbes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Financial Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>100,048</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>66,698</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>33,350</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>George B. Abercrombie</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Commercial Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>800,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>80,038</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>53,358</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26,680</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Theodore J. Witek, Jr.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Scientific Officer Clinical and Medical Affairs</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>800,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>80,038</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>53,358</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>26,680</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Michael E. Faerm</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Senior Vice President and Chief Business Officer</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,000,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>100,048</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>66,698</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>33,350</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Granted
in the form of RSAs for all named executive officers other than Mr.&nbsp;Witek, who received RSUs due to his Canadian tax considerations.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Reflects
the number of shares earned if achievement is at target. At maximum performance, each named executive officer can earn up to two times the
target shares.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
2017 Performance Awards granted to Messrs.&nbsp;Aguiar and Faerm were forfeited in their entirety upon their termination of employment with us. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
all of our named executive officers other than Mr.&nbsp;Witek, the time-based portion of the 2017 annual equity award as originally granted was scheduled to vest over a period of
four years (with the first 25% scheduled to vest on February&nbsp;20, 2018 and the remainder in equal quarterly installments over the next three years thereafter), subject to the named executive
officer's continued service through each vesting date. Pursuant to the terms of the separation agreements entered into with Messrs.&nbsp;Aguiar and Faerm in connection with their termination of
employment with us, we accelerated the vesting of 41,687 shares and 16,675 shares, respectively, that were subject to the time-based portion of their 2017 annual equity awards and were scheduled to
vest on February&nbsp;20, 2018. The remainder of such awards were forfeited upon their termination of employment with us. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Due
to Canadian tax considerations, the time-based portion of Mr.&nbsp;Witek's 2017 annual equity award vests over a three-year period as follows: 25% on February&nbsp;20, 2018,
6.25% on each of May&nbsp;20, 2018, August&nbsp;20, 2018, November&nbsp;20, 2018, February&nbsp;20, 2019, May&nbsp;20, 2019 and August&nbsp;20, 2019, and the remaining 37.5% vests on
November&nbsp;20, 2019, provided Mr.&nbsp;Witek remains in continuous service through each vesting date. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>37</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=9,SEQ=40,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=952912,FOLIO='37',FILE='DISK121:[18ZAE1.18ZAE11201]DO11201A.;20',USER='CHE108062',CD='22-MAR-2018;18:11' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dq11201_1_38"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
2017 Performance Awards are eligible to vest based on the relative performance of our common stock compared to the NASDAQ Biotechnology Index during the following two performance
periods: January&nbsp;1, 2017 through December&nbsp;31, 2018; and January&nbsp;1, 2017 through December&nbsp;31, 2019 (or, in the case of Mr.&nbsp;Witek, through September&nbsp;30, 2019).
After the end of each performance period, the number of shares for which the performance-based vesting conditions have been satisfied will be calculated by multiplying the "payout percentage" by the
target number of shares granted, rounded down to the nearest whole share. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the 2017 Performance Awards, the payout percentage is calculated as follows: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="153pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="8pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="8pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->





<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="BOTTOM">
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-left:solid #000000 1.0pt; "><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-left:solid #000000 1.0pt; " -->


&nbsp;</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Total Relative Share Performance<BR>
("TRSP")<SUP>(1)</SUP></B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>Payout Percentage<SUP>(2)(3)</SUP></B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=1><B>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


 </B></FONT><FONT SIZE=2>&nbsp;</FONT><BR></TH>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><B>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </B></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><b>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</B></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><b>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</B></FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;<font><B>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </B></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2><B></b></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-left:solid #000000 1.0pt; "><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-left:solid #000000 1.0pt; " -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2> Greater than 0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>



<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>100% plus 5% for each positive percentage point of TRSP, up to a 200% maximum</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


</FONT> <FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-left:solid #000000 1.0pt; "><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-left:solid #000000 1.0pt; " -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>100%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


</FONT> <FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
</TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-left:solid #000000 1.0pt; "><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-left:solid #000000 1.0pt; " -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>Less than 0</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>100% minus 5% for each negative percentage point of TRSP</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;border-right:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_GRID,"border-right:solid #000000 1.0pt;" -->


</FONT> <FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF" VALIGN="TOP">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT>
</TD>
<TD ALIGN="CENTER" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;<font>


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
</TR>

</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Calculated
by subtracting the performance of the NASDAQ Biotechnology Index from our share performance over the applicable performance period.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Straight
line interpolation will be used for TRSP of less than a full percentage point and for the corresponding payout percentage.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>In
the event the payout percentage is less than the 200% maximum for the first performance period, the payout percentage for the second performance
period will be determined by deducting the payout percentage achieved for the first performance period (i.e.,&nbsp;only incremental performance will be rewarded).  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
the extent the performance-based vesting conditions applicable to the 2017 Performance Awards are satisfied during the first performance period, two-thirds of the related shares will
vest on February&nbsp;20, 2019 and the remaining one-third of such shares will vest on February&nbsp;20, 2020, subject to the named executive officer's continued service through the applicable
vesting date. If the performance-based vesting conditions are satisfied during the second performance period, all of the related shares will vest on February&nbsp;20, 2020, subject to the named
executive officer's continued service through such date. Due to Canadian tax considerations, any RSUs granted to Mr.&nbsp;Witek for which the performance-based vesting conditions have been satisfied
will vest no later than November&nbsp;20, 2019, subject to Mr.&nbsp;Witek's continued service through such date. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event we are acquired prior to the end of the second performance period, the performance period then in progress will terminate and the performance-based vesting conditions will
be deemed vested as to the greater of (i)&nbsp;the target number of shares and (ii)&nbsp;the number of shares that would vest based on the TRSP as calculated on the closing date of such
acquisition. The service-based conditions applicable to the 2017 Performance Awards will be deemed satisfied if the named executive officer remains in continuous service through the date of the
acquisition. Any 2017 Performance Awards for which the performance metric is not satisfied as of the closing of the acquisition will be forfeited. See the section entitled "Potential Payments Upon
Termination or Change in Control" below for further details on the treatment of the 2017 Performance Awards in the event we are acquired. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
2017 Performance Awards also provide that in the event of the named executive officer's death or disability prior to the end of the second performance period that the awards will
vest at target, less any amounts previously vested, if applicable. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>38</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=41,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=386452,FOLIO='38',FILE='DISK121:[18ZAE1.18ZAE11201]DQ11201A.;16',USER='CHE105627',CD='21-MAR-2018;14:45' -->
<A NAME="page_dq11201_1_39"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Post-Termination Protection  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We believe that the possibility of a change in control creates uncertainty for our officers regarding their continued employment by the Company
because such transactions frequently result in senior management changes. We provide change in control protections to our officers to alleviate concerns regarding the possible occurrence of such a
transaction, allowing them to focus their attention on the business of the Company. In addition, these protections encourage executives to remain with the Company during the threat or negotiation of a
change in control transaction, which preserves the value of the Company and the potential benefit to be received by our stockholders in the transaction. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
change in control severance benefits are structured under a Company plan, which was initially adopted in 2004, instead of using individual employment agreements. With this change in
control severance plan, we sought uniformity of results among the officers based on their positions at the Company. For officers who were eligible to participate in the plan prior to
December&nbsp;16, 2009, Innoviva provides gross-ups for excise taxes potentially due in connection with a change in control. Mr.&nbsp;Aguiar was our only named executive officer who was eligible
for this benefit. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior
to his termination, Mr.&nbsp;Aguiar was also eligible for severance benefits outside of the change in control context pursuant to the letter agreement we entered into with him at
the time he became our Chief Executive Officer in 2014. Pursuant to such letter agreement, if Mr.&nbsp;Aguiar's service was terminated without cause and he was not eligible for severance benefits
under our original change in control severance plan, he would receive a lump-sum severance payment of 24&nbsp;months of his then-current salary plus two times his then-current target bonus. As our
interim Principal Executive Officer, Mr.&nbsp;d'Esparbes is now eligible for similar severance benefits pursuant to a letter agreement entered into with him in February 2018. In the event his
employment is terminated without cause, provided he executes a general release of claims, he will receive a lump-sum severance payment of 24&nbsp;months of his then-current base salary plus his
current target bonus, a pro-rata bonus for the year in which his termination occurs, and continuation of his health and welfare benefits for the shorter of 12&nbsp;months, the expiration of his
coverage under COBRA or the date when he obtains new employment offering comparable health insurance coverage. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
2009, our Board of Directors adopted a new change in control severance plan which applies to any officers hired, or non-officers promoted to officer level, after December&nbsp;16,
2009 (the "2009 plan") that
was essentially identical to the original change in control severance plan except that it does not provide for excise tax gross-ups. All of our named executive officers other than our former CEO
participate in the 2009 plan. Since 2015, the 2009 plan also provides our named executive officers who are senior vice presidents with cash severance benefits in the event of a termination without
cause. We believe this is consistent with practices within our peer groups and should help reduce the likelihood of employee disputes in the event of a termination of employment. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our
severance and change-in-control arrangements generally do not affect the Compensation Committee's decisions regarding other elements of compensation. Those arrangements serve
specific purposes that we believe are not related to the determination of an officer's current compensation. The specific terms of our severance and change in control arrangements are described in
detail in "Potential Payments Upon Termination or Change in Control" on page 48. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Perquisites  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company does not provide a non-qualified deferred compensation program or a supplemental executive retirement plan. Generally the Company
does not provide perquisites or other personal benefits to named executive officers, and during 2017 we did not provide any perquisites to executive officers that were not provided to all employees
other than the reimbursement of expenses incurred by Mr.&nbsp;Witek in the preparation of his personal income taxes (due to his residency outside of the United States). </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>39</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=42,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=4544,FOLIO='39',FILE='DISK121:[18ZAE1.18ZAE11201]DQ11201A.;16',USER='CHE105627',CD='21-MAR-2018;14:45' -->
<A NAME="page_dq11201_1_40"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Former CEO Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As CEO, Mr.&nbsp;Aguiar's level of responsibility was much greater than those of our other named executive officers and therefore his
compensation was higher than that of our other named executive officers. Notwithstanding this fact, Mr.&nbsp;Aguiar's total compensation for 2017, as reported in the 2017 Summary Compensation Table,
was below the median of other CEOs in our peer group. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;Aguiar's
compensation generally consisted of the same elements provided to our other named executive officers. For 2017, Mr.&nbsp;Aguiar's merit salary increase was 3.5%,
consistent with our other named executive officers. As with our other named executive officers, Mr.&nbsp;Aguiar's 2017 annual equity award consisted of both time-based RSAs and performance-based
RSAs and was set at 110% of guideline due to the Company's overachievement of its 2016 goals. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
February&nbsp;6, 2018, Mr.&nbsp;Aguiar resigned as our CEO and member of our Board at the request of the Board. Mr.&nbsp;Aguiar's resignation was treated as a termination
"without cause" under the letter agreement we entered into with him at the time he became our CEO in 2014. As a result, pursuant to the separation agreement that was entered into between the company
and Mr.&nbsp;Aguiar on February&nbsp;6, 2018, in exchange for a mutual release of claims we paid Mr.&nbsp;Aguiar a lump sum equal to 24&nbsp;months of his former base salary plus two times his
target bonus (at the time of his termination). In addition, we agreed to (i)&nbsp;pay Mr.&nbsp;Aguiar $250,000 in lieu of his 2017 performance bonus and (ii)&nbsp;accelerate the vesting of an
aggregate of 164,045 shares of our common stock underlying restricted stock awards previously awarded to him, and which would have vested on February&nbsp;20, 2018, if he had remained with the
company through such date. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Tax Deductibility of Pay  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;162(m) of the Internal Revenue Code places a limit of $1,000,000 on the amount of compensation that Innoviva may deduct in any
one year with respect to each of its CEO and certain other executive officers. Prior to changes in tax law taking effect in 2018, there was an exception to the $1,000,000 limitation for
performance-based compensation meeting certain requirements. Historically some of our named executive officer compensation arrangements were intended to qualify for this exception. However, to
maintain flexibility in compensating executive officers in a manner designed to promote varying corporate goals, the Compensation Committee has not adopted a policy requiring all compensation to be
deductible. Although deduction of some amounts paid as compensation by Innoviva to certain executives may be limited by Section&nbsp;162(m), that limitation has not resulted in the current payment
of increased federal income taxes by Innoviva due to its significant net operating loss carry forwards. The Compensation Committee may approve compensation or changes to plans, programs or awards that
may cause the compensation or awards not to comply with Section&nbsp;162(m) if it determines that such action is appropriate and in our best interests. The exemption from Section&nbsp;162(m)'s
deduction limitation for performance-based compensation has been repealed, effective for taxable years beginning after December&nbsp;31, 2017, such that compensation paid to our CEO and certain
other executive officers in excess of $1,000,000 will not be deductible unless it qualifies for transition relief applicable to certain arrangements in place as of November&nbsp;2, 2017. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>40</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=43,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=1009733,FOLIO='40',FILE='DISK121:[18ZAE1.18ZAE11201]DQ11201A.;16',USER='CHE105627',CD='21-MAR-2018;14:45' -->
<A NAME="page_dq11201_1_41"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dq11201_compensation_committee_report(1)"> </A>
<A NAME="toc_dq11201_1"> </A>
<BR></FONT><FONT SIZE=2><B>  COMPENSATION COMMITTEE REPORT(1)    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee has reviewed and discussed the foregoing Compensation Discussion and Analysis with management and, based on such
review and discussions, the Compensation Committee has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Submitted
by the following members of the Compensation Committee: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:100%;margin-left:0%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>Catherine J. Friedman, Chairperson<BR>
Barbara Duncan<BR>
Odysseas Kostas, M.D.(2)<BR>
Paul Pepe</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>

 <p style="font-family:times;line-height:1pt;margin-left:18pt;"><font> </FONT> <FONT SIZE=2>
<!-- BLANK LINE TO FORCE PARA -->
&nbsp;&nbsp;&nbsp;
<HR NOSHADE COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT"> </FONT></P>

 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(1)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>The
material in this report is not "soliciting material," is not deemed "filed" with the SEC and is not to be incorporated by reference in any filing of Innoviva
under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>(2)</FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Dr.
Kostas joined the Compensation Committee on January&nbsp;4, 2018. </FONT></DD></DL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>41</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=44,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=738692,FOLIO='41',FILE='DISK121:[18ZAE1.18ZAE11201]DQ11201A.;16',USER='CHE105627',CD='21-MAR-2018;14:45' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_ds11201_1_42"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Summary Compensation Table  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth all of the compensation awarded to, earned by, or paid to our "principal executive officer," our "principal
financial officer," and our three other executive officers (our "named executive officers") for fiscal years 2017, 2016 and 2015. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="23pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="35pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="64pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="63pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Name and Principal Position </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Year </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Salary<BR>
($)<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Bonus<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock<BR>
Awards<BR>
($)<SUP>(2)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Non-Equity<BR>
Incentive Plan<BR>
Compensation<BR>
($)<SUP>(3)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Compensation<BR>
($)<SUP>(4)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(d)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(e)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(g)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(i)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(j)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael W. Aguiar<SUP>(5)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>772,822</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>250,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,134,018</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>20,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,176,840</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 President and Chief</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>746,688</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,159,152</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>672,019</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>19,667</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,597,526</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Executive Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>721,438</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,314,256</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>516,206</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,560,900</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Eric d'Esparbes<SUP>(7)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
441,546</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,253,605</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
220,773</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
12,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,927,923</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Senior Vice President and</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>422,920</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>863,662</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>253,752</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,605</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,549,940</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Chief Financial Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>383,840</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>485,997</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>182,585</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8,958</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,061,380</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 George B. Abercrombie</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
436,684</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,002,879</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
218,342</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
20,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,677,906</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Senior Vice President</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>421,917</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>21,096</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>690,929</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>253,150</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>12,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,399,092</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 and Chief Commercial Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>408,208</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>938,934</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>194,456</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>12,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,553,598</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Theodore J. Witek, Jr.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
435,340</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
999,678</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
217,670</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
31,983</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,684,671</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Senior Vice President</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>420,619</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>681,902</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>252,371</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>23,712</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,378,604</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>and Chief Scientific Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>407,105</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>938,934</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>193,857</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>12,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,551,896</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Clinical and Medical Affairs</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:9pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael E. Faerm<SUP>(8)</SUP></FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
2017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
436,392</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
100,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><BR><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,253,605</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
20,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
1,809,997</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Senior Vice President</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>422,372</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>500,925</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>253,423</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>193,214</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,369,934</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 and Chief Business Officer</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2015</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>199,640</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>75,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,644,599</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>114,333</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>33,003</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,066,575</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Includes
amounts deferred pursuant to our 401(k) plan.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in this column represent the aggregate grant date fair value of stock awards granted to the officer in the applicable fiscal year computed
in accordance with FASB ASC Topic 718. In accordance with the SEC rules, the grant date fair value of any award subject to a performance condition is based on the probable outcome of the performance
conditions. See Note&nbsp;6 of the notes to our consolidated financial statements in our Annual Report on Form&nbsp;10-K filed on February&nbsp;23, 2018 for a discussion of all assumptions made
by the Company in determining the grant date fair values of its equity awards.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts in this column reflect cash bonus awards earned by the named executive officers under our 2015, 2016 and 2017 annual cash bonus plans,
which were paid in the first quarter of the following year. The 2017 annual cash bonus plan is discussed in greater detail in the "Annual Cash Incentive Compensation" section of the "Compensation
Discussion and Analysis" beginning on page 33.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>The
amounts for 2017 in this column reflect a 401(k) matching contribution made by the Company, which was provided to our named executive officers on
the same basis as it was provided to all other regular U.S. employees. For Mr.&nbsp;Witek, the amount also includes a reimbursement by the Company of $12,013 for personal income tax preparation
fees.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Aguiar
resigned as our President and Chief Executive Officer on February&nbsp;6, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(6)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Reflects
the amounts paid to Messrs.&nbsp;Aguiar and Faerm in lieu of their 2017 annual cash bonus pursuant to the terms of the separation
agreements each entered into with us following the termination of their employment.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(7)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;d'Esparbes
was appointed interim Principal Executive Officer on February&nbsp;6, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(8)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Faerm
was hired as our Senior Vice President and Chief Business Officer on July&nbsp;8, 2015 and resigned from this position on
February&nbsp;7, 2018. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Salary, Bonus and Non-Equity Incentive Plan Compensation in Proportion to Total Compensation  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amount of salary, bonus and non-equity incentive plan compensation awarded to, earned by, or paid to our named executive officers for fiscal
year 2017 in proportion to the total compensation reported for each of our named executive officers is set forth below. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:70%;margin-left:15%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="157pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="26pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Aguiar:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>25</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;d'Esparbes:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>35</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Abercrombie:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>40</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Witek:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>40</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Mr.&nbsp;Faerm:</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>31</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>%<SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:15%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>For
Messrs.&nbsp;Aguiar and Faerm, the bonus amount includes the amounts paid to each of them in lieu of their 2017 annual cash bonus pursuant to the
terms of the separation agreements each entered into with us following the termination of their employment.  </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>42</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=45,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=579629,FOLIO='42',FILE='DISK121:[18ZAE1.18ZAE11201]DS11201A.;21',USER='CHE108062',CD='22-MAR-2018;17:09' -->
<A NAME="page_ds11201_1_43"> </A>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Grants of Plan-Based Awards  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth each non-equity incentive plan award and equity award granted to our named executive officers during fiscal year
2017. Unless indicated below, all equity awards were made under our 2012 Equity Incentive Plan. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="49pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="55pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated Possible<BR>
Payouts Under<BR>
Non-Equity Incentive<BR>
Plan Awards<BR>
($)<SUP>(1)</SUP> </B></FONT></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Estimated Possible<BR>
Payouts Under<BR>
Equity Incentive<BR>
Plan Awards<BR>
($)<SUP>(2)(3)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=3 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=3 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>All Other<BR>
Stock<BR>
Awards:<BR>
Number of<BR>
Shares or<BR>
Units<BR>
(#)<SUP>(4)(5)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH ROWSPAN=2 style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant Date<BR>
Fair Value<BR>
of Stock<BR>
Awards<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Name </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Grant<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Target<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Maximum<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Target<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Maximum<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(d)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(e)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(g)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(h)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(i)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(l)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael W. Aguiar</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>579,617</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,159,234</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>166,747</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,814,207</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>83,374</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>166,748</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1,319,810</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Eric d'Esparbes</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>220,773</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>441,546</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>66,698</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>725,674</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33,350</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>66,700</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>527,931</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 George B. Abercrombie</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>218,342</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>436,684</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53,358</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>580,535</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,680</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53,360</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>422,344</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Theodore J. Witek, Jr.&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>217,670</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>435,340</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53,358</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>580,535</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>26,680</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>53,360</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>419,143</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael E. Faerm</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>N/A</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>218,196</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>436,392</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>66,698</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>725,674</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>1/17/2017</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>33,350</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>66,700</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&#151;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>527,931</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Each
named executive officer was granted a non-equity incentive plan award pursuant to our 2017 annual cash bonus plan which is discussed in greater
detail in the "Annual Cash Incentive Compensation" section of the "Compensation Discussion and Analysis" beginning on page&nbsp;33. The amounts shown in the "target" column reflect the target payout
under the plan. The target amount is equal to 50% of each named executive officers' base salaries, with the exception of Mr.&nbsp;Aguiar, whose target bonus amount was 75% of his base salary. The
amounts shown in the "maximum" column reflect the maximum payout under the plan if all of the goals were achieved. No "threshold" is applicable to these awards. The actual amounts paid to each named
executive officer are shown in the Summary Compensation Table on page 42 and, for Messrs.&nbsp;Aguiar and Faerm, reflect amounts paid pursuant to the terms of the separation agreements each entered
into with us at the time of their termination of employment.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Each
of our named executive officers was granted a performance-contingent stock award (RSAs for all of our named executive officers other than
Mr.&nbsp;Witek, who was granted RSUs) under our 2012 Equity Incentive Plan. Vesting of these awards is contingent upon both a performance-based vesting condition as well as continued service, with
the performance-based vesting condition satisfied based on the relative performance of the Company's common stock compared to the NASDAQ Biotechnology Index during the two- and three-year performance
periods beginning on January&nbsp;1, 2017 and ending on December&nbsp;31, 2018 and December&nbsp;31, 2019 (or, in the case of Mr.&nbsp;Witek, the two- and three-year performance periods
beginning on January&nbsp;1, 2017 and ending on December&nbsp;31, 2018 and September&nbsp;30, 2019), as described in greater detail in the "2017 Annual Equity Awards" section of the
"Compensation Discussion and Analysis" beginning on page&nbsp;36. No threshold is applicable to the awards, as the payout ranges from 0 to 200% of the "target" payout reflected in the table above.
Stock awards for which the performance metric is </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>43</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=46,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=269463,FOLIO='43',FILE='DISK121:[18ZAE1.18ZAE11201]DS11201A.;21',USER='CHE108062',CD='22-MAR-2018;17:09' -->
<A NAME="page_ds11201_1_44"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <UL>

<P style="font-family:times;"><FONT SIZE=2>achieved
during the first performance period will vest for all of our named executive officers other than Mr.&nbsp;Witek as to two-thirds of such shares on February&nbsp;20, 2019 and the remaining
one-third of such shares on February&nbsp;20, 2020, subject to the holder's continued service through each such date. Stock awards for which the performance metric is achieved during the second
performance period will vest for all of our named executive officers other than Mr.&nbsp;Witek in full on February&nbsp;20, 2020, subject to the holder's continued service through such date. For
Mr.&nbsp;Witek, RSUs for which the performance metric is achieved during the first performance period will vest as to two-thirds of such RSUs on February&nbsp;20, 2019 and the remaining one-third
of such RSUs on November&nbsp;20, 2019, subject to Mr.&nbsp;Witek's continued service through each such date; RSUs for which the performance metric is achieved during the second performance period
will vest in full on November&nbsp;20, 2019, subject to Mr.&nbsp;Witek's continued service through such date. The amounts included as the "target" and "maximum" in the table above assume the
holder will remain in continued service through the applicable quarterly vesting date. In connection with their termination of employment with us in February 2018, these awards were forfeited in their
entirety by Messrs.&nbsp;Aguiar and Faerm.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>In
the event we are acquired prior to the end of the second performance period, the performance period then in progress will terminate and achievement
of the performance metric will be deemed satisfied with respect to the greater of (i)&nbsp;the "target" payout and (ii)&nbsp;the number of shares (or in the case of Mr.&nbsp;Witek, RSUs) that
would vest based on actual performance as calculated on the closing date of such acquisition. The service-based conditions applicable to the performance-contingent stock awards will be deemed
satisfied if the holder remains in continuous service through the date of the acquisition. In the event the payout is at less than the maximum for the first performance period and we are acquired
prior to the end of the second performance period, the achievement will still be determined as described above at the time of the acquisition, but the payout percentage for the first performance
period will be deducted from such amount. See the section entitled "Potential Payments Upon Termination or Change in Control" below for further details on the treatment of the performance-contingent
stock awards in the event we are acquired.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Each
of our named executive officers was granted a stock award with time-based vesting under our 2012 Equity Incentive Plan (RSAs for all of our named
executive officers other than Mr.&nbsp;Witek, who was granted RSUs). For all of our named executive officers other than Mr.&nbsp;Witek, 25% of the RSAs were scheduled to vest on
February&nbsp;20, 2018, and the remaining 75% of the RSAs are scheduled to vest in equal quarterly installments over the next three years, provided the holder remains in continuous service through
each vesting date. For Mr.&nbsp;Witek, 25% of the RSUs vested on February&nbsp;20, 2018, 6.25% of the RSUs vest on each of May&nbsp;20, 2018, August&nbsp;20, 2018, November&nbsp;20, 2018,
February&nbsp;20, 2019, May&nbsp;20, 2019 and August&nbsp;20, 2019, and the remaining 37.5% of the RSUs vest on November&nbsp;20, 2019, provided Mr.&nbsp;Witek remains in continuous service
through each vesting date. Pursuant to the terms of the separation agreements entered into with Messrs.&nbsp;Aguiar and Faerm in February 2018 in connection with their termination of employment with
us, the vesting of 41,687 shares and 16,675 shares, respectively, that were scheduled to vest pursuant to these awards on February&nbsp;20, 2018 was accelerated. The remainder of such awards were
forfeited by Messrs.&nbsp;Aguiar and Faerm.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>These
stock awards will become fully vested if we are acquired and the holder is subject to an involuntary termination. Such vesting acceleration is
described in greater detail in "Potential Payments Upon Termination or Change in Control" beginning on page 48.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Outstanding Equity Awards at 2017 Fiscal Year-End  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth information regarding each unexercised option, all RSAs and RSUs held by each of our named executive officers as
of December&nbsp;31, 2017. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>44</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=47,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=904284,FOLIO='44',FILE='DISK121:[18ZAE1.18ZAE11201]DS11201A.;21',USER='CHE108062',CD='22-MAR-2018;17:09' -->
<A NAME="page_ds11201_1_45"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise indicated below, all of our equity awards were granted under our 2012 Incentive Plan and will fully vest in the event of a change in control unless the awards are
assumed by the successor corporation or replaced with comparable awards. For additional information regarding other vesting acceleration provisions applicable to the outstanding equity awards held by
our named executive officers, please see the section titled "Potential Payments Upon Termination or Change in Control" beginning on page 48. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="54pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="46pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="59pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=11 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Name </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options<BR>
Exercisable<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options<BR>
Unexercisable<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Exercise<BR>
Price<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option<BR>
Expiration<BR>
Date </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number<BR>
of Shares<BR>
or Units<BR>
of Stock<BR>
That<BR>
Have Not<BR>
Vested<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Market<BR>
Value of<BR>
Shares<BR>
or<BR>
Units of<BR>
Stock<BR>
That<BR>
Have Not<BR>
Vested<BR>
($)<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Number<BR>
of<BR>
Unearned<BR>
Shares,<BR>
Units or<BR>
Other Rights<BR>
That Have<BR>
Not Vested<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Market<BR>
or<BR>
Payout<BR>
Value of<BR>
Unearned<BR>
Shares,<BR>
Units or<BR>
Other Rights<BR>
That<BR>
Have<BR>
Not<BR>
Vested<BR>
($)<SUP>(2)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(e)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(f)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(g)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(h)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(i)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(j)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael W. Aguiar</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,125</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>44,344</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8,232</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>116,812</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>55,017</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>780,691</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>81,374</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,154,697</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>18,083</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(7)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>256,597</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>166,747</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(8)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,366,140</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>83,374</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(9)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>1,183,077</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Eric d'Esparbes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>25,618</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(10)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>363,519</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>11,554</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>163,951</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>32,549</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>461,870</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,233</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(7)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>102,636</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>66,698</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(8)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>946,445</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>33,350</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(9)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>473,237</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 George B. Abercrombie</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>87,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>12,500</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(11)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>29.32</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6/18/2024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,000</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(12)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>70,950</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>22,321</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>316,735</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>26,039</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>369,493</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,786</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(7)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>82,103</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>53,358</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(8)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>757,150</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>26,680</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(9)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>378,589</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Theodore J. Witek, Jr.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>106,771</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>18,229</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(13)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>23.88</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7/23/2024</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>26,039</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(14)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>369,493</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>5,786</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(15)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>82,103</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>53,358</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(16)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>757,150</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>26,680</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(17)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>378,589</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael E. Faerm</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>46,063</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(18)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>653,634</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>18,878</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>267,879</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,195</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(7)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>59,527</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT>
</TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>66,698</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(8)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>946,445</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>33,350</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(9)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>473,237</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Computed
in accordance with SEC rules as the number of unvested shares multiplied by the closing market price of our Common Stock on
December&nbsp;29, 2017 (the last business day of our 2017 fiscal year), which was $14.19. The actual value (if any) to be realized by the officer depends on whether the shares vest and the future
performance of our Common Stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Computed
in accordance with SEC rules as the number of unvested shares multiplied by the closing market price of our Common Stock on
December&nbsp;29, 2017 (the last business day of the 2016 fiscal year), which was $14.19. The actual value (if any) to be realized by the officer depends on whether the performance milestones
related thereto are achieved, whether the shares vest following achievement of the performance milestones, and the future performance of our Common Stock.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Aguiar
received RSAs under our 2012 Incentive Plan on June&nbsp;2, 2014. The first 25% of the RSAs vested on February&nbsp;20, 2015,
and the remaining 75% of the RSAs vest in equal quarterly installments over three years thereafter, provided Mr.&nbsp;Aguiar remains in continuous service through each vesting date. Pursuant to the
terms of the separation agreement entered into with Mr.&nbsp;Aguiar in February 2018 in connection with his termination of employment with us, the vesting of the remaining 3,125 RSAs that were
scheduled to vest on February&nbsp;20, 2018 was accelerated.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Aguiar
received RSAs under our 2012 Incentive Plan on August&nbsp;15, 2014, in connection with his promotion to Chief Executive Officer.
The first 25% of the RSAs vested on August&nbsp;20, 2015, and the remaining 75% of the RSAs vest in equal quarterly installments over three years thereafter, provided Mr.&nbsp;Aguiar remains in
continuous service through each vesting date. Pursuant to the terms of the separation agreement entered into with Mr.&nbsp;Aguiar in February 2018 in connection with his termination of employment
with us, the vesting of the 2,744 RSAs that were scheduled to vest on February&nbsp;20, 2018 was accelerated. The remainder of the RSAs were forfeited by Mr.&nbsp;Aguiar.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Messrs.&nbsp;Aguiar,
d'Esparbes and Abercrombie each received RSAs under our 2012 Incentive Plan on January&nbsp;7, 2015. 25% of the RSAs vested
on February&nbsp;20, 2016, and the remaining 75% of the RSAs vest in equal quarterly installments over three years </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>45</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=48,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=690505,FOLIO='45',FILE='DISK121:[18ZAE1.18ZAE11201]DS11201A.;21',USER='CHE108062',CD='22-MAR-2018;17:09' -->
<A NAME="page_ds11201_1_46"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <UL>

<P style="font-family:times;"><FONT SIZE=1>thereafter,
provided the holder remains in continuous service through each vesting date. Pursuant to the terms of the separation agreement entered into with Mr.&nbsp;Aguiar in February 2018 in
connection with his termination of employment with us, the vesting of the 11,003 RSAs that were scheduled to vest on February&nbsp;20, 2018 was accelerated. The remainder of the RSAs were forfeited
by Mr.&nbsp;Aguiar.  </FONT></P>

</UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(6)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Messrs.&nbsp;Aguiar,
d'Esparbes, Abercrombie and Faerm each received RSAs under our 2012 Incentive Plan on January&nbsp;14, 2016. 25% of the RSAs
vested on February&nbsp;20, 2017, and the remaining 75% of the RSAs vest in equal quarterly installments over three years thereafter, provided the holder remains in continuous service through each
vesting date. Pursuant to the terms of the separation agreements entered into with Messrs.&nbsp;Aguiar and Faerm in February 2018 in connection with their termination of employment with us, the
vesting of 9,041 RSAs and 2,097 RSAs, respectively, that were scheduled to vest on February&nbsp;20, 2018 was accelerated. The remainder of the RSAs were forfeited by Messrs.&nbsp;Aguiar and
Faerm.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(7)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Messrs.&nbsp;Aguiar,
d'Esparbes, Abercrombie and Faerm each received performance-contingent RSAs under our 2012 Incentive Plan on January&nbsp;14,
2016. The vesting of these RSAs is contingent upon an increase in the Company's cumulative TSR over a period of up to three years from the date of grant as well as continued service. In accordance
with SEC rules, the number of shares in column (i)&nbsp;and the value of those shares in column (j)&nbsp;reflects threshold performance. In the event we are acquired prior to the third anniversary
of the date of grant, the performance period then in progress will terminate and achievement of the performance metric will be determined based on TSR Compound Annual Growth Rate using the closing
price of a share of our Common Stock three days prior to the closing date of such acquisition. The service-based conditions applicable to the performance-contingent RSAs will be deemed satisfied if
the holder remains in continuous service through the date of the acquisition. Any RSAs for which the performance metric is not satisfied as of the closing of the acquisition will be forfeited. See the
section entitled "Potential Payments Upon Termination or Change in Control" below for further details on the treatment of the performance-contingent RSAs in the event we are acquired. Pursuant to the
terms of the separation agreements entered into with Messrs.&nbsp;Aguiar and Faerm in February 2018 in connection with their termination of employment with us, the vesting of 96,446 RSAs and 22,376
RSAs, respectively, was accelerated. The remainder of the RSAs were forfeited by Messrs.&nbsp;Aguiar and Faerm.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(8)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Messrs.&nbsp;Aguiar,
d'Esparbes, Abercrombie and Faerm each received RSAs under our 2012 Incentive Plan on January&nbsp;17, 2017. 25% of the RSAs
vested on February&nbsp;20, 2018, and the remaining 75% of the RSAs vest in equal quarterly installments over three years thereafter, provided the holder remains in continuous service through each
vesting date. Pursuant to the terms of the separation agreements entered into with Messrs.&nbsp;Aguiar and Faerm in February 2018 in connection with their termination of employment with us, the
vesting of 41,687 RSAs and 16,675 RSAs, respectively, that were scheduled to vest on February&nbsp;20, 2018 was accelerated. The remainder of the RSAs were forfeited by Messrs.&nbsp;Aguiar and
Faerm.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(9)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Messrs.&nbsp;Aguiar,
d'Esparbes, Abercrombie and Faerm each received performance-contingent RSAs under our 2012 Incentive Plan on January&nbsp;17,
2017. The vesting of these RSAs is contingent upon both a performance-based vesting condition as well as continued service, with the performance-based vesting condition satisfied based on the relative
performance of the Company's common stock compared to the NASDAQ Biotechnology Index during the two- and three-year performance periods beginning on January&nbsp;1, 2017 and ending on
December&nbsp;31, 2018 and December&nbsp;31, 2019, as described in greater detail in the "2017 Annual Equity Awards" section of the "Compensation Discussion and Analysis" beginning on page 36. The
number of shares in column (i)&nbsp;and the value of those shares in column (j)&nbsp;reflects target performance, as no threshold is applicable to the awards. In the event we are acquired prior to
the end of the second performance period, the performance period then in progress will terminate and achievement of the performance metric will be deemed satisfied with respect to the greater of
(i)&nbsp;the "target" payout and (ii)&nbsp;the number of shares that would vest based on actual performance as calculated on the closing date of such acquisition. The service-based conditions
applicable to the performance-contingent stock awards will be deemed satisfied if the holder remains in continuous service through the date of the acquisition. In the event the payout is at less than
the maximum for the first performance period and we are acquired prior to the end of the second performance period, the achievement will still be determined as described above at the time of the
acquisition, but the payout percentage for the first performance period will be deducted from such amount. See the section entitled "Potential Payments Upon Termination or Change in Control" below for
further details on the treatment of the performance-contingent stock awards in the event we are acquired. In connection with their termination of employment with us in February 2018, these awards were
forfeited in their entirety by Messrs.&nbsp;Aguiar and Faerm.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(10)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;d'Esparbes
received RSAs under our 2012 Incentive Plan on October&nbsp;16, 2014, in connection with the commencement of his employment.
25% of the RSAs vested on October&nbsp;20, 2015, and the remaining 75% of the RSAs vest in equal quarterly installments over three years thereafter, provided Mr.&nbsp;d'Esparbes remains in
continuous service through each such vesting date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(11)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Abercrombie
received a grant of an option to purchase shares of our Common Stock under our 2012 Incentive Plan on June&nbsp;19, 2014 in
connection with the commencement of his employment. 25% of the shares subject to the option vested on June&nbsp;19, 2015, and the remaining shares vest monthly over the following three years
thereafter, subject to Mr.&nbsp;Abercrombie's continuous service through each such vesting date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(12)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Abercrombie
received RSAs under our 2012 Incentive Plan on June&nbsp;19, 2014, in connection with the commencement of his employment.
25% of the RSAs vested on August&nbsp;20, 2015, and an additional 25% of the RSAs will vest on each of August&nbsp;20, 2017, August&nbsp;20, 2018 and August&nbsp;20, 2019, provided
Mr.&nbsp;Abercrombie remains in continuous service through each such vesting date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(13)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Witek
received a grant of an option to purchase shares of our Common Stock under our 2012 Incentive Plan on July&nbsp;24, 2014 in
connection with the commencement of his employment. 25% of the shares subject to the option vested on July&nbsp;1, 2015, and the remaining shares vest monthly over the following three years
thereafter, subject to Mr.&nbsp;Witek's continuous service through each such vesting date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(14)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Witek
received RSUs under our 2012 Incentive Plan on January&nbsp;14, 2016. 25% of the RSUs vested on February&nbsp;20, 2017, 6.25% of
the RSUs vest on each of May&nbsp;20, 2017, August&nbsp;20, 2017, November&nbsp;20, 2017, February&nbsp;20, 2017, May&nbsp;20, 2018 and August&nbsp;20, 2018, and the remaining 37.5% of the
RSUs vest on November&nbsp;20, 2018, provided Mr.&nbsp;Witek remains in continuous service through each vesting date. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>46</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=49,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=175071,FOLIO='46',FILE='DISK121:[18ZAE1.18ZAE11201]DS11201A.;21',USER='CHE108062',CD='22-MAR-2018;17:09' -->
<A NAME="page_ds11201_1_47"> </A>
 <DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
<DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(15)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Witek
received performance-contingent RSUs under our 2012 Incentive Plan on January&nbsp;14, 2016. The vesting of these RSUs is
contingent upon an increase in the Company's cumulative TSR over a period of up to 32&nbsp;months from the date of grant as well as continued service. In accordance with SEC rules, the number of
shares in column (i)&nbsp;and the value of those shares in column (j)&nbsp;reflects threshold performance. In the event we are acquired prior to September&nbsp;30, 2018, the performance period
then in progress will terminate and achievement of the performance metric will be determined based on TSR Compound Annual Growth Rate using the closing price of a share of our Common Stock three days
prior to the closing date of such acquisition. The service-based conditions applicable to the performance-contingent RSUs will be deemed satisfied if Mr.&nbsp;Witek remains in continuous service
through the date of the acquisition. Any RSUs for which the performance metric is not satisfied as of the closing of the acquisition will be forfeited. See the section entitled "Potential Payments
Upon Termination or Change in Control" below for further details on the treatment of the performance-contingent RSUs in the event we are acquired.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(16)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Witek
received RSUs under our 2012 Incentive Plan on January&nbsp;17, 2017. 25% of the RSUs vested on February&nbsp;20, 2018, 6.25% of
the RSUs vest on each of May&nbsp;20, 2018, August&nbsp;20, 2018, November&nbsp;20, 2018, February&nbsp;20, 2019, May&nbsp;20, 2019 and August&nbsp;20, 2019, and the remaining 37.5% of the
RSUs vest on November&nbsp;20, 2019, provided Mr.&nbsp;Witek remains in continuous service through each vesting date.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(17)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Witek
received performance-contingent RSUs under our 2012 Incentive Plan on January&nbsp;17, 2017. The vesting of these RSUs is
contingent upon both a performance-based vesting condition as well as continued service, with the performance-based vesting condition satisfied based on the relative performance of the Company's
common stock compared to the NASDAQ Biotechnology Index during the two- and three-year performance periods beginning on January&nbsp;1, 2017 and ending on December&nbsp;31, 2018 and
September&nbsp;30, 2019, as described in greater detail in the "2017 Annual Equity Awards" section of the "Compensation Discussion and Analysis" beginning on page 36. The number of shares in column
(i)&nbsp;and the value of those shares in column (j)&nbsp;reflects target performance, as no threshold is applicable to the awards. In the event we are acquired prior to the end of the second
performance period, the performance period then in progress will terminate and achievement of the performance metric will be deemed satisfied with respect to the greater of (i)&nbsp;the "target"
payout and (ii)&nbsp;the number of RSUs that would vest based on actual performance as calculated on the closing date of such acquisition. The service-based conditions applicable to the
performance-contingent RSUs will be deemed satisfied if Mr.&nbsp;Witek remains in continuous service through the date of the acquisition. In the event the payout is at less than the maximum for the
first performance period and we are acquired prior to the end of the second performance period, the achievement will still be determined as described above at the time of the acquisition, but the
payout percentage for the first performance period will be deducted from such amount. See the section entitled "Potential Payments Upon Termination or Change in Control" below for further details on
the treatment of the performance-contingent RSUs in the event we are acquired.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(18)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Mr.&nbsp;Faerm
received RSAs under our 2012 Incentive Plan on July&nbsp;23, 2015, in connection with the commencement of his employment. 25% of
the RSAs vested on August&nbsp;20, 2016, and the remaining 75% of the RSAs vest in equal quarterly installments over three years thereafter, provided Mr.&nbsp;Faerm remains in continuous service
through each such vesting date. Pursuant to the terms of the separation agreement entered into with Mr.&nbsp;Faerm in February 2018 in connection with his termination of employment with us, the
vesting of the 6,580 RSAs that were scheduled to vest on February&nbsp;20, 2018 was accelerated. The remainder of the RSAs were forfeited by Mr.&nbsp;Faerm. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2017 Option Exercises and Stock Vested  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table shows the number of shares acquired upon exercise of options by each named executive officer during fiscal year 2017 and the
number of shares of restricted stock and restricted stock units held by each named executive officer that vested during the 2017 fiscal year. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="40pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="98pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="93pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="6pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="83pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Option Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=5 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Stock Awards </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Name </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Security </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares<BR>
Acquired on Exercise<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value Realized on<BR>
Exercise ($)<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of Shares<BR>
Acquired on Vesting<BR>
(#) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Value Realized on<BR>
Vesting ($)<SUP>(2)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(d)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(e)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Michael W. Aguiar<SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>INVA</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>194,541</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,444,455</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>TBPH</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>18,216</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>521,539</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Eric d'Esparbes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>INVA</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>60,177</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>739,205</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>George B. Abercrombie</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>INVA</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,611</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>498,312</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Theodore J. Witek, Jr.&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>INVA</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>60,432</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>761,579</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:8pt;text-indent:-8pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Michael E. Faerm</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1>INVA</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>41,006</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>504,040</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Value
realized is based on the fair market value of our Common Stock on date of exercise minus the exercise price and does not necessarily reflect
proceeds actually received by the officer.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Value
realized is based on the fair market value of our Common Stock (or, in the case of Theravance Biopharma ordinary shares received by holders of
Innoviva RSAs in the Spin-Off, the value is based on the fair market value of Theravance Biopharma's ordinary shares) on the vesting date multiplied by the number of shares vested and does not
necessarily reflect proceeds received by the officer.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>In
connection with the Spin-Off, Mr.&nbsp;Aguiar, as a holder of Innoviva RSAs received ordinary shares of Theravance Biopharma. These shares were
subject to the same terms and conditions, including vesting, as the underlying Innoviva RSAs. </FONT></DD></DL>
 </DIV>
 <P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>47</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=6,SEQ=50,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=417490,FOLIO='47',FILE='DISK121:[18ZAE1.18ZAE11201]DS11201A.;21',USER='CHE108062',CD='22-MAR-2018;17:09' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_du11201_1_48"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Potential Payments Upon Termination or Change in Control  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of our named executive officers is entitled to severance benefits pursuant to one of our severance plans. In addition, prior to his
termination of employment, Mr.&nbsp;Aguiar, our former Chief Executive Officer, was entitled to severance benefits pursuant to his letter agreement entered into in connection with his appointment as
Chief Executive Officer. Effective as of February 2018, Mr.&nbsp;d'Esparbes is also entitled to severance benefits pursuant to his letter agreement entered into in connection with his appointment as
interim Principal Executive Officer. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Change in Control Severance Benefits  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to our severance plans, if a named executive officer is subject to an involuntary termination within 3&nbsp;months prior to or
24&nbsp;months after a change in control of Innoviva, he is entitled to the following benefits provided he signs a release of claims:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> In the case of our Senior Vice Presidents, a lump sum payment equal to 150% of the officer's annual base salary and target bonus. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> In the case of our Chief Executive Officer, a lump sum payment equal to 200% of the officer's annual base salary and target bonus. </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> A pro-rata portion of the named executive officer's target bonus based on the number of full months of employment completed in the year of
termination. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Continuation of the officer's health and welfare benefits for the shorter of 18&nbsp;months (in the case of our Senior Vice Presidents) or
24&nbsp;months (in the case of our Chief Executive Officer), the expiration of the officer's continuation coverage under COBRA or the date when the officer obtains new employment offering comparable
health insurance coverage. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Full vesting of any unvested stock options, restricted stock and RSUs held by the officer other than the performance-contingent stock awards
that were granted to our named executive officers on each of January&nbsp;14, 2016 and January&nbsp;17, 2017. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Non-Change in Control Severance Benefits  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Former Chief Executive Officer.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;In addition to the severance benefits Mr.&nbsp;Aguiar was entitled to pursuant to our Change in Control
Severance
Plan, Mr.&nbsp;Aguiar's offer letter provided that if his employment was terminated by Innoviva without cause, he would receive a lump-sum severance payment of 24&nbsp;months'
salary plus two times his current target bonus provided he signs a general release of claims. "Cause" was defined as Mr.&nbsp;Aguiar's (i)&nbsp;unauthorized use or disclosure of the confidential
information or trade secrets, which use causes material harm to the Company, (ii)&nbsp;conviction of a felony under the laws of the United States or any state thereof, (iii)&nbsp;gross negligence,
or (iv)&nbsp;repeated failure to perform lawful assigned duties for thirty days after receiving written notification from the Board of Directors. In the event that Mr.&nbsp;Aguiar was eligible for
cash severance benefits under our Change in Control Severance Plan, then the severance benefits under his offer letter would not apply. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interim Principal Executive Officer.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the letter agreement entered into with Mr.&nbsp;d'Esparbes in February 2018 in
connection with his
appointment as our interim Principal Executive Officer, if his employment is terminated by Innoviva without cause, provided he executes a general release of claims, he will receive a lump-sum
severance payment of 24&nbsp;months of his then-current base salary plus his current target bonus, a pro-rata bonus for the year in which his termination occurs, and continuation of his health and
welfare benefits for the shorter of 12&nbsp;months, the expiration of his coverage under COBRA or the date when he obtains new employment offering comparable health insurance coverage. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>48</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=51,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=639311,FOLIO='48',FILE='DISK121:[18ZAE1.18ZAE11201]DU11201A.;12',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_du11201_1_49"> </A>

<P style="font-family:times;"><FONT SIZE=2><I> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All Other Named Executive Officers.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to our 2009 Severance Plan, in which all of our named executive officers other than
Mr.&nbsp;Aguiar
participate, if a Senior Vice President is terminated by the Company for reasons other than misconduct and the termination does not otherwise entitle the officer to severance benefits under such plan
(i.e.,&nbsp;the termination is not within 3&nbsp;months prior to or 24&nbsp;months after a change in control of Innoviva), he is entitled to the following benefits provided he signs a release of
claims:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> A lump sum payment equal to 100% of the officer's annual base salary. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The officer will remain eligible to receive a pro-rata bonus (based on the number of full months of employment completed in the year of
termination) for the year of termination, subject to the terms and conditions of the bonus program, including achievement of any performance conditions, payable at the same time as bonuses are paid to
active employees. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> Continuation of the officer's health and welfare benefits for the shorter of 12&nbsp;months, the expiration of the officer's continuation
coverage under COBRA or the date when the officer obtains new employment offering comparable health insurance coverage. </FONT></DD></DL>
</UL>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Conditions to Receive Severance Payments Under our Severance Plans  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to receive severance benefits under our severance plans, an officer must sign a general release of claims. In addition, severance
benefits may be conditioned upon the officer's compliance with any confidentiality agreement between the officer and the Company. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Definitions  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following definitions are used in our severance plans: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
"change in control" includes:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The consummation of a merger or consolidation if persons who were not our stockholders prior to the merger or consolidation own 50% or more of
the voting securities of the surviving company and its parent. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> A sale, transfer or other disposition of all or substantially all of our assets. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> A change in the composition of our Board of Directors as a result of which fewer than 50% of the incumbent directors either were directors on
the date 24&nbsp;months prior to the change in control (the "original directors") or were appointed or nominated for election to the Board of Directors by a majority of the original directors or
directors whose appointment or nomination was approved by at least 50% of the original directors. </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> A transaction as a result of which any person becomes the beneficial owner of 50% or more of our outstanding voting securities. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
transaction shall not constitute a change in control if its sole purpose is to change the state of the Company's incorporation or to create a holding company that will be owned in
substantially the same proportions by the persons who held the Company's securities immediately before such transaction. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
"involuntary termination" means a termination of an officer's employment by the Company for reasons other than misconduct, or an officer's resignation following (1)&nbsp;a material
diminution in the officer's authority, duties or responsibilities, (2)&nbsp;a material reduction in the officer's base compensation, (3)&nbsp;a material change in the officer's work location or
(4)&nbsp;a material breach of the officer's employment agreement by the Company. In order to qualify as an involuntary termination, the officer must give written notice to the Company within
90&nbsp;days after the initial existence of one of the conditions described above and the Company must not have cured such condition within 30&nbsp;days thereafter. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>49</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=52,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=711362,FOLIO='49',FILE='DISK121:[18ZAE1.18ZAE11201]DU11201A.;12',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_du11201_1_50"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;"Misconduct"
means an officer's (1)&nbsp;commission of any material act of fraud, embezzlement or dishonesty, (2)&nbsp;material unauthorized use or disclosure of our confidential
information or trade secrets or (3)&nbsp;other material intentional misconduct adversely affecting the business or affairs of the Company. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


280G Tax Gross-Up  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to our original Change in Control Severance Plan, in which Mr.&nbsp;Aguiar participated prior to his termination, if an officer meets
the conditions for severance payments under
such plan, and if an independent accounting firm selected by the Company determines that the officer would be subject to excise taxes under Section&nbsp;4999 of the Code as a result of payments
under the plan or otherwise, then the Company will pay the officer an additional amount equal to the excise taxes and any income and excise taxes due as a result of the Company's payment of the excise
taxes, along with any interest or penalties stemming from these taxes. Officers hired after December&nbsp;16, 2009, which includes all of our other current named executive officers, participate in
our 2009 Severance Plan. The 2009 Severance Plan does not provide for excise tax gross-ups. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
table below reflects the potential payments and benefits to which our named executive officers would be entitled under the arrangements described above (other than the letter
agreement entered into with Mr.&nbsp;d'Esparbes in February 2018 in connection with his appointment as interim Principal Executive Officer). The amounts shown in the table below assume that both the
change in control (if applicable) and termination of employment occurred on December&nbsp;29, 2017 (the last business day of the 2017 fiscal year) and that all eligibility requirements under the
severance plans (or in the case of Mr.&nbsp;Aguiar, pursuant to his offer letter) were met. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following assumptions were used in calculating the values described in the table below: </FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Value of Option
Acceleration:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;Since the exercise price per share of all unvested options held by our named executive officers was greater than the closing price
of our Common Stock on December&nbsp;29, 2017, no value is assigned to the acceleration of the options.  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Value of Restricted Stock and Restricted Stock Unit
Acceleration:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;The value of the vesting acceleration of the Innoviva RSAs and RSUs was calculated by multiplying the number of unvested shares by
the closing price of our Common Stock on December&nbsp;29, 2017 (which was $14.19 per share).  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Value of 2016 Performance-Contingent Stock Award
Acceleration:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;The value of the vesting acceleration of the performance-contingent stock awards granted to our named executive officers on
January&nbsp;14, 2016 was calculated based on maximum achievement (determined utilizing the Company's TSR Compound Annual Growth Rate in accordance with the terms of the awards).  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> Value of 2017 Performance-Contingent Stock Award
Acceleration:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;The value of the vesting acceleration of the performance-contingent stock awards granted to our named executive officers on
January&nbsp;17, 2017 was calculated based on achievement at 134% of target (determined utilizing the relative performance of the Company's common stock compared to the NASDAQ Biotechnology Index,
in accordance with the terms of the awards).  </FONT> <FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2><B> 280G Tax Gross-Up:</B></FONT><FONT SIZE=2>&nbsp;&nbsp;The
calculation of the gross-up payment in the table below to Mr.&nbsp;Aguiar is based on an excise tax rate of 20%, a 39.6% federal income tax rate, a 2.35% Medicare tax rate and a 13.30% state income
tax rate. For purposes of this calculation, it is assumed that no </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>50</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=53,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=583521,FOLIO='50',FILE='DISK121:[18ZAE1.18ZAE11201]DU11201A.;12',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_du11201_1_51"> </A>
<UL>
<UL>

<P style="font-family:times;"><FONT SIZE=2>amounts
will be discounted as attributable to reasonable compensation and no value will be attributed to Mr.&nbsp;Aguiar for executing a non-competition agreement. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>
 </UL>
</UL>
 <DIV style="padding:0pt;position:relative;width:54%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"150%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="150%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="51pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="42pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="36pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="39pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="61pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="47pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="45pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="4pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="44pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Name </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Bonus for<BR>
Year of<BR>
Termination<BR>
($)<SUP>(1)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Cash<BR>
Severance<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Vacation<BR>
Payout<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Options<BR>
that Vest ($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Restricted<BR>
Stock or RSUs<BR>
that Vest<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Health and<BR>
Welfare<BR>
($)<SUP>(2)</SUP> </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Excise Tax<BR>
Gross-Up<BR>
($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Total($) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(d)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(e)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(f)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(g)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(h)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(i)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael W. Aguiar<SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Termination Without Cause</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,716,361</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>74,697</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,791,058</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>



<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Involuntary Termination in Connection with a Change in Control</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>582,077</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,716,361</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>74,697</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>8,100,620</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>66,347</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6,766,428</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>18,306,530</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:8pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Eric d'Esparbes</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Termination Other than for Misconduct</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>221,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>443,420</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,519</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>23,082</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>695,731</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Involuntary Termination in Connection with a Change in Control</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>221,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>997,695</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>7,519</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,390,979</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>34,632</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,652,526</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:8pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 George B. Abercrombie</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Termination Other than for Misconduct</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>219,269</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>438,538</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,058</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>23,082</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>720,947</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Involuntary Termination in Connection with a Change in Control</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>219,269</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>986,710</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>40,058</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,678,478</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>34,623</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,959,137</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:8pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>Theodore J. Witek, Jr.</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Termination Other than for Misconduct</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>218,594</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>437,188</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>59,902</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>6,011</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>721,695</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1><I>Involuntary Termination in Connection with a Change in Control</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>218,594</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>983,673</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>59,902</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,290,793</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>9,016</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>3,561,977</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-top:8pt;margin-left:7pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


 Michael E. Faerm<SUP>(7)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1><BR>
&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Termination Other than for Misconduct</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>219,122</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>438,245</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(6)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>30,704</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>33,173</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>721,245</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:14pt;text-indent:-7pt;"><FONT SIZE=1> </FONT><FONT SIZE=1>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#CCEEFF" -->


</FONT> <FONT SIZE=1><I>Involuntary Termination in Connection with a Change in Control</I></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>219,122</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>986,051</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(4)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>30,704</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>2,978,277</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1><SUP>(5)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>49,760</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>&#151;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=1>4,263,915</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Reflects
payment of the officer's 2017 bonus at target.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Reflects
the cost of each officer's COBRA premiums for 12, 18 or 24&nbsp;months, as applicable.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Pursuant
to the separation agreement that was entered into with Mr.&nbsp;Aguiar in connection with his termination of employment on
February&nbsp;6, 2018, he received a lump sum severance payment of $2,704,879 (which was equal to 24&nbsp;months of his former base salary plus two times his target bonus), plus $250,000 in lieu
of his 2017 performance bonus and accelerated vesting of an aggregate of 164,045 RSAs that would have vested on February&nbsp;20, 2018.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Reflects
payment of 150% of the officer's base salary and target bonus or, in the case of Mr.&nbsp;Aguiar, 200% of his base salary and target bonus.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(5)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Reflects
full vesting of all unvested RSAs and RSUs other than the performance-contingent stock awards that were granted to our named executive
officers on January&nbsp;17, 2017, of which 134% of target would have vested in the event of a change in control on December&nbsp;29, 2017 (as determined in accordance with the terms of such
awards).
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(6)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Reflects
100% of the officer's base salary.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-9pt;'><FONT SIZE=1><SUP>(7)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=1>Pursuant
to the separation agreement that was entered into with Mr.&nbsp;Faerm in connection with his termination of employment on
February&nbsp;7, 2018, he received a lump sum severance payment of $456,505.08 (which was equal to 12&nbsp;months of his former base salary plus 1/12<SUP>th</SUP>&nbsp;of his target 2018
performance bonus) plus: $100,000 in lieu of his 2017 performance bonus; Company-paid COBRA until the earlier of (i)&nbsp;12&nbsp;months following his termination of employment, (ii)&nbsp;the
expiration of his continuation coverage under COBRA and (iii)&nbsp;the date he obtains new employment offering comparable health insurance coverage; and accelerated vesting of an aggregate of 47,728
RSAs that would have vested on February&nbsp;20, 2018. </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Pay Ratio Disclosure  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As required by the Dodd-Frank Act and SEC rules, we are providing the following information about the relationship of the annual total
compensation of our employees and the annual total compensation of Michael Aguiar, our Chief Executive Officer as of December&nbsp;31, 2017: </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
our fiscal year ended December&nbsp;31, 2017:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The median of the annual total compensation of all employees (other than our CEO) was $382,460; and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> The annual total compensation of our CEO, as reported in the 2017 Summary Compensation Table included elsewhere in this Proxy Statement, was
$4,176,840. </FONT></DD></DL>
</UL>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>51</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=54,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=474060,FOLIO='51',FILE='DISK121:[18ZAE1.18ZAE11201]DU11201A.;12',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_du11201_1_52"> </A>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on this information, the ratio of the annual total compensation of Mr.&nbsp;Aguiar to the median of the annual total compensation of our employees was 11:1. </FONT></P>


<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
above ratio is appropriately viewed as an estimate. To identify the median of the annual compensation of our employees, we reviewed the Box&nbsp;1 Form&nbsp;W-2 compensation of
our employees (or, in the case of our Canadian employee, Box&nbsp;14 of the T4 Statement of Remuneration Paid) as of December&nbsp;31, 2017 for the period from January&nbsp;1, 2017 through
December&nbsp;31, 2017. As of December&nbsp;31, 2017, we had 12 employees, including 1 employee in Canada. No cost-of-living or other adjustments were made. Once we identified our "median
employee" using the methodology described above, we determined that employee's annual total compensation in accordance with the requirements of Item&nbsp;402(c)(2)(x) of Regulation&nbsp;S-K for
purposes of calculating the required pay ratio. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Securities Authorized for Issuance Under Equity Compensation Plans  </B></FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Equity Compensation Plans  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table provides certain information with respect to all of our equity compensation plans in effect as of December&nbsp;31, 2017: </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:62%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"130%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="130%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="122pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="94pt" style="font-family:times;"></TD>
<TD WIDTH="18pt" style="font-family:times;"></TD>
<TD WIDTH="7pt" ALIGN="RIGHT" style="font-family:times;"></TD>
<TD WIDTH="122pt" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="BOTTOM">
<TH ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Plan Category </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of securities to be<BR>
issued upon exercise of<BR>
outstanding options,<BR>
warrants and rights </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Weighted-average<BR>
exercise price of<BR>
outstanding options,<BR>
warrants and rights </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=1><B>Number of securities<BR>
remaining available<BR>
for future issuance under<BR>
equity compensation plans<BR>
(excluding securities<BR>
reflected in column (a)) </B></FONT></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR VALIGN="BOTTOM">
<TH ALIGN="LEFT" style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(a)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(b)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH COLSPAN=2 ALIGN="CENTER" style="font-family:times;"><FONT SIZE=1><B>(c)</B></FONT><BR></TH>
<TH style="font-family:times;"><FONT SIZE=1>&nbsp;</FONT></TH>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity compensation plans approved by security holders</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>1,956,470</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(1)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>24.34</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,597,491</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(4)</SUP></FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Equity compensation plans not approved by security holders</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>53,493</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>10.79</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>&#151; </FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR BGCOLOR="#CCEEFF" VALIGN="BOTTOM">
<TD style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT><FONT SIZE=2>Total</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>2,009,963</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(1)(2)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>
<!-- -->
$</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>23.90</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(3)</SUP></FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD ALIGN="RIGHT" style="font-family:times;"><FONT SIZE=2>3,597,491</FONT></TD>
<TD style="font-family:times;"><FONT SIZE=2><SUP>(4)</SUP> </FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>

<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0.75pt;font-size:0.75pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0.75pt;font-size:0.75pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
</TR>
<TR bgcolor="#FFFFFF"  VALIGN="BOTTOM">
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2>


<!-- COMMAND=ADD_ROWSHADECOLOR,"#FFFFFF" -->




<!-- COMMAND=ADD_GUTTERGRID,"line-height:0pt;font-size:1.5pt;" -->


 </font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;



<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 </TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD ALIGN="RIGHT" style="line-height:0pt;font-size:1.5pt;font-family:times;border-bottom:solid #000000 1.0pt;"><FONT SIZE=2></font>&#8203;


<!-- COMMAND=ADD_GRID,"border-bottom:solid #000000 1.0pt;" -->


 <font></FONT></TD>
<TD style="line-height:0pt;font-size:1.5pt;font-family:times;"><FONT SIZE=2></font>&#8203;<font> </FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->


<!-- COMMAND=ADD_LINERULETXT,NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" -->
<HR NOSHADE  COLOR="#000000" SIZE="1.0PT" WIDTH="26%" ALIGN="LEFT" >
 </DIV>
<DIV style="padding:0pt;position:relative;text-align:left;margin-left:10%;">
 <DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(1)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
1,586,719 shares issuable upon exercise of outstanding options and 369,751 shares issuable upon vesting of outstanding restricted stock units.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(2)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
53,493 shares issuable upon exercise of outstanding options and no outstanding restricted stock units.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(3)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Does
not take into account outstanding restricted stock units as these awards have no exercise price.
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2><SUP>(4)</SUP></FONT></DT><DD style="font-family:times;"><FONT SIZE=2>Includes
205,979 shares of Common Stock available for issuance under our 2004 Employee Stock Purchase Plan.  </FONT></DD></DL>
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Innoviva,&nbsp;Inc. 2008 New Employee Equity Incentive Plan is a non-stockholder approved plan, which was adopted by the Board of Directors on January&nbsp;29, 2008 and amended
on July&nbsp;21, 2009 and was intended to satisfy the requirements of Nasdaq Marketplace Rule&nbsp;5635(c)(4). Non-statutory options, RSUs and RSAs were granted under the New Employee Equity
Incentive Plan to new employees of the Company. The Board of Directors authorized 700,000 shares of Common Stock for issuance under the New Employee Equity Incentive Plan. All option grants had an
exercise price per share of no less
than 100% of the fair market value per share of Common Stock on the grant date. Each option, RSU and restricted stock award vests in installments over the holder's period of service with the Company.
Additional features of the New Employee Equity Incentive Plan are outlined in Note&nbsp;6 to our consolidated financial statements in our Annual Report on Form&nbsp;10-K filed on
February&nbsp;23, 2018. Following the approval by stockholders of the amendment and restatement of the Innoviva,&nbsp;Inc. 2004 Incentive Plan at our Annual Meeting on April&nbsp;27, 2010, no
additional awards have been made or will be made in the future under the 2008 New Employee Equity Incentive Plan. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>52</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=5,SEQ=55,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=1011910,FOLIO='52',FILE='DISK121:[18ZAE1.18ZAE11201]DU11201A.;12',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P style="font-family:times;"><FONT SIZE=2><A
NAME="page_dw11201_1_53"> </A>

<!-- COMMAND=ADD_BASECOLOR,"#000000" -->




<!-- COMMAND=ADD_DEFAULTFONT,"font-family:times;" -->




<!-- COMMAND=ADD_TABLESHADECOLOR,"#CCEEFF" -->




<!-- COMMAND=ADD_STABLERULES,"border-bottom:solid #000000 1.0pt;" -->





<!-- COMMAND=ADD_DTABLERULES,"border-bottom:double #000000 2.25pt;" -->




<!-- COMMAND=ADD_SCRTABLERULES,"border-bottom:solid #000000 1.0pt;margin-bottom:0pt;" -->




<!-- COMMAND=ADD_DCRTABLERULES,"border-bottom:double #000000 2.25pt;margin-bottom:0pt;" -->


</FONT></P>

<!-- TOC_END -->
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dw11201_certain_relationships___dw102286"> </A>
<A NAME="toc_dw11201_1"> </A>
<BR></FONT><FONT SIZE=2><B>  CERTAIN RELATIONSHIPS AND RELATED PERSONS TRANSACTIONS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to the compensation arrangements with directors and executive officers described elsewhere in this Proxy Statement, the following is
a description of transactions since January&nbsp;1, 2017, in which we have been a participant, in which the amount involved exceeded or will exceed $120,000 and in which any of our directors,
executive officers, beneficial holders of more than 5% of our capital stock, or entities affiliated with them, had or will have a direct or indirect material interest. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Agreements with GSK  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have previously entered into significant agreements with GSK, which resulted in transactions with GSK during the fiscal year ended
December&nbsp;31, 2017 and transactions that have and may occur during the current fiscal year. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


LABA Collaboration  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In November 2002, we entered into our long-acting beta<SUB>2</SUB> agonist (LABA) collaboration with GSK to develop and commercialize
once-daily LABA products for the treatment of chronic obstructive pulmonary disease (COPD) and asthma (the "Collaboration Agreement"). For the treatment of COPD, the collaboration has developed three
combination products:</FONT></P>

<UL>
<DL compact>
<DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> RELVAR&reg;/BREO&reg; ELLIPTA&reg; (FF/VI) (BREO&reg; ELLIPTA&reg; is the proprietary name in the U.S.
and Canada and RELVAR&reg; ELLIPTA&reg; is the proprietary name outside the U.S. and Canada), a once-daily combination medicine consisting of a LABA, vilanterol (VI), and an inhaled
corticosteroid (ICS), fluticasone furoate (FF), </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> ANORO&reg; ELLIPTA&reg; (UMEC/VI), a once-daily medicine combining a long-acting muscarinic antagonist ("LAMA"), umeclidinium
bromide (UMEC), with a LABA, VI, and </FONT><FONT SIZE=2>
<BR><BR></FONT></DD><DT style='font-family:times;margin-bottom:-11pt;'><FONT SIZE=2>&#149;</FONT></DT><DD style="font-family:times;"><FONT SIZE=2> TRELEGY&reg; ELLIPTA&reg; (the combination FF/UMEC/VI), a once-daily combination medicine consisting of an ICS, LAMA and LABA. </FONT></DD></DL>
</UL>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result of the launch and approval of RELVAR&reg;/BREO&reg; ELLIPTA&reg; and ANORO&reg; ELLIPTA&reg; in the U.S., Japan and Europe, in
accordance with the LABA Collaboration Agreement, we paid milestone fees to GSK totaling $220.0&nbsp;million during the year ended December&nbsp;31, 2014. Although we have no further milestone
payment obligations to GSK pursuant to the LABA Collaboration Agreement, we continue to have ongoing commercialization activities under the LABA Collaboration Agreement, including participation in the
joint steering committee and joint project committee that are expected to continue over the life of the agreements. The milestone fees paid to GSK were recognized as capitalized fees paid to a related
party, which are being amortized over their estimated useful lives commencing upon the commercial launch of the products. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are entitled to receive royalties from GSK on sales of RELVAR&reg;/BREO&reg; ELLIPTA&reg; as follows: 15% on the first $3.0&nbsp;billion of annual global net
sales and 5% for all annual global net sales above $3.0&nbsp;billion. For other products combined with a LABA from the LABA collaboration, such as ANORO&reg; ELLIPTA&reg;, royalties
are upward tiering and range from 6.5% to 10%. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are also entitled to 15% of royalty payments made by GSK under its agreements originally entered into with us, and since assigned to TRC in connection with the spin-off of Theravance
Biopharma,&nbsp;Inc. ("Theravance Biopharma") in June 2014 (the "Spin-Off"), relating to TRELEGY&reg; ELLIPTA&reg;, which royalties are upward tiering and range from 6.5% to 10%. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><I>



<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


2004 Strategic Alliance  </I></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In March 2004, we entered into the Strategic Alliance Agreement with GSK where GSK received an option to license exclusive development and
commercialization rights to product candidates from </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>53</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=56,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=406204,FOLIO='53',FILE='DISK121:[18ZAE1.18ZAE11201]DW11201A.;10',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_dw11201_1_54"> </A>

<P style="font-family:times;"><FONT SIZE=2>certain
of our discovery programs on pre-determined terms and on an exclusive, worldwide basis. In 2005, GSK licensed our MABA program for the treatment of COPD, and in October 2011, we and GSK
expanded the MABA program by adding six additional Innoviva-discovered preclinical MABA compounds (the "Additional MABAs"). The development program has been funded in full by GSK as of
December&nbsp;31, 2017 and is in Phase&nbsp;II clinical studies stage. GSK is in the process of determining next steps for the program. As a result of the transactions effected by the Spin-Off, we
are only entitled to receive 15% of any contingent payments and royalties payable by GSK from sales of products that may be developed under the Strategic Alliance Agreement, such as MABA, and MABA/FF,
while Theravance Biopharma receives 85% of those same payments. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Agreement with Sarissa  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On February&nbsp;12, 2018, we entered into an agreement (the "Sarissa Agreement") with Sarissa Capital Management&nbsp;LP, and certain of
its affiliates (collectively, the "Sarissa Group"). Concurrently with the execution of the Sarissa Agreement, pursuant to resolutions approved by the Board of Directors, the total number of directors
constituting the Board of Directors was increased from eight&nbsp;(8) to ten (10)&nbsp;directors in accordance with our Amended and Restated Bylaws, and each of Jules Haimovitz, Sarah Schlesinger,
M.D. and Mark DiPaolo Esq. were appointed as directors to fill an existing and the resulting vacancies on the Board of Directors with a term expiring at the Annual Meeting or until their respective
successors have been duly elected and qualified. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Sarissa Agreement, we also agreed, among other things, to (a)&nbsp;convene the Annual Meeting no later than May&nbsp;1, 2018, and to not postpone or adjourn (once
convened) the Annual Meeting without the prior written consent of the Sarissa Group, and (b)&nbsp;nominate a five-person slate for election as directors at the Annual Meeting consisting solely of
Odysseas Kostas, M.D., George Bickerstaff, III, Jules Haimovitz, Sarah Schlesinger, M.D. and Mark DiPaolo, Esq. If prior to the Annual Meeting, any of the foregoing nominees is unable to serve or
informs us that he or she does not wish to serve or ceases to serve (or indicates to us his or her desire to cease to serve) as a director for any reason, the Sarissa Group will have the ability to
identify a replacement, subject to the provisions of the Sarissa Agreement. We also agreed to reimburse the Sarissa Group for its reasonable out-of-pocket fees and expenses (including legal expenses)
in an aggregate amount of up to $2.7&nbsp;million. In addition, we agreed that prior to the completion of the Annual Meeting, we will not, without the prior written consent of the Sarissa Group,
(i)&nbsp;increase the size of (or support any person who is seeking to increase the size of) the Board of Directors or fill any vacancy on the Board of Directors, or (ii)&nbsp;amend our
certificate of incorporation or bylaws. </FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Sarissa Agreement further provides that, so long as we have not materially breached the Sarissa Agreement, the Sarissa Group will, and will cause its affiliates to, vote all of the
shares of Common Stock that are beneficially owned by them as of the record date for the 2018 Annual Meeting for the election of each of Odysseas Kostas, M.D., George Bickerstaff, III, Jules
Haimovitz, Sarah Schlesinger, M.D. and Mark DiPaolo, Esq. at the Annual Meeting. </FONT></P>

<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


REVIEW, APPROVAL OR RATIFICATION OF TRANSACTIONS WITH RELATED PERSONS  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transactions, arrangements or relationships in which we were, are or will be a participant and the amount involved exceeds $120,000, and in
which any related person had, has or will have a direct or indirect material interest are subject to review, approval or ratification by our Board of Directors or a committee of our Board of
Directors. Our Audit Committee, which has the principal
responsibility for reviewing related person transactions, has adopted written policies and procedures with respect to related person transactions. In conformance with SEC regulations, these policies
and procedures define related persons to include our executive officers, our directors and nominees to become a director of our company, any person who is known to us to be the beneficial owner of
more than 5% of any class of our voting securities, any immediate family member of any of the foregoing persons, and any firm, </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>54</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=2,SEQ=57,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=943068,FOLIO='54',FILE='DISK121:[18ZAE1.18ZAE11201]DW11201A.;10',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_dw11201_1_55"> </A>

<P style="font-family:times;"><FONT SIZE=2>corporation
or other entity in which any of the foregoing persons is employed, is a general partner or in which such person has a 5% or greater beneficial ownership interest. As set forth in our
policies and procedures, it is our general policy to approve or ratify related person transactions only when our Board of Directors or a committee of our Board of Directors determines that the
transaction is in, or is not inconsistent with, our and our stockholders' best interests, including situations where we may obtain products or services of a nature, quantity or quality, or on other
terms, that are not readily available from alternative sources or when the transaction is on terms comparable to those that could be obtained in arm's length dealings with an unrelated third party. </FONT></P>


<P style="font-family:times;;margin-left:10.0pt;text-indent:-10.0pt;"><FONT SIZE=2><B>


<!-- COMMAND=STYLE_ADDED,"margin-left:10.0pt;text-indent:-10.0pt;" -->


Delivery of Documents to Stockholders Sharing an Address  </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A number of brokers with account holders who are Innoviva,&nbsp;Inc. stockholders may be "householding" our proxy materials. A single proxy
statement will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker
that they will be "householding" communications to your address, "householding" will continue until you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to
participate in "householding" and would prefer to receive a separate proxy statement and annual report, please notify your broker and direct your written request to Innoviva,&nbsp;Inc., 2000 Sierra
Point Parkway, Suite&nbsp;500, Brisbane, California 94005 Attention: Corporate Secretary or contact Eric d'Esparbes, Interim Principal Executive Officer, Senior Vice President and Chief Financial
Officer, at (650)&nbsp;238-9640. Stockholders who currently receive multiple copies of the proxy statement at their address and would like to request "householding" of their communications should
contact their broker. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dw11201_other_matters"> </A>
<A NAME="toc_dw11201_2"> </A>
<BR></FONT><FONT SIZE=2><B>  OTHER MATTERS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are
properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>55</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=3,SEQ=58,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=1028469,FOLIO='55',FILE='DISK121:[18ZAE1.18ZAE11201]DW11201A.;10',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<A NAME="page_dw11201_1_56"> </A>
<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2><A
NAME="dw11201_forward-looking_statements"> </A>
<A NAME="toc_dw11201_3"> </A>
<BR></FONT><FONT SIZE=2><B>  FORWARD-LOOKING STATEMENTS    <BR>    </B></FONT></P>

<P style="font-family:times;"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Proxy Statement contains certain "forward-looking" statements as that term is defined in the Private Securities Litigation Reform Act of
1995 regarding, among other things, statements relating to goals, plans, objectives and future events. The Company intends such forward-looking statements to be covered by the safe harbor provisions
for forward-looking statements contained in Section&nbsp;21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks,
uncertainties and assumptions. Examples of such forward-looking statements include statements relating to: prescription and market share trends, payor coverage, the strategies, plans and objectives of
the Company, future purchases under the Company's future capital return program or otherwise, the status and timing of clinical studies, data analysis and communication of results, the potential
benefits and mechanisms of action of product candidates, expectations for products, and projections of revenue, expenses and other financial items. These forward-looking statements are based on the
current estimates and assumptions of the management of the Company as of the date of this Proxy Statement and are subject to risks, uncertainties, changes in circumstances, assumptions and other
factors that may cause the actual results of the Company to be materially different from those reflected in the forward-looking statements. Important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements include, among others, risks related to: lower than expected future royalty revenue from respiratory products partnered with GSK;
delays or difficulties in commencing or completing clinical studies; the potential that results from clinical or non-clinical studies indicate product candidates are unsafe or ineffective; dependence
on third parties to conduct its clinical studies; delays or failure to achieve and maintain regulatory approvals for product candidates; risks of collaborating with third parties to discover, develop
and commercialize products; significant litigation and environmental matters; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as
inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural
disasters; the ability to protect and enforce the Company's intellectual property rights; and the ability to respond to the actions of the Company's competitors. In addition to the risks described
above and in the Company's other filings with the SEC, other unknown or unpredictable factors also could affect the Company's results. Past performance is not necessarily indicative of future results.
No forward-looking statements can be guaranteed and actual results may differ materially from such statements. Given these uncertainties, you should not place undue reliance on these forward-looking
statements. The Company assumes no obligation to update its forward-looking statements on account of new information, future events or otherwise, except as required by law. </FONT></P>
 <div style="display:none;*display:block;margin-top:-1pt;"></div>

 <DIV style="padding:0pt;position:relative;width:80%;margin-left:10%;">
 <!-- COMMAND=ADD_TABLEWIDTH,"100%" -->

<!-- User-specified TAGGED TABLE -->
<DIV ALIGN="CENTER"><TABLE width="100%"  BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR><!-- TABLE COLUMN WIDTHS SET -->
<TD WIDTH="48%" style="font-family:times;"></TD>
<TD WIDTH="12pt" style="font-family:times;"></TD>
<TD WIDTH="48%" style="font-family:times;"></TD>
<!-- TABLE COLUMN WIDTHS END --></TR>

<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>By Order of the Board of Directors</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:10pt;text-indent:-10pt;"><FONT SIZE=2> </FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD VALIGN="BOTTOM" style="font-family:times;"><p style="font-family:times;margin-top:12pt;margin-left:0pt;text-indent:0pt;"><FONT SIZE=2> </FONT><FONT SIZE=2><B>
<IMG SRC="g303095.jpg" ALT="GRAPHIC" WIDTH="132" HEIGHT="36">
 </B></FONT><FONT SIZE=2><BR>
<BR>
Eric d'Esparbes<BR></FONT> <FONT SIZE=2><I>Interim Principal Executive Officer, Senior Vice President and Chief Financial Officer</I></FONT></TD>
</TR>
</TABLE></DIV>
<!-- end of user-specified TAGGED TABLE -->
 </DIV>
 <P style="font-family:times;"><FONT SIZE=2>March&nbsp;23,
2018 </FONT></P>

<P ALIGN="CENTER" style="font-family:times;"><FONT SIZE=2>56</FONT></P>

<HR NOSHADE>
<P style='font-family:times;page-break-before:always'></p>
<!-- ZEQ.=4,SEQ=59,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=934845,FOLIO='56',FILE='DISK121:[18ZAE1.18ZAE11201]DW11201A.;10',USER='CHE109864',CD='21-MAR-2018;13:52' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">VOTE BY   INTERNET - www.proxyvote.com Use the Internet to transmit your voting   instructions and for electronic delivery of information up until 11:59 p.m.   Eastern Time the day before the cut-off date or meeting date. Have your proxy   card in hand when you access the web site and follow the instructions to   obtain your records and to create an electronic voting instruction form.   INNOVIVA, INC. 2000 SIERRA POINT PARKWAY, SUITE 500 BRISBANE, CA 94005   ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the   costs incurred by our company in mailing proxy materials, you can consent to   receiving all future proxy statements, proxy cards and annual reports   electronically via e-mail or the Internet. To sign up for electronic   delivery, please follow the instructions above to vote using the Internet   and, when prompted, indicate that you agree to receive or access proxy   materials electronically in future years. VOTE BY PHONE - 1-800-690-6903 Use   any touch-tone telephone to transmit your voting instructions up until 11:59   p.m. Eastern Time the day before the cut-off date or meeting date. Have your   proxy card in hand when you call and then follow the instructions. VOTE BY   MAIL Mark, sign and date your proxy card and return it in the postage-paid   envelope we have provided or return it to Vote Processing, c/o Broadridge, 51   Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK   INK AS FOLLOWS: E42320-P03943 KEEP THIS PORTION FOR YOUR RECORDS DETACH AND   RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.   INNOVIVA, INC. The Board of Directors recommends you vote FOR the following:   1. Election of Directors Nominees: For Against Abstain ! ! ! ! ! ! ! ! ! ! !   ! ! ! ! 1a. George W. Bickerstaff, III 1b. Mark DiPaolo, Esq. 1c. Jules   Haimovitz 1d. Odysseas D. Kostas, M.D. 1e. Sarah Schlesinger, M.D. The Board   of Directors recommends you vote FOR proposals 2 and 3. For Against Abstain !   ! ! ! ! ! 2. Approve the non-binding advisory resolution regarding executive   compensation. 3. Ratify the selection by the Audit Committee of the Board of   Directors for Ernst &amp; Young LLP as the Company's independent registered   public accounting firm for the fiscal year ending December 31, 2018. NOTE:   Such other business as may properly come before the meeting or any   adjournment thereof. Please sign exactly as your name(s) appear(s) hereon.   When signing as attorney, executor, administrator, or other fiduciary, please   give full title as such. Joint owners should each sign personally. All holders   must sign. If a corporation or partnership, please sign in full corporate or   partnership name by authorized officer. Signature [PLEASE SIGN WITHIN BOX]   Date Signature (Joint Owners) Date </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="935" height="1209" src="g22122bgi001.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=60,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=675481,FOLIO='',FILE="DISK135:[18ZAE2.18ZAE11202]2212-2-BG_ZAE11202.CHC",USER="DSCHWAR",CD='Mar 21 02:46 2018' -->

<br clear="all" style="page-break-before:always;">
<div>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">Important   Notice Regarding the Availability of Proxy Materials for the Annual Meeting:   The Notice and Proxy Statement and Annual Report are available at   www.proxyvote.com. E42321-P03943 INNOVIVA, INC. Annual Meeting of   Stockholders April 24, 2018 THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS   The undersigned hereby appoints Eric d'Esparbes, with power of substitution,   as proxy and attorney-in-fact and hereby authorizes Mr. d'Esparbes to   represent and vote, as provided on the other side, all the shares of   Innoviva, Inc. Common Stock which the undersigned is entitled to vote, and,   in his discretion, to vote upon such other business as may properly come   before the Annual Meeting of Stockholders of the company to be held April 24,   2018 or at any adjournment or postponement thereof with all powers which the   undersigned would possess if present at the Meeting. This proxy, when   properly executed, will be voted in the manner directed herein. If no such   direction is made, this proxy will be voted in accordance with the Board of   Directors' recommendations. Continued and to be signed on reverse side </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="935" height="1209" src="g22122bgi002.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- ZEQ.=1,SEQ=61,EFW="2234992",CP="INNOVIVA, INC.",DN="1",CHK=596416,FOLIO='',FILE="DISK135:[18ZAE2.18ZAE11202]2212-2-BG_ZAE11202.CHC",USER="DSCHWAR",CD='Mar 21 02:46 2018' -->

<BR>
<P><br><A NAME="18ZAE11201_1">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_be11201_1">Innoviva, Inc. 2000 Sierra Point Parkway, Suite 500 Brisbane, California 94005 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held On April 24, 2018</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_de11201_1">Innoviva, Inc. 2000 Sierra Point Parkway, Suite 500 Brisbane, California 94005 PROXY STATEMENT FOR THE 2018 ANNUAL MEETING OF STOCKHOLDERS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dg11201_1">PROPOSAL 1 ELECTION OF DIRECTORS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk11201_1">PROPOSAL 2</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk11201_2">ADVISORY VOTE ON EXECUTIVE COMPENSATION</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk11201_3">PROPOSAL 3</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk11201_4">RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dk11201_5">REPORT OF THE AUDIT COMMITTEE(1)</A></FONT><BR>

<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dm11201_1">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_do11201_1">COMPENSATION DISCUSSION AND ANALYSIS</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dq11201_1">COMPENSATION COMMITTEE REPORT(1)</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dw11201_1">CERTAIN RELATIONSHIPS AND RELATED PERSONS TRANSACTIONS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dw11201_2">OTHER MATTERS</A></FONT><BR>
<FONT SIZE=2 style="font-family:times;"><A HREF="#toc_dw11201_3">FORWARD-LOOKING STATEMENTS</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=DSCHWAR,SEQ=,EFW="2234992",CP="INNOVIVA, INC.",DN="1" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g114007.jpg
<DESCRIPTION>G114007.JPG
<TEXT>
begin 644 g114007.jpg
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M'EO"5CU?K.#&F-,,CE5O8(3*LS?7$NX+>ZO3QAEHZ2I%729HBE8C/OC2.EU
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M$J[<G8UE)1[7[A J5UFKQ((@;A-WV$![A^;RA_ZAG#%P" A\P$! 0$!]P$!
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M8Q3=0W\2]0+EQK\SVIG*'B"+5CVF35Z-E!^JR0*S8S>7M>I2%K.2*T_.W$J
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A(&*("(" @(" B AVZXP(R-*'8L<P*']0,FP!_H"77__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g303095.jpg
<DESCRIPTION>G303095.JPG
<TEXT>
begin 644 g303095.jpg
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MH?YITCZ,Q"LAUBRJU*FLZBILI8U#7]14OS"+?J*8.&S=L_?Q8\JS)-,LC&C
M7L7'.V6^'"XD4]:.F! >W=ZQ[RUY!\O<J1ZXBT7+VO.>F^@8W+0-O]QV9-MI
M9UU(W4Q%/Q;TT L]TPPC7;D7J\0=A!T"#@1*1 ."(F&AL@,1=_(/H[^/GYXU
MW&Y#_P"W0V8=HV[.)J<G]A=#=43$Q-K@FQ\T@.8_4P:!NHVPRS8#A#!LU2_
M6=K+ZO"+Y\[>/U]\/$^'P^'P^'P^'P^).N;FR"2/WAXTZ3?E9AI.H5PST6!$
M"&YAG_AV[87,&0%!RY#.!3EYJ^68W1*LO%V!5CH[781Y19+;4<XT?NQ^'P^'
&P^'P^?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g22122bgi001.gif
<DESCRIPTION>G22122BGI001.GIF
<TEXT>
begin 644 g22122bgi001.gif
M1TE&.#=AIP.Y!'<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M@8A-4M!$HR4[H0-+$HT0B(A#'%:@MQ_XJ06 V!LG'&E1@<A@GF7\(A\FE3(
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M- 5 A4C  EI0-"XP6JF("=>7;1+C VGP3 >@!11 !R5C!VKU KRXC->6 T:
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M,@RJP *W@(IOOA32$-B;7*<FN )$+)T/RG ""#R8+,YVI1]@,.=$OD +7L"
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MK" Q/S@$C< *CSO!0]@#/4C!G2E+)7"XTY%((XC(-6I()7 GH_3+AJF,0=0
M'ZC);:&+ 1"(GI2;V6""-%!#D3&C!$C,O_Q+B0/)(CB!E9.!I<R O,Q,)2 $
ML,R D].9A;- "?!(1TE-"4"$E<, U!P&I*K((\" >(B"(M@!2PA(HD,-G<.V
M_S28 12P!"Z@@(53 AZ8S<*DS.5DSN9T3D'2/X? "A/P0,S,"B;@.':\31$P
MRX9$N-V9RYRKR"]8R\=(S>HRA&$@SXY3@ /@ R(H"2K8.=X\#?<<!AK @-8\
M N"\J1FX@*2"3_I\S@$ET (U4).1 $,@ GW134E24!QP32M8N00]!'#8.0RP
M!"+X-7PDP9P[R';@ WUTI2A(A9+4.12 R:E(@P0<LA082]5H@7QL@*M,P98[
M R%(P3RXOP [T![UT1\%THCYRH*TOV% QX$S _@4@-3$T <P@]@$ *PH@H03
M.#R8.  HRSB . #H 8PDNBQ5!<=H.3SPAP!X ']X /\+5 VD;#A"\ ,+S(--
MT,!+\(D,O-(@Q=/5X$$ZBHDC8[NG8P&RF@V<R0 J<QL,40U"A8V6,(*GZ\O8
ML  9"$JWX32@D-2=JM1W2:Y'E0VT:3\3DH$8W VT$57=6*G6.("HB0WKRU/;
M0,E;4,J)Y-(H\(<(M("E7, H>(""!  =-8,@8 - ,$!T)(B%2\ Q6U''J*/]
M*U']$X.0P,>8=$\BH #>+(496$C;1#DZV+^)RP- , ,N: =ODH%\Q,]6Q=/G
M,!"@"($J"$KP (% +57#81L$( 2;T8UZA0TFR(+)M(T7F(!U?8U.? B E<)[
MD0$DH)K:P N( *"#-54Z@-C_W"@,8%R-R5!.=.6-DU. 'M@";HP 75TCVYR#
M@3@ D34:%/D#(L""(># 'M@_I4A0UWR(+B6"/;/-"(0(V(R!KN3-F?T<^?2"
MA,.*FR4Z%.D$,X@#,0@!C.1(C?U+4\2"3N& V)F=SE01&QB$=:4+._B!&@@#
M+?@@XR&#*9#7&D2.#8B/## .;&,;6@H>S(JB&(F!TNF$+I +>%4@&+F'9,(!
M+ @S9H&//L""(7,(7@*I3A@ ("B1/9@'YG@"^L@X6:1;2^S;B @@U"D *AR
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M@22>!Q (B5MJ#W3*@YDQIB]8S.H: Q[+@EI  TC!GS>H _^Z$H$NV("#N)F
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M;N<8$[I @@U0J2Q8@H2@ *80W47@8Y+ -'=BBD&@6J%^ Q1@+=P=DT)I/ [
M@B-C ^U&%?-JK]EUBX9-:^,HG'*Z@T3#GLEB@"KHM0*HJHA(900A%/@BHDJ!
M":GQ@'+MMR&HY$+U'UU&!!TXLB4P&H').*%H"P_ @%(H(7[Q@PKOC!, W#ES
MJG0Q(\4XML(XAX'0FL@& !.7@1S \<KV\1^_%[HP@ :( "A @1UKS^H(X@H
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MYZ3.:<.ZRM4&'X2.::7(G$@J\(=Y!B 5_[-/%@S  2&,J@!"(%%'Y,6!/D
M4)TKJ#([5@ VQ" $$X "_Q0<0+ N?& >GBC>%%@ A)Q-8 H;\)T$M( )'R:2
M R3 0 A T(4I@"4+(%A "(!  0L8P < *, $OC !%8BD>$L0 ,3>X$F"00$-
M=?!!\18!%@&(8 D' (%C0P"%N^*+$'6XP $X ('B(>%@8;TM;G.K6R<5A @U
M$$EKSL$0:R)B!A>83!1N(8/D6D0U+F/7'V[108HH %(IR0-V'% ]B? F: G1
MC'R(T X#I  XE/L(&_: HT M121.,6ZRYE20*]AQ!OS 6IUFL*_K_@<&&V@
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M7#4&"#Z)C8MT5%+=Q&PA:]P03R<N%O A"(($!(J..BUM<8*BB<829K70CB%
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M5,B 'O1=L,3$=S:'(0S#$"0$R1!"932 #&S :6P!?+ IK,:JK"HD?Y;,+7A
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M%2@Q$JG(P3!!" @!4A#Q\):Q&>O6^?*(C\A "GC@>@0)!(1!&8"Q&W !"K
M&MS2'-5 &3Q!']S &^Q(#'PO)&Z $'"!#X3Q ]Q &=!!(>!8(1!50K0#'E\*
M]04!>>1/ X0+(^\ !H1+^53 '[]!'S3G"W0J#3B4#Y@F&V,!"O02!(C A.V
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M)&"(M%(O69C B!)@,(*0%+!8!-2TZ/B!$QH*2. ''<:B_Y2!.)K8@P%R8["
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M+850G00^"8!&>B"5:5@,*B\@ T  H0@6T,(1(J")+0V/E[WT)8^.1X$@)8^
M4( >"):@ )E,@ WS0  +E_ <"WCIB3 8P@:J, ]FA0!\$SC?%-)E &_*Q #F
MBA*Z !&$)14 ! WS$I@T=81)66 >ED*59>!WJ?E%8@%Q N<$K#<&)&S 5/3,
M6@'($*DVD<I,"ZC9(C;PF!0Z@#0D3,L;'N,I%J2@!ADX !W8=X\]Z*EF-SM3
MFU" T9BT2:)#<Q,&A!9(,@JM'6?RBIV\HHE^AH $,L#!$&X9_Q,9,. A;8+
M(I]$MI>ZI0 ZG1I2+^4"-,QI,@T3 01"L)7+'+0. [B"#.;$A HHX0 X^((>
M\,&84B@!K/T<JUL(057-Q>I)$\!!(7;   J4@G.:R%Q;XLH"%PA*!D[-2UO*
M2@,K'($):X3(.020AC;TA@Y*X*N>?IE9S6Z618GR ?]&AH@@^&!9SW&>.*5'
MIQ!H 04; ,$]F.>EYX1@ N%KX)3""5!56HE2\,-M"CBQI!;@0 =U@,%(T]@H
M=B[I "I-2Y2(- @@0($-(&#6!=,501 0M#9YX  6@ "#*FRI2]%LZ $V@ (Z
M@%>\6VKH#3/:4/QUH0R;$FH=:.8F$_\Z]*I09>E*R*92(L7@*."E;A4^Y<%6
M[9<)6:@='70PV)6JT(M7%;!>W826MMX0D3=E0: LH$(+A. *2#5<#J=%B"X4
MMI^+O(P.=.F6$)PCKAZP("0QT#D/W.8(-R[  &A@2\4>@<0'R,$.%BN  TPB
M#$X]@(338@55V;(!FK/ "-J2%27XA@ON4%XA$J JSHZ9S&7V$)2.,$RTW*4!
M6;"2!,C'@F?Y#Q/[2P%=*D*"##C+ 4Q8UAN01^=TH6%[ N# /;:4*RF!DP/A
M$XQ]NU.M([R@AS)I)Z7JR8028$]25GJ!%IP0!@X<P0*9< (%;2.":'9GH:5R
MZ!M:2ZKN%&#_U%,;0Q<^Q@$O/(?67R@!!=SRWA>:= &BNAFN;TB"CV!2I4+K
MC0CJ+%0HAC@9=,J"%;?*A"?,0%;TRM-0*7#597]AJ4)=(T:Z@ !M_TFN#:N
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M2)&8D JE<P!*N^.RF5.G!K#$\(:5NV*1T'?@AK<"=%=H"0Y/UZ@[FPPKQNH
M:N'65>D!6?!JH0\C"F$LC*S);&SKDRR7O'N-<BD#T"\MIKO9T;X&XP06&Q=?
M7EQ(X Q[_\;')"^C"_*2TFJ@#'*\;L-]?>HJZS0-"HS@>S: W5F(2M2=!8H8
M! R@7=P,<K=5M@K 7:%@#^8!!#) 5*!@W[ND%MA )>+P3)-JB@6 %)QSNM
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M(68A76R0@@9)Z%D704S@M8  (;CQPPH^D-*'!EC4@(%!/VA @@QM%A5" D
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M*,$":X*\@?$O#<9[R;TJ")0!=6H2Z2N?!S\(PA &25TI^$$->#4L&#0@!"G
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MCH0KL L!!^I@AU.U(\(^(*F<M= .,$Z"'\7^X?WJ8P/ D"10!!L#C)43;B!
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MDBO)DBWIDB\)DS$IDS8Q5%IA+RP0;"\A V5@D"F112LQ/TLB !,Y.N8A$@5
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M71 #M!*L?_MT4. )T-H:P?$?I=0%DMI%SWI_]Z(#+F $9S80%L@&;<%$KUL
MQ2(#F? %$I009? >0$=P,- ."WPJ4%"TQ>,=$E$;$R(A&- "# P%2\"P(:#&
M>X @]])T#G "(@P$BV!I.M-;E;NP=Y !:> %#)L]3^8'7TQR$J %R:0R@CB]
M6J(%:$ C&B.X\4!)5L %<-$"6( #&/2]G>S)-S%4Q^8)]&H %##_5&0%51F5
M%HJ:C'CA> 21!1NU%8IQ '50 Y#")D,PL_' #P\T+D70H-5!4DW[RO]+81!,
M&;:G/R*082!0KE+5M;*B.Z;ZM6.P"*D!/R40=:?Q EH@JT]65V)H(1/P!?KC
M(KLZ'M':F<G"<'Z;/P\TN">7<^/1&#G @XO0/H)+!S.@G5D /=YA9G631U6'
M()*B"<Z2&Z20H'1PB7#U9!EB+VHVL*)%QA5@L1 M 6F0C[0"'Q)@T<08!W6C
M02(A(M>"',/+K SAHB; L5<A:P7QK=(A Q4QTREC"=>230L1*2,R7";0 DWP
M!N9T )N0"MKSR4>-U#!1%BR;%B_ !D? _T0Z ,=WH@%?T+(LY0 VFS-?B  M
M4 >-22%NX :7@ +\VR81T$128)HA\(8+6U._JKH>Y1B2^841=@$>HD:&(9^@
M@@%&^22 J$5D.#L=Q0*PV05\$0)VT [#4240\ %C  A @PD?  )/Y+8KK(CC
MHBCW8+<&>D.EFBA)4!T6"&,MM +@04*'@BQ>P"S0F4B @,?3A0,2(0%-I"]F
MND@W!,4I4% ZL%*1'0?>52$ZJ@'FY#$ Q7A98)ZR*+SM(R'W%P(?HZ,XX .A
M!%#N4H RX <=<3"%X ;SVAT8.KUT<C#0H@$,. ($QV%S]*-9\"T<:@FI@@+B
MU#)YHRG--#/1H?^C5-K(#ZL$(A(,79K4 T[@3V.1:9D2&$EO,S',V*.N4P.[
M,"03+J*X/"$ ;J.[+R$!Q%7@'>[A4L,]RJ,3"RX3 NH2%L"3$$X*]Q"8+!%.
M@#A[XC/>+Y%)[O7A-X[C.:[C.\[C/>[C/P[D03XX%B #"+X5!G ]12&^*4'B
MQU,Z KX5S78\[5NG$T5A23X2%PK6TC&50N[E7_[C:6J6H[-59"XZ)C&G47<3
MTRSE+M%A1BVX1 SF<T[G)TL(=1 'KV(E\,0 /[">:,  G0 !:$ *I:D"HA4'
M-P "$V $?9Z&1H 7ED1P$2)#D0DIA#((=48(=\)#8_U#O7EQ=[(")E7_F[?Y
M.LT(!$. *5>H57G! 6Q0IC*05MD% H".G9RR<9OI2 D,<F-M $UL8:@5!TW@
M+D* !;A9 ""1/UY@W0::!!I [*84)1-0*9%5Y]>.[;BVIJU!"O198'D  C4@
MYI%*MVA0!W43E)O1#O, 8%9CF";%&7@A HK1 B# 5##5LIQZ&3A%J0EF &3P
M!:,B$G,:8B#P)T]5;ED[SOP& 5C+(=E'"'M!7QPU2*98[F30\(CE15KCM8C%
M!N\Q&Y)A&"1 <8'! 5:>[2FO\A0U;4<P4_#3@[7ALW<@ZQ0 *66! E5 <MP&
M2'7PLWY2!R303;O7%__UM/0Z 1D\$&D.;4E1_V$G);5/E52<* (<@&.'! )&
M, \P, \G+.MG86W-1E\=MWBZPR_7+,XD]04;4!ADEK>U<2B((7ZXH@57O[9T
M$ 0T .4KS_=]3SEE4526QQ5H$.[Y.P1#10-T +_+Q@)2NR<H8 'Z^SX94P)0
M0#U/H@-[MP?L_K[QVPZFMQB@47E(\<"MPV!2B&T/!A^;X05E( +[Z^J2J@<Z
M(,,1K\)HFY2S"@(>0%*P@XG"NL(IC!\N,@GQ:_FS.ONKX0?&#TN(N @FO#!W
M[C]^3_W5?SEI"A=DP#X.QB>$  4U(.M'@)8%P08[#V")]P*VO.33MC]EI<K%
MS!\^8!617W:6)^O8M/]O4MMYA \>2.E%(  0$+) 83'!P8$4@V( 8"B#PY=Y
M/@ 0FK 0@( L@3PX/&*! R8/(NY8F"!&0 4<--Z8$%! BP.&,0&\T,,E1@$H
M, $XC.%1(!(/##&Z6"#3Z%&D294N9=K4Z5.H4:5.I5K5ZE6L6;5NY=K5ZU>P
M8<6.)5O6[%FN!]BH$#!F"H80!M!PT. &RYT#''08X&"W"PL#$@O([2L%RY)Y
M(#C8T= %@= L;C1H^.+6 @._#@BEP )C3X@$[0Q,62!@,Y8!/@X$!E!@ AN#
MA!!A 3*D,!8269 4=&"!#*:B#%VC68F!$ B=.T$@$%#"QHI"73* AL$BA8;_
M'SI4FKA80G*3Y,U!"B!E0T,3(][MDF"!9($,1!I2CP&.UOY]_/GU[^??W_]_
M  ,4<$ ""]P/@Z<.F( [_DABT$ ((Y1P0@HKM/!"##/4<$,.99)!"Q@>V^\
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M@'CPN\L[PR$A! ,PET3C,910@0\@@R7  +6(/Q'0 AVH@<%P  &00QE@ S:
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M,P\L6, OK1=#\#N(^8$$<)T0T(!%&$V/8)K/+ ! &+<@4,'>7%0+^%2N_TP
M<!$:& @##6P>0Z [B74AWC$!K]*!(6C"_+(!+YB.';0"'[ $++ !L&(R/E@!
M+&@"#T $PR@$.0M:#2##+.S."AJ$(9@\5X,U40U;)G$-=$P1BM!1&>&(_L"(
M4M.0C!1;N&43D,D!0G.1Q[01T\ !$E#!^\@O-\"=#:G3N!U<-0%;PCU<Q$U<
MQ5U<QKT/D+F'AWO<NHV)6[T'(%@"?:L#8K-7K3C2%8"!*CBR>E$RJ>@E'#",
MY$D,T64S&3 "!X$*62S;HV ^I9 93G!+I[  )^*)JXC *TL*O3D,&0 $$J R
MW@53&<#=LK" /5!(PST*P;W7Y#6T.RT*(7RTQO_-W@TI  ;H@KHM.AB8W!V;
MN=DS#M';"C64W1*M-:K8OB6PBEY:A,I\BKM]LDA+"K"<"BE5UZL@"5$SBBV]
M@(,LM)&=S5"S#Y"I#ZJX7ME) X9""D+0O_?47@H^$0LP@/?%F=D#(! @C3UD
M"."[8,U[@3J(@^R8-Q(Q8?DXX34S48*Q F*[ 2,X. VXASJ0 AG&MT7X@'##
M@G8H89/CW*NL@8MP"^LP# U(@$[H AH(%2%8@;H%&3>X! ,(+),CM'Z;+5IR
MMR<0MR:@Q>\#"HN:C"9@F@J(MQH0FD)HAQG^CA@@A&C:+,XPD9U !.3YN7$;
M &(Z8X?[.]U!C2H@"KW_@X T<"T::"D83CK'Z81!  (W*(3)_3H-2()G[*C)
MH(!"+H(#.MG2 IG=D5CG =S7&;DU6@&\F3L'>YRI*X $X()][<!PC=B.<"8W
MB /P_#J<K:<M6($?. )2Z)H8.(";W2>A: $)OEX$HCL5($(7A+FG!;0*CN8&
M,0!/&)@\H.;*0C8=J (C:+1^(00H\!T2P1M%^ZN2P #?RQT2_1T#0$>2@ '/
MVU'H"XP#F <4* $70(!&0T@2E;TYA$H6J(,>Y0"N<HLW$#U9_![W]0D,Z,7J
MX]DQ "L?/:\<P"01@(%Y6 0> $9",,+M6T#Q0Q?56HX$Q(AE,\(#*(%5%8'2
M_]I?(S1I' UF#O@?$OD>&;A%9;2 )\!0"<@"X-#I*V@N<\D"$,*XU8D'._@>
MC,@[.E !5)OE__D0LRF ',C2!W&7(F "0B@$!W@!1*  '3P)3FC.]\@!!&@!
M3.C-DADS27T##2R9+%Q!.N .%YRB$ B"4#$!)O#!*S3#LUE.!'G"*6J!(!"!
M9JE4/ ,92Y5FQNZ/>IY#]RG?V<2 "OC)(UVY6ET-%9B(=M[1#X2]#^:K.OC<
MT-4[/$2!+,"!&E  YZLG68W*M\!%_A'%Y BS?S9B@ZCG#Q0!)(!%0++*,)/?
M3R0$,N"+7Y%&2(,)<A6!.M !,7")#:@#BY!%Y=8" __ :1, RVL4%L',T1@M
M5^%8CH-MB=[&[HM [BS3.RV:Z99BZ8LPQYE.X(%1V\M@FA"H@P& @'+Z5D$.
M@<H#2-:,3GO$F0H@TEH I$R@ (K<QPEXH(P, ?W[5,&UP#?(0H7T2(DJ1PZ
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M!R/@2KN@IH^=7 L@!8YU&(@)I0+H].;!@4D>  HXX^X!EQ!H@D7((.C )$$
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M'"$)M2(!$$ !A2"8@D^N9@ #:(EK$]"5F+:&@3Q!@0TJ.  ;)*.UZM"A$#&
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MGP7<>+"I3D G8\QE> 1 AQF8H%3$>JD(M@6]'%G 5!C@#MFT@((W+)6,C%Q
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MJ]Y.'5B.\OP<BE! /$1/@-6?CDD !SA<\.#/L>"(BADJC]0(5XV(?<93#L2
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M1@S,DU&0/>,#!0% "PA0#P2!S)6"_\-9<5!D$R$4@@,8UD(+0$*G:1Q;M(Z
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MG.V @+!8"(#ZE;=47!(3R( 10(6$4SA5Z%>\E("]7O"%3P5># UY-R4.BP5
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M$Q08@=B0C=W(4XN  !+9C6>,XN1LP&W*EG38/-M()DBI,NT 576TEJZ4BN2
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MIAQ,^(*-CQ)3/(^I0L8&&("8(B$ (-("A2I Z((-&DJP P@@%C&"J3'X.\
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M( 8%F$3=0I4$?B2A"7YJ"B"PH($R,0&,;IB! 'T3$@OHX813B4 *5H!'!QP
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MJJ8024 789"!<W$-,2Z@;@'@@Z(,L#^!.HC!9WX@A11"/X..28'&D)^6W6I
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MB'9=Z;:B6N!3868/6H $UE0 ,D&,],@*EO_@E X "I:/M/IV"%I "@:!HT(
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M0JJ:!6$ !L"(^GD%,&.(2CC)VG4!2H&&X\&*A?^",7Y K=['G2%@!^B@"MX
M!60 !Z+UBN$&2TX 6 TD! 8 ]10GL*$ UF18 @*!+0PZ$)@U!);@8-)@#V)L
M'FX;$(+  -"@T;+@'F1X0$<: .(A&)H72(6"= [G7U/6:M-7(8(@)"8YJ6_)
M$!R =.A ":X6 ?+@$2ZC#F;@ EJ HBP6RKI !NQ@VS)U)&PCW(1:F_>W>HL
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M H1[]F\?]W-?]W>?]WO?][WP)W[ Z[59 &[E!LH $9( "YI@_AA@"[  "U1
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M+:B:1J-%*4),(DA2]0[@?)DM]&$+HV:A)24Q$ ' $;.R&NQ!,$0HUM[Z]K?
M#:YPE6(!384F"&^ #!2J4(;*0&%+"UT4'<K24+E %%$"T@"3+!!*U82@/)WX
M)P$)D8*/+/0$PSH (KC@AD$X@$TQ;4'_'[XF0 VV +S"V:Q&TU0JO6&S$TYX
MZ1-^,,NX.(N%C=M@GC" ""7$TI-0P>D65M")U$@ $8=P Q<^DEILG2,>ATB
M&<1 &.RD8!!-':Z*5\SB%KOXQ3".L8QG3.,:V_C&.,ZQCG?,XQ[[^,= ]J(^
M^C%D50RYR$?NAY$%<!(E)]G(1'9RE)E@D@<\^<I1-C*506+E+&.YR!^HLI21
M[.4HE\$D9B"SFJ5\9C2O&<ID;O- TCSF.L-9!NB;P9?MS(*3Q&'/<%8R&DSR
MYS*_61]90%\2 /WD#9BD$X<VM*-! FD[8[D*)_D!H[-L )-H8--([C1(/FUH
M.T/!)&X(M*J?_WQJD P U$JNPTE>76I5 \$D.-!'I,E\:Y   =:JZ+6O@3T
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M+E"#J($^FA@AG'(2A  (*U 6N8(%K*@%-,  :2$!J'0M;:(GM8  T55,%L8
M3>@"'\ =^V$!AH %_W;",K6$*6B32!+C F&@!6GB77FB- Z0+3@"*5+%4Y'R
M@LJ"0H,@$!)@"":0!\)P"7WB2_'PC2&A!^-8CASF!"156Q^1!L% B?9XC_BX
M8B\C,%IP!,AX+04P+<2! @S@#M;55/^(0^<2$EEP V] *<0!!>3R IGP!:30
MA'=X)P&)*S0S6W[2-,RH*D#3-"'@!/X!">1BA7=R8(0P+<7BCWBE*RC!2S.#
M!H#3%(4S6U9HA2[U." 1 D7  W90!]#S02S45CU0!'E0" PP+..2!QDI %0
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M9/I10C (A<D'9_ ^0+JC(\)0=- 'SC8(>X !+\ 'JN!"KK(%$" #&%8#$L
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M 0L@ 6D0!46 .O>%JAKQO$'  BG@#P?L #-* OI[" P!OAX\KJ@J47K IR$
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M1Y]>_7KV[=V_AQ]?_GSZ]>W?QY]?_W[^__W]_P<P0 $%) 2,.1H 0("\Q,@
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M;\XRF(E,9'[,F<I<)C.+W1QG-O,9R&MV<Y[_+&@)_],9RL%<HYH'0&0*,WH
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M@$TP W%H%"48OR@PO"(0@208 #/P@MCPN/@SP1-$P?[9-=T#GZ![@%Y#N.Q
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M=(_F;%2L,)$9<#SGV[@YT,2-HYX 2/^%& #"P2&[B) 'Y[O4F.N>0+P#JQ0
M<X0+",2 YF,_RHB8&QF[7.2^Z\N I^M44PG9(14 *A@&%6 "6!4_<S0![IO1
M*% 5!/C7M<4 *P@2"? #3E!8+W!.TS,"U.&"#<"*MFB#(XB')/ "&?"#(LB;
M\(/8"BB$G:""09B6AL6X.>B=(,&X(@B#H<""OJ2,Q^4$0-"!!GC<CQE=#G#9
M@$U-C."#(." S T!EWW7!DB#0A"#!4@#++@10[@!(["+$4DF"&  X&T0@-W,
M <T>68W9ZN4/#&""U*K9 2M4D.!'1/7'^UA4YU2#<PC:"T@#/' :K]%;2M74
M(E7,(-R$6RC_ _/4AV&@@<M4@,L,6N2P"[&\VR)0 %C=@W^U@IIAPJRX3$G-
M ,I+6E6H 9? .\TLWE@M.1^@R@"%#1_MS+55WGQZ@"+@@#@@@5YLNV:TU0T0
M M*%51JH/B_@ :S8 4>A@!=^ C/0IP 8AFD)#/,K@E68W,8,8@DH@3YX";MH
MB0<E 09TV=7D@$Y0$D1( @H@2ZN(@TX8A$UM8N(K@U)(62:P @75I[4$@) Q
MDQ9(4JUH"8-MWB%@@#BH"^N58_TH WT@T,W"8_BR6?S02%$,RK(AROQXNEMH
MD 3NW\<-WA= WC%5CAH0@2A(!0_@NB,( 85#TB+@@?6[5 !(X#+8_P35P!'*
MFX-6%=JN=3Y(B1@24).JE ?KPXH,D(#;-0(+* ,F"$2\.9M 1($,N&46( Z[
MM0 C0 LRS@GQ&]Z^E($,: $_F) R*(G'2. P>(0BF.%#. (OA@"TH.9B]6(Q
M0&,20 !:'CNH2(E1EE(?4)Q1+H,/L(*58>0_0$T,*-*#%0.+@==KJ%UHZ00.
M10",.XTGZ) GA0 $&-X:R( 7B-8/"0QOB8T;&(Y@96?=[80PG>.*;A_JZMX'
M.%3O251!GF;R[4.J+)<3^(, 4 0-'%-+^*I8Q8 (T(/<R JK, ,BZ 1-%6F"
M2 ,U4(4X( )5M0N#^,^Q! !8[9>4QN'J\?^2#-[6!ME154 (F<8#-46+*ZR-
MDL:3)QU+,P2> AY3MWC+TA@)]@N!M4D%&FB)LZ/<E"@"QJ6 4H@#+S"_0=B!
MN=B#"H@#YJB ]GR QT2$-J" U42 '34#[RM=HQGH\WC<'VV*M,!+9QR!F>X$
MNC@/C!N&NFCJPU8(,PB"'7B1D4@[G"A36:V-CUB.P5G9.PB9?+;HU7XVZKA9
M_$B EDS.>>39]ZOMZXT'CQT>UN;M%'JFC/Y>C@[?G51>1NWMXSZAX:0W/O8[
METP8A"1'Y);NZ9Z@W\8/DB3,B<0/ 2@ 3S"1GN[9EW[$U%,X&?B#(KCMGQ5@
MZF;O]H:/F7V U[[_#Y;TX]UC-^9\Q32X0YYM.JT\C]\3AQ;(CI==#PD8 S%U
M[P17<,I0@-3B8S L2?P 0.,9!@9X@$[ @^-H5#[PFM2$.-P0A_X\N^Y8Q&#H
M <_ST*.  >(S@H1+.0'W@FW5SSC0Z<=$BP# @B$DA/,F\ 7W<3I5[@"0;_OX
MR?IN0>7$[\R#O2)X@7JXA1D^@QD>QC,]OA%)A2\PB"M8.W$@OQW/"N48@!E0
M =@;!PJ@ FNF/''0S[)V56&D@32X0!Z8!]3]\3J/6>NV#\$,;H<<;OH87_V^
M  R80VG6P'A8:&B9 240O=.9WU7@0#.\ N[CY"CX!C_P CUX4!30@T=T_\SK
MP;Y A &LT#RL\$L[-W7 A.\AKP_D#)^@&\KT3@]5)-D[3,!;<'2C4 6*HW(E
MT,]'3,!#4,PYV%9KW</LH((S&,)-0/8^+%%A)_7J@P)2-]M3IW;@S%YFR@\(
M)TS#G \)V(11I@*32\!AV(')S0!:Y@F+$_18K8#L*+P=GU@IY+C?> 3OVY.1
MF_0K8&"QK(=#H($!G5@0H/-J)_B43'4^9G7P*<4'6(&BG,H,YP=%P$RN\P"N
M<)K?M BY4X+.T0/O1 "64_.#8,^[#%Z9O@(SS$7UE@%2S^ " )TXP(.0-^Z"
MIWF1Q'/[H+\]5QB_T^X 4N2.V0*AKOFA#\D@5__U^<" OS(#G7_N^Q:@:.F'
M)BU-HJ?ZBO0LX,9);J_ZK>?Z^SCXZ\[9\!%*K>_ZLC=[][CY^AB WV%ZA*$_
MLC_[N)=[BS!ZY@9*L0>)AI_[O>=[ ( VULKHC>;SPNS[PH_[K[</ 4CX[PFZ
M $@ PX?\KK]V0KT//8_PR,=\HD=\^UA\[Z$_&,0/"QB!\;:/$=$!(.@"2-1"
M]2 $!(F'QYS*%;C:!+&"-PK6P[4"%>CQ\[" /6""4L_\X'<A@DA[I.]&P=_Y
M/C],*@""( !^^!  +3 3 .B!U4^/4C"!YX</"<@$6;6*?ND8ZW>/%NB"11;^
M\X>ANL>/SC](ZEG._(C_@"#8_?>0 #F8_M>/N1_X@>R'/@TH!"@ "#YG[L2[
MPB2$#3>#8DCP\V,%EA@8   00 =+'TX?./1I(I&B%143#[AH8,5'" U)((3X
MD<1+!@EZ-!1BHX4+C!UT-/P(@B >EC@H&&@0(B8#Q:1*ES)MZO0IU*A2IU*M
M:O4JUJQ:MW+MZO4KV+!BQY(M:_8LVK1JUSX(\."!UWMO#:RU.N#M + M,"W@
M*D!+C*0]E,C0Y"!/#B.(+DP$4,H$@!Y79$QR "!>$!Y^C@ X<91B*2=]1WC!
MD"DP10%6CB@ ($&.$2L4XETZG*.!A%IH&/AHG*<+@A-7,JA&><E([@9UES-O
M_^[\.?3HTJ=3KV[].O:Q3/2]->-U0+\'&[++]3> R=<(09!N%6!(!Y!%"PJ6
MNC+1TI#*24]X42 YQ'  Y*%)&"5=%B  5/1VX >G-9:@"JW]1<-)(2B1@63$
MI<&&88U%T$495$08V1450(#4"3J,F!V++6HE@2%XZ*/*(,I=10@?1'PFU0&
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M1*P 1EM!<!"%/D20(((;.MO_$(<9 11Q)<=QRSTWW6=-Y-9;W\V%)EYZ\05
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MK0>,<"O9<LNVKE.>\T2SF][\BGN,!I)><0T+$_@!K9H2C_\J[2$,=-@"!&0
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M>?S6=;S)@_S+TY6"&#A+P_1&&GA!?1"'%5A,;;@':[1 (9A$;UA"J5!$07S
M&#S!#-Q!!#R, 1[%"3A-"\138DQ$"W "!_C*">;&@EU" W1CK43 'VZ*^L4#
M3,A@!2J%.7K*[U >ZQG"3267&ZR16&# #SJ+!(S $(K%3VT5L-1>+\HB0ZH%
MTPE2*"4?=9B+3(E '3"?5;R+ D@ &:1 N$7*@2!"\?1)*2B! N2!@?](@ N$
M@:8,!GNT@":@P1(HV16(0.DD10MHP#T PHG\QQ)11 MTH:MTHX90RHDP 2+
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MYUEFY]*YI7\0GD-'F>  JU]%Z>9P5[3 >BQ%"C_Z4K2IK0LF19BW75N%L"N
M#-AZU"7O4K0 \QJW[3FQ]'H%]>H=\,UZJW<0IHM%"FD =GQO=[JHPF1 )48*
M<D7P1PR&\(;%5$K=_JYE4H1E(WM% $.RK1HP0B%P EY[81$ZK.LY)P]URJS
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M+0NL^$,5?__ ?. 2&M3;4L\]^>SSO1+ORD\O?_KRT]!#$4U4T449;731*!_
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M"V5 Q""7DY 4%) P,(C@5&HHD#RX@)#;B@[ZZ&<_M?R.A%09 >C$PY4 #F2
M3H3B+_&BN05R+O\^@<%*!#3A  %8(B(^28/D2&.)+^AA.O%(QA<80 %DOJ&9
M$LB!XS:2PF=.I04W>$(SJ:(2AI2&)D^) P1D@LC1/# %*1S("1Q)$$)TX9S=
M85%"-I <&K+!!0V8"BF&@)!,T*!_Q3(2#V<R&2?DL"E/2<(B4@> [P!O+3[L
M"DU"\ /: 9.D<LG=>E+6T.9(0 Y8Z<$5&#(\GY3"!(RA AN2J=%OED()I;C"
M#@P!@]&<H D4P,AH7JH &4P !T$(@Q:$.A8KI"\AK21(*?28N(\P10*UV,
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MFQ2@@_H0-C:C,TZ TL) $Q8S;F3L==*H#1S AU:@$'Q@>.(AS^+1.P_$NF1
M$VB@!S2 'Y(@"+PB.NY 'IEE-GELT5PS*()+^A#DAZ84_R@$ /OZ"A$N@?L
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M)]+ #(!W!2UA!BA@#2V!"&I !/B ".Y  K( 4&_B /Q@#CH71"S*4_^BM+@
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M<!$A*AA@$0$G'O;X"T9@!GP $<Q@!6Z #^+ "R!I$"23!F&3$U)@FF5 "(+
M?@M-J>:A 1SD!O#[!J@2!=K6'K&Y/-86-PJA'0:<$VIY$#J2$S8 $(9!@3<2
M$)"$HN-C<M$V#%@ $8;ADH5@#GB@'HB $T:*)C[7"ZS@$!  FA?3_PS.@1 6
M(264.'J_H!Z*O(@Y00\X]P46X&Q#UR:Z\JVIX!"4R1(>P+'Y(!48 '0U.QY2
M& -( 3;XX!;"8!-,8174X!(0P! 0;"=BF"<LUBQ>UX;_S(@3.Q7HP'B72=#'
MR \" ,J*X)$/832*^,P3>P[$>@ZPQH@QH-,1@I<Y7<$MP7C'8M6G(SH.X0W&
M>FJ+P />-(4L 0O X')51WAWP!+*UWPB7 \.@0;R(%2QX(4C@(P1X'=P?0X8
M@-0;L T6XFQ1@)>/(!XB_/^*8!4L.S6HO122  ;\(")\X]J5^'7G('X-2]MA
M@)*Q8!*#BPO88!&?(#8C(+8Y8!$S@+!#R/](..$-^L G^?U_BOE.Z.!.5B?$
M"$,(+OT:ZF#@_SLJZD -Q&0.;G&V9^1W.,$!88,>W<@*Z!T0@!B4L2 *OK1*
MH4 (9F"P- IVWL &.&$"HH (2, (QJ(JS)MX1@<"J%(,+ "3$J 0:"=^(5JC
M,F&9@]+'V>,IH"P #@$,;L$#+("PAV 3IGY[-P%T6Z /3* %U. <,* 'MN *
M2(/LH5RYL=X#P/X*$&&=^_8$BO8F)&#K+V!JCS@-3!@ HI<?U( (8"#3YAY/
MAZ&8#V$5RK[459?)ZE5A;!<HA+@,16@&+B"Q38$!X(!._.$6O.*L-R@>MB#,
MA\$KJ& &AH"2PV3_#@3A#R+B;!=C!J$)UF5Q!A?<$*=BF928^LAXNAU[K#--
MG3^&"#IATRO]$H!*AC!@!H> V+'" NB6UR7#LG]?\X<!$FA0 7"?H5R?#ZC]
M;+V UL4:M7DY!DX@#H @"O" 5#\O!=K@"[B=#N(@)J "D.A@^,LO@Y(@"918
MW&?D_>EW 0 "41L*&   2(/%#9<E(9) R!#!3Y$P@+C00/1'E;X'<XP8;"&$
M$P( $OA<B@% @!4N*!AP&<*@4(V" .(YS' B"0PM7.[D,1E#P(A"[0#-:1 !
M4)PH<V@(0%3(APP&42YM2&&FWX,@;Y*0R" (AYF'!@7027)C9-D00OP%_R "
M(V:- X"P\$MR!X.5)"9H&F1"!XL8OP8+&SZ,.+'BQ8P;.WX,.;+DR90K6[Z,
M.;/FS9P[*V:29L8%  ?X)/,@P1*1(:87)&820HTJMP^*B(AR3D \,U="9/1'
MQ(L5(E_\<%G08LLY"73Z$#E2RHR)USW4/'C@KW8&U4<$6)IQI #6*[NG6\&3
M?=B73;<$J5GG_;EC#=<W>-X,!/L PI8E/)J3P4$SF"# )JFLLH47&,A01F%Y
M^)'*$'3P1L<,2D3 1RIU#"B('W/($$4P&+0011$\Z*'(!325,H,8,ABX@Q7@
M^?4="2((,2 A45PA2(D9M)"$&!F\8 2+#Y61A_\AJ=# XA4RZ''(%X8,$\."
M&" RS!$%Y>$CD ]98$0+?EQB1!E&AJ$'%U\@<@@%\<S@!2%\%+'*G!\(1,$)
M,Z  R" Q,%&&!8AP<02&1;SAQR!H(&(&"7M88,4P*M!4$AY%&%':(#2<!4%#
MG"#:)DURXG$&#:59Q"D3AKP46 T*O%"&J)TX,9( .0VR 0=1#&+$7CX(TD<1
M:L73B9J#^L! $C[H50@)+/"A*"![BM ')SAXQ4*?:&"JQQEN8('"LX?:< ,:
M&83@1A"UGA %%U64D4%!%NB!Q1YT-)NL%_,.4H<40: A;5X&R9 %&GK$L0@+
M(-"@P'T./PQQQ!)/3''_Q19?W!@3>D['A&H^A-#')6&PY\%K'I?Q[##:^'$(
M#58\<(5).TSH!16KD>R>DPB$9L*;2BC 7WQ>H,P'E6G4)D.&931 XAPAF*%$
M;%?,2P0-[*VBQA4"I$'$:(QA@,-U\V#\V #7#;#9 ?\%&-H%!=Y2QA,9C=.7
M07D\DI4J12R@$AX/'!(#AF:<\<<<@OQ11$%IJ#&.)%TW#  35I@10"I56I)E
M8=Z9X187DT90(HA%9&#K'P\HH@2D65V!TQ_#^&#%'P&T*0&;#92&!Q$D,&%0
M!(]<X5$\4?B#^@(A1/' DK'//NFJ,;!H NA%R"!1&(,R&8>+*?A]R44#12"$
M_[#L/A '7'SD?H-K97VG(  A\/$ $>G7;@81G1PR:5DC\!9@"_#+/Y+C#:,E
M4=!'UVC2@FJI96O(@\,5&J"2GD@@330HB$W,8(890. #R<J+!1A@A@><1 ;2
MPN @&O!!TUV" H00PEN6( A F"$.9K@!!W[ "0ZHL((DT4,(53$.,31, !6(
M A'B, ,2R(4NFJ+#'^ P@T,LHB!/R0H1(%"&>XF!;%SLHA>_",8PBM%A$@B-
M.PQR $3X;1 .2-II$", .5VB9+:"6@5,1\,KG""$&H 3%6;@ S[< @.[N8(A
M@!.$!5A@$WKC3VD&:9 ]*L$2#^A$_(YP NXY8)$/./^#6.PW#'QLXAJ"4$Y\
MCC"?^HS1,/=X0  &P+M5RG*6DQ$ 96SY& %(SB+\H65BB"4&]37F 'I@HR^/
MB<QD*G.9S&SF?61@A ^*AC&X=.9AP'8= ]#2; ] FS6_"<['D(@(=Q"F-8E%
M%L=DJ@'A;*<[WPG/>,KS,%OS&Q$&,T_%T.<!]IEE?OR1@%[F<Z $+:A!#XK0
MA"ITH0G%Y@/&-DNS!> >#*VH12^*T8QJ=*,<5>@^^RG+_/0#EATMJ4E/BM*4
MJG2E*W6H-B-Z-I;*=*8TK:E-;XI3BWV4EOGIID!S"M2@"G6H1"UJ0\/VT&W&
MU*A,;:I3GPK5J&)LI[,,6P#_ BK5K&IUJUSMJE-=JM1N>G6L9"VK6<]:4:J&
M5#^Q1*M;WPK7N,KUBPZ%J"PEZLVYZG6O?.VK7QNCUE6VTJ=_+:QA#XM8KH(5
MIF)-K&,?"]G(SC2P8_SG"MHJV<QJ=K.<S6==E?K*SHIVM*0MK2\I*\96^B.O
MIFVM:U\+V\TL]JY+C:UM;XO;W!H$M6'LZ65U"]S@"C>SGX5I ' PW.0J=[E\
MY2T8D:J!GS)WNM2MKD$(*81^Z$.[JGA .CTC  L8(@#:Y>XEV'F?\"*"O-O5
MARK.@-[+S':5W&2M=>^+W^0R04Z),XQ-E"!=RPC*<H8IR274TIF.#<,!!69/
M@##C_]PO_M.^^:VPA6-KJP$=9I&W0#!G(M+?PC"A%)GS#(;F8$X L,AKEBDN
M;4.+&2;L9@5\P6QE%@D@BC$A"T;(PR3BZ[!X7*%!!A$RD7_I)!?P\#*2&\*#
M(V<%)U_L +78 W\LP((RM  "0*X8E>U5!0_KF$$92$.8E<D$+". $.U0P84U
M"YII&D:\ETAQ9N)8(L((@$6H[(P ?#<'_IQ $7V^3(2].-C?;J8%;7! @!U#
M" T4(@:0BY@ ,A$#"=3""(^^3 ^4\&3';%G,ETF#"D+-10D@P<J'.0 FNGPQ
M"02"U603 !F68&=D%H -#'[S9C,\G3DCXA8E,_$C0OR7$_^4N#-JJX:>X['L
MRLQWC-S$0:<ATP-U848 5/#""!3DG4Y@@2\8L(2X:VQNBS  "T((P@=20 $%
MG. *!0"$%$8WQ+/H  U^^,$*"G$$&6.A#UZ G.0ZH8$D>($),DB!I!=N!80K
MG DTB8<&V*VN3_, $$E80;TP@! ;="+)9;""%,;MA0P0 A :Z$0;>*BQ))S\
M48BX>!*&D(,A*" >G-"""@K@!C=,Q H:^,$-&M ##<1A $VP\@B6$""Z).%?
M*?A!$(P@B 2XX83H^M8>-+TIJ&MZ PPPN@BP&(($_  +*IA7$BZN<S1JH0^*
M2H&_:""!LO_ *R3$P@]@L ,])&'_$ 9PN!2XL(<2#($%"8B##8) @P\6/0F<
M>#!H+KX$&=R#(3#8U+>@3@B'#P($G( @*0Q@ )8/H01LJ,,4$- "&,#D!SK(
M7^0JX 8<[H$!)X>!$2K !RP@O.@P:, )W"!NWW^0]BH@! [BP'P9:$$*.JA"
MU;$ @T5AP48HB('SUUX##O;AY(M M:_E&N<S&N8 AJ@S>'4D(L-DN-"<(<1_
M^,/GS!RZBSW5 &>\ V"8D0<Y0 ,]D P(4&X_XV,-8 E7@ $^A@"(\#.EP#HJ
M43,*8@D^H 4^   9"#F7QFE^,"GQH 0\D ,-( $Y4"4&T8 9<  N8 2(L"P#
M^ 56P#IY_Z )\=4"YR44/B!D/# )(R@&+ "#WG$%/ "#5E!Y.!@&F; LA#!I
M@N8%=/ E>H "=)!R:8 L0\ !*M P\0 !1L!M-1 "31 4F: "+\A#%J %2X !
M=(!K)X "'!!W>> "5M8"-Q &M5 &BI<!>1 (D0<%3(,":'"' )"':* %,Q$/
M)(!>$B 'Y5<"58 3-4 ').  3[$(ZG, 7:"(4Y !I(!KA& '*C")+- %DT('
M52 "[0!!#/!Z'^&*$=!Y\0 $ \ 0B]  ;+8!(. )!1$!W0< %>!D9+ '&5 !
M&[ !;-  %< &(, &"% !9P8 ;(821 0%&2 !(# %;P %WI>*%O\  DL@ C"0
M:;6P!"5@  B0!6R !D"0%Z10!1.PCNL'!<UG  WP FPP!..( 1$ !54  E"P
M9FQ ?^>'?M"S8<-6;)TA/?P1&@=Y9WD@#(%V&/$P#A(I&2Y&7[65&?%P8-MV
M D'@ 7D " %G!<LB '* #Y8P&I"(#U9 $)80;S41->Z6 VAP@@#P:0]V:4=@
MAP@H9"%P!0K ;?G#;00A 2Y A![!;4-@!9.2![407SU %B?@!43Y@L'3&ZS#
MDT?H EDDE;6@D^RD:?$E  4  H!P!0P0;P) "BJ0AWNX*2H@ SA0?G0@95MV
M=L$# 2(@$@8!=E-905O& G90?BU  B/_H6F&B 9T<&I@%P%3P#1_"0&,&0@;
M<(B$@ (>01*;IFEX" -U(&45L <(<  E4 ?_@@1X5PL5I&I[( (;P +%!P"D
ML $3<&;)J!9I(':S-B]'1XS:& @@  $H48VN2$0&L .BB '3R +M\ 5D8 !W
MB &<>8W3B)FL%@]L, %#@  1T Z91@:>4 'K")<;  5N2 ALP ;"& ]5$ 9:
M8)L6( )UT 0_QVN$4 5L\(TD0093, ]NN(\4@)![%6?!5ACB!4E^9G_50$_*
MII'R%0&(\VS@H7^J5%6NE ";$0$ =V># @1 L".2\Y):T"L78)0,X#*3DI)%
M=@4I^ :<\ %^_\ /,  $KE(6F$9E[-0#O8$%0% 'Q4<340D =DB$#5 05* "
M#."%4ZF(-G )3^"56!D")4B5B-B5 4*"2$@#<:D FI:DGZFD*4$*[>  \3"'
M0U 04?8!@< !89@&.@<8/2<P5GEV(W$ ]P (*6<W@<B& S"BE&@K-W!V9ED+
M&[!JBA>FL]:)A/@&*("H:$"5(X("O1::$I )=H"C7"AE<QH",* "$>")529K
M>T 2LZ9X(2"IP]B/4D8*X!E) W /0- .F((#FG("M&JKD8J<V#F,&Q"*QYB,
M94 &(  #7Y )@@H#5>"9VID2M]8PYTF/$#&>3'!K(A"- C &!J %"?\PFBC0
MCD&1!6<6JOYY!P<P!7O G[?3#@:  F[&!/,  KYXG57@9@<Z5UL3!PHJF.W7
MD+*E-L@621CJ9Q1ID8:A)RPF;4CU4K356)A!3!,J&1$P";W6 LFP PVH !&@
M"1[0@/^H"0CPHO-&.M]6;GRAJ1()B3& @Q[1 V(@")C@F9I#!4<0II.P R/@
M*@= @'&) 9I6LSN(@B.P!T2)A# + 3)P@BIQ!7M8!FX9ICD0M<?8 I. G"D(
M05:  GEJDGD1<5FH JZA:0S "0Q&!61XF2EA"?@#.1; ATS  +]88(E*@!C0
M S! EVE0 S]B!Q0 D$80LSI907E+E]48AH+_&8@8P %[H#X]0 )&( %:L B-
M^R/9!P56!H=^ZP-TL <L(*FVL@$B(*EY-P7%IJ:]!I=0X'IO@*8&P89N"
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M3=G+#=W1;53&/3$3-MO2C=W9;5*_[46CK=W?#=XR1=T2,U@D%=[GC=X;U=S
M_=SI[=[O?5#C'3'_A%7P;=^.C5WEY5[>Q=#;)E[L95XX[=_KI=_O)>"0P=U=
M)%'Y?-\-_M?[-2>$\5_7_1@#)M(D81("'6.8\] 2X& EO4UFH _F[> E7M?
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M!! 0@0DDX,+Q,8 -2-#4&:^4!1<L $LP,%-$AM1ECM!AQ$IP%%!1]:D0U&$
M07A#)X\C.$$!(,:<("5T7, ##MBJ )I80-\PX*@=,,!6,M $&M(<D4L3$U0S
M^"5G+&"(6Y!3F_^M>D0U.#6K85#SFQ#!0 3^@,QJQ6.9S!Q6L59]:X@ X0']
M2("H=RDN!R256@+(!+DFT8 #V"%DURH7U+XZ+<H=FS-IZ&>]%"  *U# "AJ
M01TN1+<4U, **^AV%P+& D ,H-LZ"AD,VV.!6CBT.R #F<UH"I$>7($R)\T
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M<3D*O(0 #"BD+Z #+YH)*9ND,,B$+ 3 H[@"H**,HT#$W/P2'V" "WB99/@
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MFHC"%7"!XU4A*>;57;7R8S9&Q?_)N:EOFJK"*Z= ^ (%((4ZZ&-+NJ@<4 '
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MN9T1JS ([N\I 3^UXRUB7AMS V\$C"D Z^'M@FU) ^CV :U6NL])@170@$7
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M"H7\%T(2/WC!A!6=</$? 'GTNP(6,6Q8!@!6^!""#6X4P8,+95CQ Q8$,W$
M(%($840+%Q<A LJ?6H (%IT$L4,:&A#<H<%2=%)( A^3D,$)24B!Q1YZJ)#!
MAC *8$702?2L-!=#,$#S#0WTH$$<-@310-(:",U#"DD$\08$'$" 0(I! L#$
M"?5RPH(60?><1B=6#_###R28K<</)5O7PLY"\$U'T$NPD((&),B@Q0J=_Y!0
M1AIN<%%#"&XP'>6\A301AA9).+S$D8,3:H$6?03M!M>>^YT$# BTO/<760"B
MP1 E5,'"SITT$8,%5FC021(W1,G$$V[\H ,-=$".@LUT_-#)(,<#\C(,:+BP
MQY%3<"D \\[3D+@44A2RA A5&%$!\<83THX* %3 1A8XQ'$#!T+T?D,8F0"M
M@09!+Y(!(2D4@A,TJ$#T.@$#&IS@!TV@04[P)84;3" %+^N"[N8W"!40 @CQ
M0X,%5> E-V!A $-@ 2!^X(-%"2N%T4'/4&Q"$%A-9$TKV ($GO6%1\S! P9I
MP1:NH "&Y1  :PK"'LJ@@!9 (5,"H$*! '  %_\H:4,IVE4/+J$D1%! 0@)0
M5-),0(@N9$  ?E !!N*A!![DP @2R $-+,&A@P@ $.L[P16>H(0.44$%#" C
M "!E!"MP(@-YT(011N ##*3!!WO,21KXJ! !9,( +L@4 )8( 0_$(VMY4-%!
M3H "$4 @ U88@A;3< -!LC$-G$" BXP@@#2@( 1!8* 5JA "$I@, FC0PJM:
M  $6N( &/8# KEH @T^1 @4_!!(=5I?)&.2!F:ORY*<BT 0RDJ(*(FA' R+0
MA0;$ P4(H$,5PLC+-QSS1T'*A/4,<H D2D +4\C I2; S?31P"#QG.<)9D2(
MZ8'@58&HP@22% \HD>+_55G8  ONL00 E,  &VA'# 1 "BA$R9@Q8%\[.)#$
M1Y*A"NB, :F6, $V?""@0B*# 4# !O]U81'CV^81.+H!-ARA5P9@ 0P6@8$0
M $%W\Y@""#!: 2 T@!!L&,)0,4 *)P555DNP0!4\P2)"& !B097 4%D  @2$
M  IHJ(-/L_#5$+!A U!0@0#"VH L)$F%<IT+?8IE'XQLRQ)GX ,1;G@+8+7@
M#SZ4P",NT:$U#21.# F!'2@@(B7U0 ETS) 9PTB%(^0D:7S<D""<($@HEO$*
M(7BC)2C   JP*)HP\J8(.)0T"A!B /U3K150NTGJF4NTLO7?;A%B 1'4H1 4
M_WB"!AP)@#2@UI>"K$6."@ "-XA!!EUX@R88V*TA+ "2-+ "&=. 72&*002K
M!$ X&1 A4FV@%@R\U X8L <&**];1>NC>BOI70Y@=U.CJ@7UUHN"8N*2O"C@
M@.=(18,0H& '0&+D>X?@OW9PR;N$.@ (]B" 0*P7!G5P,*G0UF$,G,#!$4"!
M ;@I@ I,H'H+V)01R&"]$]0.!1NM@ $*JJ0*Q/7$<4T?$(80K[05@ -VD&F2
MN.J)'K3# #"(@76\)&0H0,&J)0U!%0Q@ "4IM0HR)F_MV##C)*6J25;-E=G8
M8.:<9J'&NI* JBB,VH,H-0:Y<@";0:#2 QB #56@@/^K,/"""<! 5P!X@0&&
MD(5YH'"NBF9+F7Y2%JFT!R-K4L*!_#$,&ACB$!L%@#QF8(*%^>$6AZ46#'<8
M!!YH@DL;JH /#=*#5G-7B[65T*L%@0E!IEJ(HL4"$(  A3]F\2 'J 6)O$G'
M#LTZ:1"001KIH (%_"@,@!A K^^@ &6[D@[ ,XCH5I4)!AY "S7(D'<5,$P?
M(0$-I(!P.#_  !Q<@486?;8 0' \!Y/BV0#PI0C$ *-X>($!*P!"';H0!F+O
MFYCQ $(AT'9<!_>Q5(P< @>L=RDU!F(#6K ##(!0 T)=REP!I[:OLS2$,$C\
MX17/0 0&H ,@P,!4[A25.C'_,.(Z)* +!5]1'Y$0)%(X.'T;N,?+@;"!') <
M!1\(Z0(JP%"*DI<-$]C C:EN$!QCN1U B*L^R0"%'8R!H%1/5152ZH9C=GT1
M"(@H$E[E*A'4&$H V)29^9QF%K2CIF1.U3R:FF8$O$#/==! KS>P@2LS0554
M]42M#/#6*P. #%,0LH91<%,*2( 4' =".R:PI4&S005F_?&B2_\58B5'-AK9
M%G_@, Q\]$ -<]B "/YP"R5=JPBLFI.@K.=6A?3 "1](XYNN8"(:13:,M;7.
M9 5@2$*<4K5"5((@'&60U[)( GX UPF4($M!RC$GD )F [B+@1^Q(!,U10BE
M^ABI_YP,$Y5H<U&'+#H$#"CW1VA0D;)]E@0(G H5 ,\3T0#0*4 \ ,\224[N
M8(![/8$7$$J'[1O>1  ?S$&\W!*)),W'64 .[ $=!!W>1%LF?,&I[-  H!;0
M/<%_'40XC9/R6 "0X%<&O!,EN1,46%B%8<"F<  +LA\(6)73(<"(H0$.7A\=
MK,KUN1B Q%A%D<(>O %%20 #J-T.490 G$ [@(#5&43ZD%0F3,$;%!D96)45
M%((86$><41@4V!@A.-3XJ%5.50 4L  4\!D#T"$*4 #[@%D@M-2KD%D$+!4(
MT(I![)WD,8EQM8"7'6+??94[&< %", 8/.+<L8$/L$\2'?\:Z9E>)VY%H_G$
MF21 J47$I.W;'UP#D\5#%#P @= (85V@$)E! -"B$J3!#$2(090"%B3 )514
M/&"!&TC!%:R8#:Q $#S!%: %%01;)5%!, (/?S0!&A 2>7%(&NC,(3A K!V$
M!)10 @S"BEC!"MB-(FF #4" Q@"; @Q;4B6 !B2!#XRC$-30"J!CZ A<$A3"
M$$P;%N@; .31$852--' $]1-)X@!R]F!PPE *9C./BI (V77"4B-R:Q $J"C
M&D7-#W#"P>53"ZR2\U5A)PV &T! &2 ".2I/(]$3"J@1D/" 'FA (?1/%^Z,
M#7!"&6  '= ,)SB "\[+SL" ST#_7#S8@1M<@B-!T@!L@,_M( H<3T^^HL3A
MV(JUPX&](Q;<0<O,9,_$0P*0 '[AW8Q!204DP \P#:&<&/'<@)UP8271P<X4
M @J\P=@% B "P?JE35S^ $V^  <\Y!2PP)6]3_%45!:<)=.P !OD4R,"X4]=
M6> =@0P8#A;4 -PAP"2N2@7800T BP5P@ [4@>--XA3,"PAUP6+NX6EBP8R$
M  X4#PU,XI7-H0UZXFTJ15VEW@/< VX^A"_]&'<!"Z.$TD3\2#ZU1JILP'!R
M1#Q@ST306&;ZYG2*!RCVA N=!74FQ(D-P#_*5Z(M!'!*Q L@0H"IAHU(#2=B
MA "4P#T8_]=#O&82:N=\7@?J 85RT&=^ZN=^4J=U\D13J,)O\.> $FB!RH=N
MWJ=9&.B",FB#;H=_[@1U"*B#4FB%6FAMV.=/X.>%<FB'>JAG0*A.K$=V?FB)
MFNB)^@6":JCJH6B+NNB+@D6(TL1A) 8IPNB-XFB.]D2&^L2&ZNB/ FF0MH2,
MNL2(1IJ0(FF2*JE&J&B/LNB20FF42BE#$&E+G,F$3FF6:BF2\FA/^.B6@FF8
MXFB5LH2$VJB8HFF:-FB3>NF3JNF;PFF#DNE*&&F<VNF=#FB7\L27XFF?^NEM
MSJE*7.F9_FFA&JI[L.F>NNFA,FJCND>@I@1V$JJC4FJE%H>>[O\$GUKJIG+J
M<D J2CP:B7;JJ))J;B1JIBYJJ:KJJJ+&IYZ$*$XJJ\KJK 8&INI$5/0FK>KJ
MKD*&JYH$=AXIKPKKL-)54U1&?1!KLBKK8+"04  HEBYKM$IK5M@J30@$04QK
MMFKK5?AJ29CIMH)KN [%J=YJJHKKN:*K2G0K2=1INKKKNYI$M;J$IL)KO=IK
M1JSK2- HM-YKO_KK0Y"KM9KKOQ)LP0) OHI$NQKLPA:LO+8$O3)LQ,(KPH;$
MH$KLQ=IKP,[KP&)LQVHKQ8+$MWKLR(:KP[($Q))LRB8KR'Z$PJKLRR:KQCXL
MQ\)LS;(JRWJ$Q=KLSNJJR:X$RO)LT'+_*LYVA*0*[=&6JLR>+,TB;=,6*M%R
M1*@&J]-2;:'ZK$H ;=5J;9Q"[4; ZM:"K9\J[<_&1*Z&[=G::==J!+"B;=NJ
MZ=6F1-:Z[=PJJ=IFQ+/&*MWJ[8V.+=8JZ-X";I3:+4:(;. :;I#"+4K([>$R
MKHD.[D6X;.-*;HOV;=PR[>1B;H4^KD7L:]YF[N?R9^*>Q.*";ND.Z.961.2:
M[NH::.4J[N6R;NSV9[-.1V_PJ^SBKG:*KDF0;N[Z[J*A+D44[N\2+VZZ[NC"
M;O$J[Y@$[T2H[O)";PKM;DGT;O1:+WDTKT3H[/5RKY@<+^\F;_>*+W9D;T08
M[?BB;WE,+TE4_V_ZNB]QE"]$2.W[TJ]V?"_UAF_]ZJ]MQ&]-],8H[F\ ,\?Z
MC@2N<D0+),$]]($8F,BN>(2BG 03$ (-'. ;>44++,*G, ' 24P$5X"/W6"5
M' 03("%XAL07!8D%Z$&8R$@=<!U&R,BF-40,RAQ)7 D+9&:1F'!0$(F1"+!7
M]*]#L*U&$((36$L.?,$D((#G^L0)F("Y63!70)+#11P%G\0!( %R&D0\O/##
M[?!'2$ FH(X0I((J?@%^J:=64!F)A-07_\0D=O$/8\7]LF_^*D0+W)H R$$8
M3((''  ?=((3#&$4M(L/B,P*M($#1  @!'*\> G*T!$)%X(41($XR/] PSS,
MJ6SPP'B!!0""#Q""'1A!A<!,WF!!(0"!!-6 &5D!AT2 BJ1A'\"C%\B 'OQ+
M#)22*ZM(!=B %#Q/Q$R,#U2 %,2!&#!!3MQ,NQ3,SP0-!<2#U?A++V>-R)!,
M _B2$1!" KP+*Q5G%T9/$J  #P "T/BC)Y/SLUG,W?A?T*A ", C!-"!\E#D
M#T37-\'1X_!,WNQ-EESDLND!R3 03_Y 6R+/QZS.(Z7!QQ4 (D0.!F#8X_0.
M+K7.++7 10ZT=:6-C9#,!,C8,S?/'.P2Z6#!$D@ $#X!_3".$;R X71"&]1
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M"KV2;1&; #@7('@!JRV73E(!&Q 2_G&"%J!6;%6A:K&(H1<!"]37.P%3CAQ
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M)-9A"1$2P,)E!.;FI P.$BBD2AP1D( ,)*Z5$_;899^=]MIMO]VAE5J:!W<
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M8@ 7A,A^1H,7&1"LD3((32/-I+$>/L1]&P00U2+"A#)0L$T+6E)&3 06A!@
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MI=$WD( _5<A "-S@AK()"PLP0&,F96"OSEJ@0$_ +0S*0(<?!,&#K<7"$#C
MA@K9(;%#JD,*PJI;"Z1P$#0@!! *5P?1&J2".-  #-" @T) SC@5P 'D:% !
M5%ZS<ZA,P^<Z 0,QQN-SBUA 5'\ 0PP<EA/3K2[&GB8%&(" (?52Z"784 ?0
M-6$O^)3PA"ELPB*^Q)8S.4D+@B"(9/#*$.?@@1]\8@@E\.4*:/& ):X@&$UX
MX"]DI%XF>,1B]O$R!GI2P DD,Y5J74*,R5I?GXS @"NP+P*A$@IC3N %.!Z9
M766PPOJ(%_\/($/DF73IP@X,L9<>7*(!=-B+!6KAT?4-IQ8$<TB30P#F0U*
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MD =,R.#IVZK,53,C')V4JP <  2F BT4"(B $\OD)6*.&08\'P8#@\R #":
M@R#0 !%=\%>9+TU(AXR&.AH;9(+HX(,0N,8M(802%(R@&@6AX W3Y&9>,F&<
MT2R@\J)A;LRFXQ +L( #A1B"".[1HH>\H YXC( -0S0!V3JD/_:Q-10FL.UN
MSZ- 6FL,$CQQ:T4*QO; G0>,YL$ 3@RA_PI[J  ;>!4(W.='VP;PF^/NH?A+
MUV$1&>C;WPPP@0V\AD9 H! 3LM;]]\HS+X#[SMYD,(\4< (*J*P@*IF0(O$4
M /M&P!$+V* "*+$! 'T"1X(,X@K0  ]0)5CB 6KI=FY)) 0@'H+ "&Y.!(Y,
M* YJ$CP  %X. [2"*20*YB)*QJ;""3Y "Z*EC X@!_:"QEK@!C)@RCA."<1"
MAHC,(49 !1@ YMS)BY2IR8C),C###^X!"*!@"7;%9KZB[5S@-<A,RO;B,E1%
MS4##"@B+S2  )RP$$$P@@#0(2KK [=  $ 8 !NJ@!BH !FB ZIAE #8@!P8
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MK9K "*P /6] 4R1#*(CB](!&])3N"$I%IX+@@EK #6! "V".S!J $ !!4%1
M+J8N)A% !44K5NI*:=K  11-!^Q@"%R@N+RE$\BN*$H!J38PL:A'#MIJ$""J
M%LI !A(@ 9+@#F:4<(J #E: 7QQ4:69*>^C #<XK*Z_2$!8( ML*6L0C J8
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MOI,_(Z(%G$ $4O0O/*,M+  0?F %$(99G.5%3?8$_U2J$R2C67[ R6R*"[X
M0!7),10*"U[HK?I(*\H $62*#?@ "^B6/51**"6C MH*=,L $ +F$JS/(08)
MX[#@@1QB4]@FF[I7]+A7M-XC#42K#L)JI38C#::%9O@P"4C@"0J!;8:@!#@K
MUV@@KQ K _IW6IK6\[0*"W)#"_K 0-^7OFBF6<+*!UK@5<KPN-! "P(%"_)#
MP73K!#@+"((E"-"  0)JA3^@.(2KNEZ'CFR HFJ _): "1B@V6A@K?J+N$+K
MAJV@B,4#O\:K#OS#A<!T$-@ ![!  YK@][3M"S*A#\)*?+/ KI;@5]6M<ZJ
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M!XR@ "8@ 9QJ$]T'HJ:C-2*/-#?@/#+  G"@';YC.N"RU]J-5[!I,CYDV-#
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M YQ&90]7A(G_9 ].I#6D &K&264:;\EII&)V/MD""4#E6>0)>RPP5@7M!"E
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M'A?' 6(#Y!;0$1AB/:R0! H,J" "%$#T\54*4@1AA 2(:-#6'8)^3H?P-^Q
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M A+[0>1?IV%57P3_D(D8G$ )3[A"&<:BR.=1P)*Q)..)?D(63M1.85<1 58
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M5-0*:(A2.@RP!/S:(&0@9OD6 C2E/ED  G>J)"& M>$JKWB*M6-A(PPB "4
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M$G6@V5.  .4: \'\S^V,PDS<7P: QWDP#RB@SI$"!<J*!@; 7^7: .Q\*RT
MZ=P\!E" T8@P"%W6!S?@ "$<01YL %Z+PH[2\;1=5P(@ V^>R^N<Z#+  !?P
M EJ@(^A\;DZ<EPBG/FG@./%CIQ'PJ'%0"![PN"G] 4EO YV@!!A !QA\ ( @
M'6TPTP) 8 :F,FV,"6FQ.(QHPWI@WU#  A1A)A7>]3KQ939PJ ]-5GZ %SA%
M.@3&!0D0!7QS6K75!ACKQ7XP]""-TF61 <.ZX;:NO&60R4!A.?@JL7HP %%@
M$NZ3!H70"<8ZM&2-_R*.OKQ[+0<#X/D LQ;ZX6-K@0)OH&7 P>[!QB'J <B2
MP@0<$!U<$-EY+BD%  0X$@,M<%5&P &K@P7_/"D"$,$_H ,:(@  O0$I\"&%
M(1\50\$:C]*G30B(4,H;D@!)T*X#(B&($;=8@\+_$<"[K;\D\.6/KK]>\ (,
M?%?PFO=]8"O<?#="L +N\ (,< , L4<+%C=.%@! F%#A0H8-'3Z$&%'B1(H5
M+5[$F%##@P<;,GZD:(#C  P@)[8P:!*B/"\**I94&5/FS(42:C6 25/G3IX]
M??X$"E("B#LY=Q(RX"!HS +SE"Z%&E7J5*I5@6+ P=& 58@B'YCI*<#2F?\4
MAQP8U5D "@VT7-W&E% ""H*W=>W>Q2LS1 (-/\2TI2E AJ>\#27(V%-8\6+&
MC:?&"=!1<1F.#U@XQIQ9\V;.G3U_!AU:]&C%3");7ARGWP,-+DF_AAU;]FS:
MM6W?QLV52:< D1EOJ/R#"9/<Q8T?1YY<^7+FS26RT' :2N.-'/5U&J!A -_M
MVKE_7[%]@/CQY<V?)X_^?(+Q[-6_AQ]?_GSZ[]W?KY]?_W[^\?&3_Z\_ =L;
M+SSV# S/C0$2S*X[![_S+L(')81P0@LKQ)!"#2_<,$,./_0P1 G3&[!$]TKL
M+SP45V2Q11=1#%# ^PQ<<#L$!U"0P0YW!)%'$7O_!/)'(7TD<D$S'CCM!\>8
M^*&RT_RIC",HHUSM@=7T>< ?5:#D,DLON<3R2S&[G++,,0. \LHLL21S3#?;
MA/--.=E\@$TTZQ332SGCY'///;>T$L\KT62ST#4/]<?01!%55)4L'=7R43W[
MI!3/12]5M-$TD?2GMTXY6BVR*?6L;%0IHR3UU"A-3;555E]%%=958Z5U5EM+
MK1776U655,M*?;743TH!!19.8HD5-ME?E7V4RV.=A;99:8M]=MIJJ8T66VNS
MO;;;;)-]T]MMK9-RRSNK[.>T4$F555=W>877U5SC;9?>>>7=%5]=3ZM, ^(P
M@\*,*B,C&$F#4468(WX5_S:8W]-.<_2!B".6N+*("TZ8X8,AMMA)C2>NN.+(
M'!W9X(L37KAAD5?&F..002ZX98UCSKAFFV_&.>.'.:*88I=/SCEHCQ&FN6B5
MC4;Z:*639GIIIYN&^FFIC29::E2IWMEIA!T%.6&N>7X9;+%#IKEKLTT6F^*Q
MHU2[XZV]AOMMN5%M>VVWZ8X;[[&-[CIOME$6FN&H!Y^Z<,(/-SQQJAF.8Q[.
M,"AC \GGF;QRRBG? //,*\^\BLXW]WSSST,W8(/23S<]]=(W\)SRUCG'?![/
M9T^===-='[WVVE</W7;?5X]]\^ OMWUUU&DOW7/4C9><=]MIIUWVYT$77?/J
MA?_'GGCML^>><@.\]U[UXL7_/OG=<>\^_>TU_YYZZH._/G[XYX>]?OGMI_]^
M_?/G'W__[R=>^6XWO=#A#GC7@U[N$A@]TNTN==);7O,<:#X*2NYU#8P@\Y@W
M0?&Q+H(>[& 5/BC"$([0A"5$(>I J$(2LO"$QWO@ B5HP=2U4'PV1!WQN">Z
M MJN?_O[WP^%&$0B M&(0UR?#)RS1"8VT8E/A&(4I3A%*E;1BE?$8A:UN$4N
M=M&+7P1C&,4X1C*6T8QG1&,:U;A&-K;1C6^$8QSE.$<ZUM&.=\1C'O6X1S[V
MT8]_!&0@!3E(0A;2D(=$9"(5N4A&-M*1CX1D)"4Y24IF5M*2E\1D)C6Y24YV
MTI.?!&4H13E*4I;2E*=$92I5N4I6MM*5KX1E+&4Y2UK6TI:WQ&4N=;E+7O;2
ME[\$9C"%.4QB%M.8QT1F,I6Y3&8VTYG/A&8TI3E-:E;3FM?$9C:UN4UN9C,@
" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g22122bgi002.gif
<DESCRIPTION>G22122BGI002.GIF
<TEXT>
begin 644 g22122bgi002.gif
M1TE&.#=AIP.Y!'<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M0D8F" )""(4*6W"! _"T !TP@8%(R8$*F+!!  R@ B#8!@<7PHT]N( (%+&
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M -4JUK<8<$$)$O&".5  !/GU+1?3(,<U_. !!J@T(.J0Z7M> 07YJ/+^T/B
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M^, #5[9^ _] 23WP<"+0@QX !0>4"!*0#T66!EY@6G40!V*  8*07G1 9B!
M9P<4"+-P!"! >P]'#:36>3ZP2!,8!"@@!G8(1 0Q05N8"/\$0TJ5 )@F!G.
M50,@ <+@>#R@A2S@ ' '1')4!W?P=#+  W]X>@<P@=UU1C[G!/$P!98$!%@6
M#WIP2V35BKCX0YA4095G5SL@ R/F <KG0S#00GP$?#30!9=' W7P _%  _K
M @I !5/@=S)B +_4 (FP!2(P! <  5$ 3 < !"K  H(8:$#40B#P"A#Y0P<@
M1R+0 PH0"R'0!;4W &JEBP3!#3K 1G1EDKZ50G%%5W9E$,W4 X'_L =_T  =
MD$-+5$,G$ 4>^0L$Y5M51P00X$,E\%Y,YD3\ V*#)A#@E #^<%7F%%A."0!
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MA7L *"0(L=UOY1B7C'M M=63Q78#\I2Y8D56G:L#>0"-%H!5:86V@44!FG
M-Y (-Z!>)+( "9D(L.!4#PD+-8FH]NQ,IZ9@%S9Y/=AZZW< OT#1[L4+178!
M":2 8H +[Y>\@1JIV*O5@P "2=  ]JUBT1NF(P4& !31M19\(G 'B 5"/& +
M!-!B:%D!*F"+_###+5!D/) ":S !X29$(@D U@E!!J"%2]#D?\!I0E0'^#!C
M@""60M2#,A &.;1[C$9H\M=Y%&"_OGH 3.QAKL9&]S2)Q @(>1E; Y7E#?A7
M5,Y0"A#4$2 &?B##!(%N]/\40$N$PD8> !?HT@(H!D![!4, =Y,*CC?0 2KP
M!V.  'DH!= %@TO7!??'!K3I4*]F6WJI1G4@OWT%?@D 00:A5('& [(*A!ME
MAA)\L07E1L@Z5EJ8 9*.7[!VK&E@!E,@ZP  74&V2'H.C@= 5H)@Y6A\R*#E
M I(.0E-TUC%.:4 N!AI@!?VF2DE4W#KE!=89!)(>!GEPR!5+:8RXA+TEV .U
MI%O@ _/G>>"&3!:$0)4< >CKM%8: [.EWDLXZ&.@ 2HY0:6DW#M 1S# RE;Z
MRG80RUWK $\GW"XM",(^!X"0!W> 3/UU92#@!"/ I%+WV'-[REB'E6^@:?@E
M!DC_7$AYID^$[@0Z+ RS%[AF5;<9&7O3: $A .. ]GY\)PSF#2-XB@2#&J93
M $T?YJ:M5I%N)G;&]'3XQ&!_! ^ D*BRI 1<T 5$0 <2MG'_U "WFU'K"D,Y
M0&7C^]@J@,_-5(!)E'%(NP20:D,?M %-8*GK]V,>O\R@%I\+=FC5Z62^Y7GQ
MY$&6!N,!^U#O-WXNEE,=9@9KL,NY-VC7]O'%7(9%F]-'4*S""D0T16V1-M04
MJP)@P /YTU$YM:!].TA-,)9VB5J.Q'QCA0'8&D:AEH=-P $9L T&8&=>U-:A
M=@2+"OS;,$87KFHZ#(8WV*^^J804D+ EGF(%\;,+-K'&_\IN2SM;4V6<;WE&
M9G $@^1T.06"R 1GY?X"FU[0>J\'/]"7/9E>@UU;3$Q]&)!56$\!?X # #%
M0@L*@):D.1!C3P0R  ;@64CFAID]>7[$T]!CP:PP/0:8.4(AB!4< $R:',"Q
MQP&3!#BX$70ES0, !#H$&7)2)P J&$)<F<"ASBN'\*:P8.E218(K35B:I*(C
M"!*=$+;406- *-$!.?3$4> 5:4T=5XC4]*,B"(\78>X,H*,$D! /*5R,H+)%
M" R=7:<X.3# 0@@G#P;LT/.&Y8(7,"TV!!!(B8J8%Q8W]K&)P!87,+A)/2M8
MT!V'"@7%$4-#DX,3>CKOA!U;]O]LVK5MW\:=6_=NWKU]_P8>7/APVD!4O%%
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M@##TD0 0#$&/0:C:26XPP7[H0VX#W./J ""!18Q!!19< 4%\L!+CM?10L8B
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M9X)YC  /8^B1&6Z7:BQL(W<?\'"!'5*P$9A  SD!P GX,(2-V"$18C#/N9,
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M@&CLSCMR @= L&#<QO*T$U.4&Y;PJ93[M+)*G\ )*BYA@R7  #-\3^6)-
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M6H/N:98*H"+$2A<)H!K4V8+_[D/(<,3'S3DKZ?F KJH=!3(9A#2)'*"K.NJ
MR"( &U 6$I(2)U$F?T$LEH  1CA8S%H9)XF<:W&!"Q@D%:6DB%V Z^H9EK
M.=@>J'F '$  1K4'!0#)#>&<3<D!@JNVD26 %G DIT2P0$HZ>E&(_:F=D"O'
M@&NX.VW*>1"I,_4P 8BPGG DM?R(,-C*\C-:$**X!SB!JZ0)UDJ)_WH .IA!
M"/ #I%N0*:W44W&=)$@7BQO.(U"6R6P5 3!76Y"61MVFG@@GK[N"U7E4T^(
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M?_(W__:/_/<W"0%@?^F_!S'8"?LW??G/?YT " 3Z_/73U^]>@H,%"1J\)P8
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M7  BX@3:(S\&2_TA!SE^BCDR8S\6I*XH81[:8A<:)$,>9,1IVSQFHQE>$A.
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M!X1 !OB!77H!9'KG!+Q-B5;H36* #R!1F3KFBF!G%VP#V=CH1F)GFS8- ;1
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M+KUJS"8!'ZC !_@.3G:!&!"WMI9I1(<!!<RWS6QX'N!""-1G-Y.M<^-"'$R
M!8RF%!RX((! 'JRQ( C!='9G N1!&&0 +G"!ZH9%4-=!D%- 'AA!]^:#Z<+N
M1--WHP)-+J4 G^<!/ER0-V\ RH!  OCDT;PF*UY!!EB! LCH%1 !M((1S]
M->0!"*QQ *C, %@.=0MZ" C"4EJXS)*!<>:YA@)"97\-3@8 R@!"G@+R%+A
M37MFVS(PH8<.VG5B3(\RV V 1VKD">P!$VAEZAQ!J*,D=C(!?';[N-]G=FK_
MJP'(0/U"A(S:=C9OC(P:9FF_+;ON:!P\K;\JK:F*-A)=4E4>)KV2 <B P&3'
M (Y;#\W.S8]>T#03[D9.\YPN;G9JIGH>07("]Y?B<9G.=],"9VKX<&KS0(7S
M9S4 J4S*P ;$@;&39Z1R3@BH=F"\0'-ZP(Z><0QL09^/#6763W]:>G\BT2 G
M9R<;S:L+0E,O@+F".'X&I?<(@R!D  ]XP IP0+$'WBI[B@;'7;<7=]!@0 A<
M;TX[Z(KLIF:6/;BC_0,H.<;;JSO?9Q3,@!O%0F->^1W%[ >\YIR:C1[$P0KD
MP[>GNAN$M:R"9+<'03^7#JA6*%*&]8U#_0M0LYIV_[N#'O@57/D.JVA89"[-
MR*G1MFL2.'7%R/%.+;@4(?+1P,-(E[0%$&P:Q"VUAR\7Y $"S+Q=GS,3-^@'
MC.O(<J>[$C3"*\ .T$ =Y"\!>,,&-#5;@H"T4A((()$>>_(I<0"'O['<V68\
MCPH18OO5 ;(**#Z\JP!; X#\@H$!;SX9G( ;H/_9IVC;N[OJ-KGUS ^DLW "
MV+9OXSM/5S('_#U K)!1YP($#$Q^*."@PH4 %&/RJ0B2)D>4.AG&H/!S!,2/
M P,X<!%"! " '5&"O!I@@<:,$B6I8/#1!*2*D247=! 184+)D@,D1.ERX4!)
M C)$Q'E@( 47%F1\1O492/_)E 1UC!25L*4+&@ #7@@3TL"GA&I=)6"H\ZKH
MSQ<T$@3PT:.M29122D+0X<-.(B4[H7X->Z4!@;\L')B@(>0E@ 6S1 B90*6%
M#XPHL!Q)JL",L""-@6Y)D !$$R]24:=6O9IU:]>O8<>6/9MV;=NW<>?6K5I
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MPJ(&4.P**7CT(8ZZP!+F"AXPV( %&+XR^)6\*OM @5DD)LFQ.87 P;"=O)#
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M_KM!,:67&Q?SUI__N"'2J30D %Q CG9E;(KE(%ID(:@NA *M.X1"\Z)BM%I
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M;(7S)N(GGL:6W*M$&8U8H'*3Y(9?;G0 GF8B&O8&Y"9)KC2 9N0\698+, <
MM,X#T<=9_.YF ;-9LK R=99P+(^$]FT_9PX>F44G'$EG%T(?*#$"NP2$Z("/
M&*-V*&"'3*?9C)4'<:(INM.EO*DHNJ[>6H-!./4%KI136:);>^(PW<#VYB4H
M_T @R4B)&:F5*CKO)10MR 1.BKH4-=Y/$';H!@S$<'MB 5Y )!J*<*F@&H)
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MY2_.3E-79(!C> .C["^#F)C_B.A51IF+^.6?&LF6O=A+[$V++L8X6X )Z&(
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M  CH !'GP0$ # UTX!(!Q@ V*GP8>< PXPT+;H(,R6A01,*,$O_V^-BV,",
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MYHSMT J79-B9$A0A#8"-H[510>JZ,X <"$!UVKG_08+B?)D;S!G2437 +-J
M38S^N<Z=RTRP'$BL15CF3-X88GLFH@G#+6P #GD#I8<B:20U,,8)GK%X" "+
M>_1C?[JF12PTX8 ?,PQ#*?L. 08Q!)"*9P$=:()P@+ &38;GSA7Z(#S6(&M8
MWR#.INF'KIFP/(VP(0Z9M@X$^% A>"RA 3> APIT?0\'O5H[!O"#%>9M6PN
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M%* /?_ TT'9$+& +?*(/=5!#:H8"A<0$'Z  $+ (U48 ,I!G)4@!15B&.B
M>T !/B!()[ & F"%9C0<1+A+!',"?Y &"\ (8X"'L.(%[E8Y.'-,6O@!*L0-
MC(!]19$!<P "3< !Y/83(7 /.--F<Y*'<B!H#T  #4#_,.H61C:1-CZ !A*@
M 0)P!/UP&PKB<J!8!Q5B $J@ 7L0!#S@!_A02&.Q&,0R-LIC"\ T-A;1=0R1
M _A0(2=R!()D 'S  V:0!!Y0) '@#RRP _- C'DH9BIA 0B  %,0 "ZX$B_0
MC&0A =*($24A2'NF *64AVIH "F@ 9H8;LS8-V31BXMT@G&B&N^6.E3 !S.A
M)7S0!V1P=WZXCKS()RW( W6S:T+@ 0UG!C2P:\HS"_-PC#& !6GP$&ZAD0T7
M%:6$-)51)6*P!!=(+V_7$$[2@_72*5O0#TP@2.,R" B@ OI0*U62 BXP!X^!
M%45#(JCH!QAG:1HP#QJP&#?P_P+SD",GL@5:6"L_X@=R0 -CN#Q[$@(;D 'X
MT ::YXZ[5B\24 U[(P@98$K^L$LGL@<9:2L<X +Y  )H@ >,D ]!"3MS004I
M8BP3,)B29U JJ!+PH %$<"=)$ 4]J(:T80'"T!8N0 2J(8A2F B3<0_TT@&G
MLS[002Q1$#,P<B*+<"5%B!(=-QD)X )C$&U)X0T1\"OTHC*%-H9A%PC>L 0F
M40(ET3>QP@8N@ 4)1"HW4 $;LA*>MRRNF4""\"$W$ ,N\)PY0 \34 %MH0\N
M, &\4 MA(@C,>0-^<9J+<7-"H$LET %O8!"[YFU@  -WHH5.\Q/]\ \&TAY%
M-EFV9O];Z.!Z9-9#&,$&+*  6185O.!J&0&#K4)L(@,"FY%E#\!LL5(!@' '
M$U%'\'!-W  ++E "-Q +U[0N -"@ ! +[%,E40 C0* "^ 0 !>H%$^&2.7!-
M%:HR;! NS_:B+B&C=/,#"C 1<:  [H::%K $/@($7 B#L', )Z !%Y (O- $
M+@$/3H D!D""XS8!& (&+$('&B!]0. &5S.B#< T=12F%0*E#8 A"+,M41H9
M-I SO5<G&'9N%U 3;! &53H1M> %;_@#9:%>@2 #,\%L((!UT+AO@S1-@W0$
MO[,#"64 90( 9^>F':"H-^ 0() 6V-B("?5O:2 !\] F3U?_=E%A E.0I/YB
M!6E@ 2B %/"P=OZ! 5?0?/B@-$01 T?0(POP OB IB8@ $]# 'Z0!(' !U:@
MJF[ A:'! Z0J!Y\JI140!KBW+B90DJF!K#7B?(P1 XX$$GQ0)P0P"_>V WL@
M!#!P \3: .&:!BH1?BM!KJDA!CP0%2_0!^T3 R+I+X5G &-@#7V$!2BQCVTP
M BZW(J6!!;27/VA2)7[P"@0P!KRD7C81!@EA:?@  P[Q& ] !W[P(<2R:'B!
M!;&(!5(@ 5B %.9:<0, L9;6!@XPF+)1*0@P!#;1F,0R!<JB$1![K.("?XHW
M/Q*0#ZZG>(VI&IL8&3LP!0FA>'^ _P.!D (?TB1)$(9O$!7P, \B9STR0 14
MH ._(P$RD'XN-W\_@A$&50.JX01*MRX_ K:TH:4K,7L'D!DL "H6H'_EN09$
M<")1H GF8A ($QH8, 34J0$$ :4ED C\4AB'N1)*T ,#\ O*,0! 8Z"8AQ2;
MAT91L1,U(**?AQ>9YQ^# !H84@=(L1.$, ! L A5 30S=W,@\!&)@',JP6R5
MNYPJ\VL.8 %"@!$WL'OZQ5^&I4'3=1ZM!X$EM! G0 \P$ L^6R6BEA$YZ"A,
M-SR]RQ %NH:+D# PV ,YF#!,)P4Y:&HCVA^5>(2WQW'+Z05()SDGL @-T'MM
MPG3;0 >+T/\F,"AU?-@F;-@ 0* 8#"' ?*@T]_MPO""E.D"D<S%N#Y #BC&D
MSR@G7*AF(U'!?'A\6G<!5,"_*?$+9'$"3J!\.L"0S,8#.*!UTE>)TC<4!+ '
M7! S.?0+Z[80OT!NM/I\ERIW<K((=0>-8[,V(!./;>(O&N!L6F(#,-P4TLAL
M9ZDE'9 $EJ%O*X"-'#<+/#"IVX!F S +*!"H'B #&5 5%L #9!!WH!$#_500
M2@PB?! )/F$!BX8M /=U3DRK:? "8FP 'I /=AP#8C !Y\IQ)H "MC +PJH2
MW+"0-%&J5:%WJ10+*( ?+:>2*S$&#PD$&A"@%-L$9H %EQQ0A4?_L0Y'=_G:
M!RY!+"@ &BO[$:"<"+.0!#1Q @5;;W'P?I<&:00@!G80"!6K,SI[R80G!?OX
M*<3#!SE"M"KS GL@ 'SAR[T!3^DW%W@@DE1 N2WG!SWP3,*"S#3I?I:FRRNQ
M>/G*?@20 CV0"!S0&IA1@'-Q C*@LHP '095 GB0>?#'&++HF)2[$.VLM7:2
M OX'$I2+ST*!>?='%"_@! I @*T20(G+!O,S$2K:$"TPT'3Q!GLR?YWY!@Z!
M3^T&HY6B+": T53 "#4 )IM!OPS-;+10%)]W(K-9? ;8 3 * !7P!DPST 51
M@+:G"._'T_F!3VPX&]R  5+@G/!Q>A<4_V)6IP/%!@#UH'] 7 ._H#C'HPU6
M!(.73&S*^09G] MZ"WM+TW140 ,PXSH;T ,PF'!,\TK+ H-ID @Z*,(P<FW0
MP88E0(!D<SD]D .S.1>W)QQ[;<#U:P%YXXT)  8E,-B+\1]SZ!9N_8:_5]83
M4(EI\(;'QZM_V0\EI'61<$9G-P&%>)54^@*>*"=8RJ%NZGM+4P%!ND-@,R>&
M:"'G%G8JP:7=2VZS_79#:AE?MZ@^[+4F4(T$00?X<'QT,:C6HP0JX ]@L W1
MMRS!=V^,Z@$IHC@!T",Q@ MM$$8UX7P2X $>(&BS# 5% 48#L,95 G $E,49
M$7<Y$GQ&L .WE/\2=(!N?H<$5'#>&O #B< /4$ DE-TW++ "L_"0*@$$CK3?
MY'< WI<_'( +@L3?=6)IZ%IXYFP%MO "%UX6Y\>Z$DX'Y$>A)K"O<P$/6$ 0
M>E<5@1<(*%!WIWS*&&%IM:QQ@> ',K1+>(L!AB@<"]"OT&$E/3#.#,YRQ,('
M3,'?&9"Z_>H%^JIJ33(';R0;$( %DD<'8M #VBQYZV<X ]#E;I"'O0%_Y%P:
M7IX2C;< O[PT>-"8LD3/9D"$IH,P8 X!D7<"N18 WHEY$X"V+<<!;T %?AX$
M8=M_[W10MR'GNK-%;$<'M$0!\$*_T&&H0S#H+'[5+=<!\Z<:'=V6VB/_"&]
M-SEW<P'0W=[I>;X1>CJ0L]X+@( "3V[02N*2HBR7 YDW ! 0SP; "SD'P2SP
MN$8WQ3T=[!>2[ %END @#&Q1-D.P -ZPE]-W&3X'= ^44BMF6TV7$4@''=Q
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M;1(BH+X3-$@C*0N2F."$/Z"SX;R/VE-@@0?1&R"6."9X" (^MD$/ #:2X&R
M$$>(98G9ALHAB?"DXD&Z%<,;Z@8.K-A! ^PHY"$0/B)QJ,!M*+0B,[F2\.*C
M!&WI@(<C_1J@QB:'6F"6,?J XDD!4&!@L 2)6 J%D2#HXP*G>DSJ0GRD<(B.
M/K8A@ \( <A!CA(&H#*)*]D00 X/R+"SCXY\FZ6/P2#B SLY4; O!A1*(,P
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MA75:$(28>40"L#*(588U+X^P"VH3'9T%PG '&KD =)'+B]\^,M*34&$0+%"
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M !05;//80P!\@,ZK9'5B5P%"%/K1A3&T80*)D %Y*7#>R'T'"Z^= ?1R%H(
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M%U6=!K&>T2W=#GJQ"@@8Z7$?^"$ ^R&:/&@(N7 =$.F!US2Y=I*+BQ"@U+4
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MF1Y(A+O""J% "958FX;4J4HB<"\0KNS+F;";"X=P<)"5@#F(6%^YJQM@C:2
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MB 4HD(![)&"$%@C!>9MP@"RAP+P^")I*MI" #<1!!TCH;IPJL 0,,.FF!Y'
M'BC0CRX@ 0);Z$<"OI@6.C3X#0HX 0;<*X1,P6U7EG*,$N@K" VW1@XJZ(<+
M2#+'$=<N! '0QP<,% )_="%2P$-P/^H@A0/_4 I1LL*(A/VQJD0UD@)72,&K
MI$.=8)TD>2%(@! PT 1"I>2R/% 3'5K@7A?L"7\J&*%BW?#E3 F*.BF1  ;\
M@5Y42<"\@CBR*SN@@3E0P <)/4$;+GF5+?AC RQPZ(+G *>_S@->"V##E*^
M@"20P74M",$]ZA!%-JA 'XY.0L/@]@(SZ]E2%DC";"2 #Y)!4P5=X$$*>A(R
MC)3UQCYHPHC/Q&;W4H8B)J"!I6$B$Q,0YBI[D'$0+H 4+'.P \0VPE6P8"8"
MI" $@KA"5J9TZP"  %X2$(#73..-/"]A#)%XV0BBMMY$Q2 *>I8*3CI:& +X
M8<5U&)1.&MEC.XWM_R"!>)R#:)" *R1!#!/0#-E<UV$W&R$07@Z "U!MZRA0
M0!!"*-UE.CTW.PQ@!U=52VS?0I'$19K-_9#X;("W!R "P'*8,[F(0N/O(*#
M:"_Y [+%(KL-+Z)AKNM<:-PP<B?8X@4NJ/E#;CUR#!I\Y%<@B>]@-!^;,Y8
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M -2!$12G'\BH/N3!)6D4W>EG(+B30;Q$&SA$(&QI$/  87UI /P!^CT$ 7#
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M;%!4$-5?\0$0O03*68 >5$I48"H5M^[,R%0++-T ?(;VM-C_50@ J-@D?4B
M'Z0!'A 4M6Y.+N7!72P+$,$;:9CP"A3FA8!-8U3N ("6@S@!:Y+.3U0N ;3
MM@)NI8@5$.G440Q."6AJ5[&!SGHE&P""?24/7$@ #2C1#00"!MPG81&!^N@G
M$6' !R'&71Q'#TA=$-!I(K!'H/C(5:RK'>]!R-I5#BS"EA@OA% !+&"'84GK
MREP)VV%6N(BJ+W<$]T .]WP0M4 .E>P(%4Q!WIFM2_"";XKR,BO/0_$/)E'
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M'DPDH(,<;[# "0<288.%'199D*$! FEA"(<(_X"R(0,ZV(2*15ZDL<C)@C2
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MT$ 1"!(?H&1U '@\:  Y$$843W"$5_@D$+8 P*F:(L8%\()79!S@*PY  !V
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MKM" \IPG/1NB0PL864CC7"=$A#!,B6!"'ZLJ@6X(;:<8"52?1+1Q%H1MDO9
MU((K3""A(,)=3;:SFJ)JX$6#301\'LD&$+!Q #N8 @I/8@#3-D&C*;!#464
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M'T%&F@ZV084M4"  0%5E#&@0@ W<TERV4HBQ5,"$5_C0Q1W@@I2OQ9P8N"$
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M(C,2CQP"'B+ 0ADL)6H!URKF7T:F$4_34=;-"N;/):\3,GY&A!A$#@3$H\:
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M/F-L5Y.E#N"@*R=R^N_^_" )/""<2\4IU@-$6"K%,$ (&F"&;^"Q4@)R..X
MVRH1='-PFT.7X2L%ZD.JAI,*_,#_,LL Q,#KP#D.X&N;?21!&N"DXB,&\F$;
M1HNP!J#KKHNN!D)U\X"-M/%UIN"FJ4 '7."]X"$??"NL/HL(IL0%FD@"\B%*
M>"<\?X*M;%H!)( &6  &#E(^3BFW$*M<.,#\%O<5BHXA+.FDM@<0?,1*VH=
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M..+%XD))H:5+W(X/=>> C,E33*(7*1!Q@AXUQ$*8;_#))RQT'-*C/8.\(9
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MXTI8\M$*"L"7]LP"+0N@X)9S=,@ 9&F2&,B!"*ZL6UEF884SS (%5ZI:'W!
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MO*K>>),T @@,'63@K!F#P$T0N/*$^9 $[!K %MN!0+;:92>=(<!- TB$+0;
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M"!FP!I_$!BB0#RM1)M_A%T-K1J3QB$&@!"R0*9WY*3+270B%*7'H>LUW'W_
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M+O7>8#Q@"TH@2K&T\3.&DZW"!K'27(%T&AE@+2?& 1G0,S*/%C*P\7#3!D1
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MS0>H@/,  OQ( H<;X-% BD1N\-&&'VQ1(-$F$N$ 'PEOL.6&0P^@0X,+*@6
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MEHP(2.5G2-R/>]"X'_K8@!0J(((39^0$PE $AD5) %BX0"GHW8(BIA3'&]Q
M6I(YP1Z>UIDU@<!%\#@"<@B@ Q>(.!9'< G%FOSDR- ! S/HC>["8 <R0R9D
M3@9 #&ZW,&D:X 53Z($"+#"%"P,X=Y=9@ GX?("1__QH>Z0Q  = $+3,W, "
M>O@## ; +!#$805MEN( =J '%F#ZI%L. @R.!^'/-+D_%A !BS<CIO(J4F(#
M,( W0-!CS-Q@ &^+A0AHP1<"5 ,,1U9-4(=[Q4*ZQJN;&=88HO"],1"K C[@
MSTH@ &0AAS*68 B1+0D0I25K50(8:$*X*D.'/<P V)SA0!CV!80C1  '!)"!
M"XAI$ MDF<X/&P#C?E!MR4 @'V@6BJ##7)FI+,(B -C!'@8\3:\,6LX1Z'"M
MV9"!"%MF*H/.2*+SL)?1+. %>AA09@80"T@OA I1^$/$K;BJ*3C! 9<!=0-B
M#8(A>";1&5#*R/6 LL^0=_^,%#, +\! :XN;( PYB04%WJ 3$H/!U=S$6':O
MV-#3=L8XLV8(+VA>32)K@@C'%B4$MF#D.MZ #6&0VF6B'&2P=R8'1VA/Y;H<
M0C _P-.BJ?? Q]T"@'NF2NJ^2 YNI_)>!AKD=[<, ;QQZ*+K@=$8N5X0.)[%
MJ>A!",&1P"" XVT]1 #Q& D$E\_=F1O$?)0D!L'H*7.#F9_X%X+8=2.Q.NPJ
M;G6N=159%GS <>'X@ <I4$'[Y#-M1>#JVXZ+S\LH\(%9N.%[@(EE%SRPAS<H
M@ #-GUFO@, %\QX@%EQ0A!E4H W 2$<$>3[ICM$?BQ P@3_" 8$4> 8&#V!/
M@6__/CX(]@T >  B#F*(@@VPH-F"!_1H/A$8P!O@A2#@@19H#SL[ @UJ HC@
M&1?@ 0P( 062#PI#G4J;$2Z[P%I8@4&P( OX#0K,DPN0#_.0 !F@  \D-Q]P
M&^>PH':1@!8(@4H##$O9G<MA T (M^MXKQ5HG+EB@GT)A-WY'E<YB1B8 Q&X
M@G@X@APZB_<9,"!P R;X%H%3@'3;%_=R-P=S 23 BR];@C&@ 1  DUB9!14
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MX( U:(!1+,4KJ!V;Y)P/, ,N\/^'NI&2'/C)"5$"%1 $(<"/ ?@Q%GB!(T@
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M@H-A%@;'&,<T.ROKZKVX.#N YY-"UR4(CA1Q@H(V#W0%Y4[1 5:V97CD&CW
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M*RKP@0=^$& -(* #0 31#8 @F8THT#<&I $(>G""R/1)LA^)2A!Q&$,4^-:
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M: <7LPH=,NV#)33H! L1F<3R8.ZBG*R4.@A!'0BNI7<+@F/$D?_95S(B@3D
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M^)T_  WXX^^B!YO80!7^];.__>Y_/_SC+__YOSVOTP=]7G]"__WSO__^_S\
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M 1-5+/5<B_#PP JLP YP'#ZD 1B)SP\ YVN\$@94Z] 2+!/QPPJ,8JJ$ 2"
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MNEHR<LQAP>!)\ IY%G/:]%(=O,(+FL2OC#?,]4,=_!E'-K-[)QW6'* B)J@
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MC!8_I (#+/^5PF,,,60 9(DL$S*@ Q?0*,B %D#0SP]\NLLABK5X\" 1,U0
M@0<_W CBLQ?T^.& !68)#0 _H31 B2"V 2"0%JZ0Z80]EAA!SK48.'0"4.$:
M($D[#D!3-1H2R* !"Z:X @5*77B* "7JB&"%1&8)HX<!Y!0D@GCF$.&- ZA
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M-XB*/.N _G>L!<&X QA@%C3P@1&@I83 _RVA :.9$X$8-@= U.$'XD.( 2H
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M?0QB>_9 !/*&,Z["!8H@3T"@"6Q!48ZG'RP%>W! *H"D1%P@#6Y@ )SC?"Q
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M3G'SAKBV1J)$3I:@8G!3:MFD;8[%6TZW8NA@B"8 -WT@#F371$I)C)C4B(Z
M,)5" M($,']'!FXW6] E.W(G#A*A6VK%!,)&/"]M4]FE(S:@*_?, 'CA*+D&
M;'K@/"P ?,X ;*,$<7OGA1:D($K'2IB(0+3C+;4C##8H%J;@ PYS14U*-E(
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MAU=E66P]\PA<,T!P%7[15E?)MY9=P#Y7P!:H8'ZK!#[!]CF#XF GH&0#%"=
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MI"U9>L*'2'Q@6H_ )]2W((+6%N977H=%7G'&(!3%B6^D6QL@*FE@)\1  W@
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MJ=*E3)LZ?0HUJM2I5 4."$,2Y%%;%!+X6U$UK-BQ9,N:/8LVK=JU#F^0_Z0
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:%_CBCT]^^>:?CW[ZZJ_/?OONOP\_6P$! #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
